Processing 00000000.tx.1: Transgenic Mouse Overexpressing Syntaxin-1A as a Diabetes Model Patrick P.L. 

Phrase: "Transgenic Mouse Overexpressing Syntaxin-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1420498:SYNTAXIN 1A [Gene or Genome]
   804   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0450344:1A [Intellectual Product]
   804   C1553633:1a [Medical Device]

Phrase: "as a Diabetes Model Patrick P.L."
Processing 00000000.tx.2: Lam1,2, Yuk-Man Leung1,2, Laura Sheu1,2, James Ellis3, Robert G. 

Phrase: "Lam1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335808:LAM1 [Gene or Genome]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Yuk-Man Leung1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Laura Sheu1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "James Ellis3,"

Phrase: "Robert G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: Tsushima1,2, Lucy R. 

Phrase: "Tsushima1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Lucy R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.4: Osborne1,4, and Herbert Y. 

Phrase: "Osborne1,"

Phrase: "4,"

Phrase: "and"

Phrase: "Herbert Y."
Processing 00000000.tx.5: Gaisano1,2 1 Department of Medicine, University of Toronto, Toronto, Canada 2 Department of Physiology, University of Toronto, Toronto, Canada 3 Program in Developmental Biology, Sick Kids Hospital, Toronto, Canada 4 Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Soluble N-ethylmaleimidesensitive factor (NSF) attachment protein receptor (SNARE) protein syntaxin-1A (STX-1A) plays a role not only in exocytosis, but also binds and regulates Ca2+ and K+ (voltage-gated K+ and ATP-sensitive K+ channels) to influence the sequence of events leading to secretion. 

Phrase: "Gaisano1,"

Phrase: "2 1 Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Canada 2 Department of Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Canada 3 Program in Developmental Biology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1709697:Program [Conceptual Entity]
   753   C2728259:Program [Pharmacologic Substance]
   753   C3484370:Program [Functional Concept]
   748   C0033333:Program Development [Health Care Activity]

Phrase: "Sick Kids Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Toronto,"

Phrase: "Canada 4 Department of Molecular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Medical Genetics,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017402:Genetics, Medical [Biomedical Occupation or Discipline]
  1000   C1555773:Medical Genetics [Professional or Occupational Group]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Canada  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Soluble N-ethylmaleimidesensitive factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(NSF) attachment protein receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0300824:NSF Attachment Protein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   756   C0169272:NSF Attachment Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(SNARE) protein syntaxin-1A (STX-1A)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420498:SYNTAXIN 1A [Gene or Genome]
   812   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450344:1A [Intellectual Product]
   812   C1553633:1a [Medical Device]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "not only in exocytosis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015283:Exocytosis [Cell Function]
   770   C0205171:Only [Quantitative Concept]
   770   C1518422:Not [Functional Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "regulates"

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "K+ (voltage-gated K+"

Phrase: "and"

Phrase: "ATP-sensitive K+ channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1708601:K' [Quantitative Concept]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the sequence of events"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "leading to secretion."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.6: Islet levels of STX-1A and cognate SNARE proteins are reduced in type 2 diabetic rodents, suggesting their role in dysregulated insulin secretion contributing to the abnormal glucose homeostasis. 

Phrase: "Islet levels of STX-1A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "cognate SNARE proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "reduced in type 2 diabetic rodents,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0441730:Type 2 [Classification]
   753   C0035804:Rodents [Mammal]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "their role in dysregulated insulin secretion contributing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "to the abnormal glucose homeostasis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1326961:glucose homeostasis [Physiologic Function]
   827   C0019868:Homeostasis [Biologic Function]
   734   C0580546:Abnormal glucose [Finding]
Processing 00000000.tx.7: We investigated the specific role of STX-1A in pancreatic -cells by generating transgenic mice, which express a moderately increased level (30% higher) of STX-1A in pancreatic islets (hereafter called STX-1A mice). 

Phrase: "We"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the specific role of STX-1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by generating transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "which"

Phrase: "express"

Phrase: "a moderately increased level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "(30% higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: ")"

Phrase: "of STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "(hereafter"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.8: The STX-1A mice displayed fasting hyperglycemia and a more sustained elevation of plasma glucose levels after an intraperitoneal glucose tolerance test, with correspondingly reduced plasma insulin levels. 

Phrase: "The STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "fasting hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "a more sustained elevation of plasma glucose levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439775:Elevation [Therapeutic or Preventive Procedure]
   744   C0702240:Elevation [Spatial Concept]

Phrase: "after an intraperitoneal glucose tolerance test,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   923   C0017741:Glucose tolerance test [Diagnostic Procedure]
   875   C0337438:glucose test [Laboratory Procedure]
   875   C0595310:GLUCOSE TEST [Medical Device]
   861   C0178665:Glucose tolerance [Physiologic Function]
   861   C0201777:Tolerance test [Laboratory Procedure]
   812   C0013220:Tolerance [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:test [Intellectual Product]
   812   C1704410:Tolerance [Qualitative Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: "with correspondingly reduced plasma insulin levels."
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   851   C1276042:Plasma insulin level [Laboratory Procedure]
   840   C0202098:insulin levels [Laboratory Procedure]
   840   C0428405:insulin levels [Laboratory or Test Result]
   840   C0857690:plasma insulin [Laboratory Procedure]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0032105:Plasma [Body Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.9: Surprisingly, -cells from the STX-1A male mice also exhibited abnormal insulin tolerance. 

Phrase: "Surprisingly, -"

Phrase: "cells from the STX-1A male mice also"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "abnormal insulin tolerance."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0598703:insulin tolerance [Pathologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]
Processing 00000000.tx.10: To unequivocally determine the -cell secretory defects, we used single-cell analyses of exocytosis by patch clamp membrane capacitance measurements and ion channel recordings. 

Phrase: "To unequivocally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the -cell secretory defects,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0243067:defects [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "single-cell analyses of exocytosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0597452:Single-Cell Analyses [Laboratory Procedure]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "by patch clamp membrane capacitance measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0242485:measurements [Functional Concept]

Phrase: "and"

Phrase: "ion channel recordings."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0022009:Ion Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.11: Depolarization-evoked membrane capacitance increases were reduced in the STX-1A mouse islet -cells. 

Phrase: "Depolarization-evoked membrane capacitance increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0442805:increases [Functional Concept]

Phrase: "were"

Phrase: "reduced in the STX-1A mouse islet -cells."
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   783   C1522528:Mouse Islet Cell [Tissue]
   770   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   770   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420498:SYNTAXIN 1A [Gene or Genome]
   744   C0007634:Cells [Cell]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0450344:1A [Intellectual Product]
   744   C1553633:1a [Medical Device]
   744   C3282337:Cells [Cell]
   737 E C1522529:Islet Cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.12: The STX-1A mouse also exhibited reduced currents through the Ca2+ channels but little change in the voltage-gated K+ channel or ATP-sensitive K+ channel. 

Phrase: "The STX-1A mouse also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "reduced currents through the Ca2+ channels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0521116:currents [Temporal Concept]
   719 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "but"

Phrase: "little change in the voltage-gated K+ channel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "ATP-sensitive K+ channel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0439799:Channel [Spatial Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1706095:Channel [Conceptual Entity]
   812   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.13: These results suggest that fluctuation of islet STX-1A levels in diabetes could influence the pathological and differential regulation of -cell ion channels and the exocytotic machinery, collectively contributing to the impaired insulin secretion. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that fluctuation of islet STX-1A levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0231239:Fluctuation [Sign or Symptom]
   748   C0231241:Fluctuation [Temporal Concept]
   748   C2827773:Fluctuation% [Qualitative Concept]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "could"

Phrase: "influence"

Phrase: "the pathological"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0030664:Pathological [Biomedical Occupation or Discipline]
  1000   C1521733:Pathological [Functional Concept]
   928 E C0205469:pathology [Functional Concept]
   928 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "differential regulation of -cell ion channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C0439799:Channel [Spatial Concept]
   766   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "the exocytotic machinery,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337076:machinery [Manufactured Object]

Phrase: "collectively"

Phrase: "contributing to the impaired insulin secretion."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0221099:Impaired [Functional Concept]
   753   C0684336:Impaired [Pathologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1880177:Contributing [Activity]
Processing 00000000.tx.14: The soluble N-ethylmaleimidesensitive factor (NSF) attachment protein receptor (SNARE) proteins are well known to mediate insulin exocytosis (1). 

Phrase: "The soluble N-ethylmaleimidesensitive factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(NSF) attachment protein receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0300824:NSF Attachment Protein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   756   C0169272:NSF Attachment Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(SNARE) proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "well known to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C0205309:Known [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "insulin exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015283:Exocytosis [Cell Function]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: In the islet -cell, glucose entry generates an increase in ATP-to-ADP ratio, which closes the ATP-sensitive K+ channels (KATP channels) [rev. in (2,3)]. 

Phrase: "In the islet -cell,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0022131:Islet cell [Body Part, Organ, or Organ Component]
  1000   C1522529:Islet Cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "glucose entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705654:Entry [Intellectual Product]

Phrase: "generates"

Phrase: "an increase in ATP-to-ADP ratio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "which"

Phrase: "closes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "the ATP-sensitive K+ channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1708601:K' [Quantitative Concept]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "(KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: ")"

Phrase: "[rev. in (2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.16: This results in membrane depolarization, which activates and opens the L-type Ca2+ channel to allow Ca2+ influx. 

Phrase: "This results in membrane depolarization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "which"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "and"

Phrase: "opens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: "the L-type Ca2+ channel to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439799:Channel [Spatial Concept]
   804   C1706095:Channel [Conceptual Entity]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "Ca2+ influx."
Processing 00000000.tx.17: An increase in cytosolic Ca2+ would then trigger exocytosis of the docked and primed insulin granules. 

Phrase: "An increase in cytosolic Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "would"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "exocytosis of the docked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015283:Exocytosis [Cell Function]

Phrase: "and"

Phrase: "primed insulin granules."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0010837:Granules [Cell Component]
   827   C0993609:Granules [Biomedical or Dental Material]
   743 E C0205248:Granular [Qualitative Concept]
Processing 00000000.tx.18: The voltage-gated K+ (Kv) channel, specifically Kv2.1, is then activated, which causes membrane repolarization, resulting in closure of the Ca2+ channel that leads to a cessation of insulin secretion. 

Phrase: "The voltage-gated K+ (Kv"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0556639:kV [Quantitative Concept]

Phrase: ")"

Phrase: "channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "specifically Kv2.1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1416554:KV2.1 [Gene or Genome]

Phrase: "is"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "membrane repolarization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3268904:membrane repolarization [Cell Function]

Phrase: "resulting in closure of the Ca2+"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0332294:Resulting in [Functional Concept]
   753   C0185003:Closure [Therapeutic or Preventive Procedure]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0678226:resulting [Functional Concept]
   753   C1521802:Closure [Research Activity]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "that"

Phrase: "leads to a cessation of insulin secretion."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C1256369:insulin secretion [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0181586:leads [Medical Device]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1880019:Cessation [Activity]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.19: SNARE proteins, particularly syntaxin-1A (STX-1A), have been shown to directly bind and regulate not only the L-type Ca2+ channels (4,5), but also KATP (6) and Kv2.1 channels (7,8) of the islet -cells. 

Phrase: "SNARE proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "particularly syntaxin-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420498:SYNTAXIN 1A [Gene or Genome]
   827   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "(STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "regulate"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "the L-type Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "also KATP"

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "Kv2.1 channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]
   734   C1416554:KV2.1 [Gene or Genome]

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: "of the islet -cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.20: This led to our broad hypothesis that these SNARE proteins could orchestrate the sequence of ionic and exocytic events leading to insulin secretion. 

Phrase: "This"

Phrase: "led to our broad hypothesis"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0332464:Broad [Spatial Concept]
   760   C1512571:Hypothesis [Idea or Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "these SNARE proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "orchestrate"

Phrase: "the sequence of ionic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "exocytic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "leading to insulin secretion."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.21: In type 2 diabetes rat models, including the Zucker fa/fa and Goto-Kakizaki (GK) rats, islet levels of STX-1A, along with its cognate SNARE partners (synaptosome-associated protein of 25 kDa [SNAP-25] and vesicle-associated membrane protein 2 [VAMP-2]) and associated proteins (Munc18a, Munc131) are severely reduced (911). 

Phrase: "In type 2 diabetes rat models,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3161035:Models [Intellectual Product]
   717   C0011860:Type 2 Diabetes [Disease or Syndrome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the Zucker fa/fa"

Phrase: "and"

Phrase: "Goto-Kakizaki (GK) rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "islet levels of STX-1A,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "along with its cognate SNARE partners"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0682323:partners [Family Group]

Phrase: "(synaptosome-associated protein of 25 kDa [SNAP-25]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   846   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "vesicle-associated membrane protein 2 [VAMP-2]"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0148340:Vesicle-Associated Membrane Protein 2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 [Gene or Genome]
   937   C0078208:Vesicle-Associated Membrane Protein [Amino Acid, Peptide, or Protein,Receptor]
   853   C1167317:vesicle membrane [Cell Component]
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   804   C0333262:Vesicle [Acquired Abnormality]
   804   C0596901:Membrane [Cell Component]
   804   C1622418:vesicle [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
   733 E C0205287:Membranous [Qualitative Concept]
   733 E C0205378:Vesicular [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "associated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Munc18a,"

Phrase: "Munc131"

Phrase: ")"

Phrase: "are"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(911"

Phrase: ")."
Processing 00000000.tx.22: In fact, real-time imaging of insulin exocytosis from GK rat islet -cells showed reduced first-phase secretion, which is accountable in part by a reduced number of docked insulin granules (12). 

Phrase: "In fact,"

Phrase: "real-time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1550177:Real Time [Idea or Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0237400:Real [Qualitative Concept]
   861   C3272377:REAL [Intellectual Product]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "imaging of insulin exocytosis"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0015283:Exocytosis [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from GK rat islet -cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   840   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   806 E C1522529:Islet Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "reduced first-phase secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]

Phrase: "which"

Phrase: "is"

Phrase: "accountable in part"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0078889:Accountability [Idea or Concept]

Phrase: "by a reduced number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of docked insulin granules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0010837:Granules [Cell Component]
   827   C0993609:Granules [Biomedical or Dental Material]
   743 E C0205248:Granular [Qualitative Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.23: Such reduction must be at least contributed by the decreased levels of exocytic SNARE proteins. 

Phrase: "Such reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "must"

Phrase: "be at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2987476:Be [Conceptual Entity]

Phrase: "contributed by the decreased levels of exocytic SNARE proteins."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   764   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
           SNARE
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0183362:Snare [Medical Device]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C1153540:SNARE [Molecular Function]
   728   C0428479:Protein level [Laboratory or Test Result]
   708 E C0456079:Level [Classification]
   708 E C0547047:Decrease [Quantitative Concept]
   708 E C1547707:Level [Geographic Area]
   708   C1880177:Contribute [Activity]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.24: In fact, normoglycemic control of the GK rat resulted in the partial restoration in the islet levels of SNARE proteins and insulin secretion (10). 

Phrase: "In fact,"

Phrase: "normoglycemic control of the GK rat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "resulted in the partial restoration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0449982:Restoration [Intellectual Product]
   760   C0728938:Partial [Quantitative Concept]
   760   C1550516:partial [Idea or Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the islet levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of SNARE proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.25: Adenoviral gene transfer of STX-1A into the GK islets also restored insulin secretion (13); 

Phrase: "Adenoviral gene transfer of STX-1A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1517499:Gene Transfer [Molecular Biology Research Technique]
   753   C0017337:Gene [Gene or Genome]
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "into the GK islets also restored insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   818   C1256369:insulin secretion [Cell Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0036536:secretion [Biologic Function]
   795   C0036537:Secretion [Body Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(13"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.26: however, overexpression of STX-1A in normal islets (13) or insulinoma cell lines (14) actually reduced insulin secretion. 

Phrase: "however,"

Phrase: "overexpression of STX-1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in normal islets"

Phrase: "(13"

Phrase: ")"

Phrase: "or"

Phrase: "insulinoma cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "actually reduced insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.27: The genetic alteration of STX-1A levels might also contribute to the abnormal glucose homeostasis in human diabetes. 

Phrase: "The genetic alteration of STX-1A levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0026882:Genetic Alteration [Genetic Function]
   778   C1704257:Genetic Alteration [Finding]
   778   C1705285:Genetic Alteration [Cell or Molecular Dysfunction]
   748   C1515926:Alteration [Idea or Concept]

Phrase: "might"

Phrase: "also"

Phrase: "contribute to the abnormal glucose homeostasis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0580546:Abnormal glucose [Finding]
   790   C1326961:glucose homeostasis [Physiologic Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0019868:Homeostasis [Biologic Function]
   753   C0205161:Abnormal [Qualitative Concept]
   753   C1880177:Contribute [Activity]
   753   C2347472:% Abnormal [Quantitative Concept]
   753   C2699333:ABNORMAL [Intellectual Product]

Phrase: "in human diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.28: In fact, an abnormal glucose metabolism was recently reported in Williams-Beuren syndrome (WBS; OMIM 194050) (15), a multisystem developmental disorder caused by the hemizygous deletion of a 1.5-millionbp region of chromosome 7q11.23, which includes the STX-1A gene (16). 

Phrase: "In fact,"

Phrase: "an abnormal glucose metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0580546:Abnormal glucose [Finding]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported in Williams-Beuren syndrome"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0175702:Williams-Beuren Syndrome [Disease or Syndrome]
           Beuren Syndrome
           Williams Syndrome
   862   C1414382:Williams-Beuren syndrome [Gene or Genome]
   760   C0039082:Syndrome [Disease or Syndrome]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(WBS"

Phrase: "; OMIM 194050"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0950133:OMIM [Intellectual Product]

Phrase: ")"

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "a multisystem developmental disorder"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   913   C0559758:Multisystem disorder [Disease or Syndrome]
   901   C0008073:Developmental disorder [Mental or Behavioral Dysfunction]
   827   C0012634:Disorder [Disease or Syndrome]
   827   C0458003:Developmental [Qualitative Concept]
   827   C0678723:Developmental [Organism Function]
   755 E C0243107:development [Physiologic Function]
   755 E C1527148:Development [Functional Concept]

Phrase: "caused by the hemizygous deletion of a 1.5-millionbp region"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   738   C0017446:Region [Geographic Area]
   738   C0205147:Region [Spatial Concept]
   738   C1442161:Deletion [Cell or Molecular Dysfunction]
   738   C1511760:Deletion [Genetic Function]
   738   C1880274:Deletion [Activity]
   738   C1881036:Hemizygous [Qualitative Concept]
   704   C0015127:cause [Functional Concept]
   704   C1524003:Cause [Conceptual Entity]

Phrase: "of chromosome 7q11.23,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1521638:7q11.23 [Cell Component]
   827   C0008633:Chromosome [Cell Component]
   827   C0450348:23 [Quantitative Concept]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the STX-1A gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.29: Patients with WBS exhibit a variety of endocrine phenotypes, including transient hyperparathyroidism, hypercalcemia, and an increased incidence of diabetes (15). 

Phrase: "Patients with WBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a variety of endocrine phenotypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "transient hyperparathyroidism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020502:Hyperparathyroidism [Disease or Syndrome]

Phrase: "hypercalcemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020437:Hypercalcaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "an increased incidence of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.30: Of 20 adults with WBS (average age, 39 years) who underwent oral glucose tolerance testing, only two (10%) had normal glucose metabolism, with the remaining 90% having diabetes (n = 3), silent diabetes (n = 6), or impaired glucose tolerance (n = 9), according to criteria established by the Expert Committee on Diabetes (17). 

Phrase: "Of 20 adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001675:Adults [Age Group]
   827 E C1706450:Adult [Human]

Phrase: "with WBS (average age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001779:Age [Organism Attribute]

Phrase: "39 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "who"

Phrase: "underwent"

Phrase: "oral glucose tolerance testing,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0595310:glucose testing [Medical Device]
   812   C0039593:Testing [Functional Concept]
   812   C0392366:testing [Intellectual Product]
   756   C0029161:Oral Glucose Tolerance [Diagnostic Procedure]
   708   C0597140:oral tolerance [Organism Attribute]

Phrase: "only two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "(10%"

Phrase: ")"

Phrase: "had"

Phrase: "normal glucose metabolism,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0860800:normal glucose [Finding]

Phrase: "with the remaining 90%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "having"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "silent diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "impaired glucose tolerance"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "(n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "according to criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "established by the Expert Committee"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C2699414:Committee [Group]

Phrase: "on Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.31: Taken together, these studies suggest that the fluctuating levels of STX-1A in pancreatic islets occurring in health and in diabetes must have an exquisite control on the different components of secretion, including the exocytic machinery and membrane ion channels. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the fluctuating levels of STX-1A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "occurring in health"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018684:Health [Idea or Concept]
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: "and in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1515981:And [Idea or Concept]

Phrase: "must"

Phrase: "have"

Phrase: "an exquisite control on the different components of secretion,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0243148:control [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the exocytic machinery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337076:machinery [Manufactured Object]

Phrase: "and"

Phrase: "membrane ion channels."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0022009:Membrane Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Ion Channels
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.32: In fact, diabetic islets seem to be particularly prone to fluctuations in the levels of SNARE proteins induced by the glycemic states (10). 

Phrase: "In fact,"

Phrase: "diabetic islets"

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "particularly prone to fluctuations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033422:Prone [Spatial Concept]

Phrase: "in the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of SNARE proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induced by the glycemic states"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0205263:Induced [Functional Concept]
   760   C1301808:states [Geographic Area]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.33: We have hypothesized that small perturbations of the levels of STX-1A in islet -cells, either a small decrease or increase, could induce distinct effects on these different components of the insulin secretory machinery. 

Phrase: "We"

Phrase: "have"

Phrase: "hypothesized"

Phrase: "that small perturbations of the levels of STX-1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0332453:perturbation [Functional Concept]

Phrase: "in islet -cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "either"

Phrase: "a small decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "or"

Phrase: "increase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "could"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "distinct effects on these different components of the insulin secretory machinery."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C1280500:effects [Qualitative Concept]
   704 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.34: To address this, we have generated a transgenic mouse that moderately overexpresses human STX-1A (by 30% of endogenous protein levels), with the anticipation that this slight increase in STX-1A might induce positive regulatory actions on the insulin secretory machinery. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this,"

Phrase: "we"

Phrase: "have"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mouse, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "that moderately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881878:Moderately [Qualitative Concept]

Phrase: "overexpresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "human STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420498:SYNTAXIN 1A [Gene or Genome]
   827   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "("

Phrase: "by 30%"

Phrase: "of endogenous protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "with the anticipation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679106:anticipation [Mental Process]

Phrase: "that"

Phrase: "this slight increase in STX-1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "might"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "positive regulatory actions on the insulin secretory machinery."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441472:actions [Functional Concept]
   711 E C3266814:Action [Activity]
Processing 00000000.tx.35: Because we used the human gene in its genomic context to generate transgenic lines, STX-1A protein is expressed in a tissue-specific manner that mimics that of the endogenous STX-1A protein. 

Phrase: "Because"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the human gene in its genomic context to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0314604:Human gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]

Phrase: "generate"

Phrase: "transgenic lines,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "STX-1A protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin-1A
   913   C0288881:Syntaxin Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "is"

Phrase: "expressed in a tissue-specific manner"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1955394:Tissue specific [Body Substance]
   753   C0040300:Tissue [Tissue]
   753   C0205369:Specific [Qualitative Concept]
   753   C1547928:Tissue [Intellectual Product]
   753   C1552740:specific [Intellectual Product]

Phrase: "that"

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "that of the endogenous STX-1A protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin-1A
   778   C1420498:SYNTAXIN 1A [Gene or Genome]
   774   C0288881:Syntaxin Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205227:Endogenous [Functional Concept]
   748   C0450344:1A [Intellectual Product]
   748   C1553633:1a [Medical Device]
Processing 00000000.tx.36: This allows us to examine which of the secretory components are more sensitive to this slight increase of STX-1A level and whether this would be sufficient to influence islet -cell insulin exocytosis and glucose homeostasis. 

Phrase: "This"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "which of the secretory components"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C0036538:Secretory Component [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C0449432:Components [Manufactured Object]
   760   C1327616:Secretory [Cell Function]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "are"

Phrase: "more sensitive to this slight increase of STX-1A level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332324:Sensitive to [Functional Concept]
           Sensitive
   739   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "whether"

Phrase: "this"

Phrase: "would"

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "influence"

Phrase: "islet -cell insulin exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015283:Exocytosis [Cell Function]

Phrase: "and"

Phrase: "glucose homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.37: To our surprise, a small increase in islet STX-1A levels actually reduced insulin exocytosis sufficiently to induce glucose intolerance, and more surprisingly, the STX-1A male mice also exhibited abnormal insulin intolerance. 

Phrase: "To our surprise,"

Phrase: "a small increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in islet STX-1A levels actually reduced insulin exocytosis sufficiently to"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   807   C0428405:level insulin [Laboratory or Test Result]
   804   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1420498:SYNTAXIN 1A [Gene or Genome]
   790   C0015283:Exocytosis [Cell Function]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0392756:Reduced [Qualitative Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C0450344:1A [Intellectual Product]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1553633:1a [Medical Device]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "glucose intolerance,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0271650:Glucose Intolerance [Disease or Syndrome]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0231199:Intolerance [Organism Function]
   861   C1744706:intolerance [Intellectual Product]
   861   C2355652:Intolerance [Organism Attribute]
   789 E C0231200:Intolerant [Functional Concept]

Phrase: "and"

Phrase: "more surprisingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "the STX-1A male mice also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "abnormal insulin intolerance."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0231199:Intolerance [Organism Function]
   827   C1744706:intolerance [Intellectual Product]
   827   C2355652:Intolerance [Organism Attribute]
   755 E C0231200:Intolerant [Functional Concept]
Processing 00000000.tx.38: We also show that the islet -cell L-type Ca2+ channel was the most sensitive of the ion channels (compared with KATP and Kv2.1) to perturbation of STX-1A levels. 

Phrase: "We also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the islet -cell L-type Ca2+ channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439799:Channel [Spatial Concept]
   799   C1706095:Channel [Conceptual Entity]

Phrase: "was"

Phrase: "the most sensitive of the ion channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332324:Sensitive [Functional Concept]
   748   C1550474:sensitive [Idea or Concept]

Phrase: "("

Phrase: "compared with KATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "Kv2.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416554:KV2.1 [Gene or Genome]

Phrase: ")"

Phrase: "to perturbation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332453:perturbation [Functional Concept]

Phrase: "of STX-1A levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]
Processing 00000000.tx.39: It therefore appears that a slight overexpression of STX-1A could profoundly alter the many steps of insulin secretion, which would collectively contribute to the abnormal glucose homeostasis in diabetes.  

Phrase: "It therefore"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "a slight overexpression of STX-1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "could"

Phrase: "profoundly"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the many steps of insulin secretion,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C1261552:steps [Conceptual Entity]
   719 E C1704379:Step [Functional Concept]
   719 E C1705117:Step [Quantitative Concept]
   719 E C2825408:Step [Manufactured Object]

Phrase: "which"

Phrase: "would"

Phrase: "collectively"

Phrase: "contribute to the abnormal glucose homeostasis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0580546:Abnormal glucose [Finding]
   790   C1326961:glucose homeostasis [Physiologic Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0019868:Homeostasis [Biologic Function]
   753   C0205161:Abnormal [Qualitative Concept]
   753   C1880177:Contribute [Activity]
   753   C2347472:% Abnormal [Quantitative Concept]
   753   C2699333:ABNORMAL [Intellectual Product]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.40: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Generation of STX-1A transgenic mice. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of STX-1A transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]
Processing 00000000.tx.41: A genomic cosmid LL07NC01-16g10 containing the entire human STX-1A gene was used. 

Phrase: "A genomic cosmid LL07NC01-16g10"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the entire human STX-1A gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0314604:Human gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.42: Cosmid DNA was prepared using Plasmid Maxi kits (Qiagen, Santa Clara, CA) and a 26-kilobase genomic fragment was excised from the cosmid backbone by digestion with EcoRI. 

Phrase: "Cosmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Plasmid Maxi kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C1690540:Kits [Qualitative Concept]
   793 E C0812225:KIT [Medical Device]
   793 E C1150635:KIT [Molecular Function]
   793 E C1705212:Kit [Medical Device]
   793 E C1705213:KIT [Medical Device]
   793 E C3273202:Kit [Manufactured Object]

Phrase: "(Qiagen,"

Phrase: "Santa Clara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551532:Santa Clara [Population Group]

Phrase: "CA)"

Phrase: "and"

Phrase: "a 26-kilobase genomic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "excised from the cosmid backbone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010167:Cosmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0037949:Backbone [Body Part, Organ, or Organ Component]
   760   C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "by digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "with EcoRI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.43: The genomic fragment was recovered from 0.7% TAE agarose gel slices using dialysis and Elutip-d columns (Schleicher & Schuell, Mississauga, Canada) and resuspended in injection buffer (10 mmol/l Tris-HCl, pH 7.5, and 0.2 mmol/l EDTA) at 0.51 ng/l. 

Phrase: "The genomic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "recovered from 0.7% TAE agarose gel slices"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C1706746:Agarose Gel [Research Device]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0036681:Agarose [Carbohydrate]
   744   C0521108:recovered [Qualitative Concept]
   744   C1382104:Gel [Substance]
   711   C1519355:Slice [Substance]
   711 E C2004454:recover [Organism Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011945:Dialysis [Natural Phenomenon or Process]
  1000   C0011946:dialysis [Therapeutic or Preventive Procedure]
  1000   C0917873:dialysis [Therapeutic or Preventive Procedure]
  1000   C1059964:Dialysis [Eukaryote]

Phrase: "and"

Phrase: "Elutip-d columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1185738:Column [Body Part, Organ, or Organ Component]
   793   C1706132:Column [Idea or Concept]

Phrase: "(Schleicher & Schuell,"

Phrase: "Mississauga,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "resuspended in injection buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "(10 mmol/l Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "0.2 mmol/l EDTA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "at 0.51 ng/l."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439297:ng/L [Quantitative Concept]
Processing 00000000.tx.44: Injection was performed on fertilized FVB mouse eggs that were then transferred into recipient CD1 female animals as we previously described (18). 

Phrase: "Injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "was"

Phrase: "performed on fertilized FVB mouse eggs"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C1517101:FVB Mouse [Mammal]
           FVB
   783   C0043544:Fertilized Eggs [Embryonic Structure]
   753   C0013710:Eggs [Food]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0232904:Fertilized [Functional Concept]
   753   C0884358:Performed [Functional Concept]
   719 E C0029974:Egg [Cell]
   719 E C1508746:Egg [Organic Chemical,Pharmacologic Substance]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred into recipient CD1 female animals"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   753   C0003062:Animals [Animal]
   753   C0015780:Female [Finding]
   753   C0043210:female [Population Group]
   753   C0086287:female [Population Group]
   753   C0348011:transferred [Functional Concept]
   753   C1413207:CD1 [Gene or Genome]
   753   C1705497:Female [Qualitative Concept]
   753   C1705498:Female [Qualitative Concept]
   753   C1709854:Recipient [Human]
   753   C3273701:CD1 [Gene or Genome]
   753   C3541222:CD1 [Laboratory Procedure]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "as"

Phrase: "we previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.45: Offspring were screened for integration of the transgene by PCR amplification of the human STX-1A 3'-untranslated region using the primers F, 5'-GTGAGTGTGCGTCTGTACGGG-3', and R, 5'-TCAGGGTCACCTCTCCCCTAAC-3'. 

Phrase: "Offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "screened for integration of the transgene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0282641:Transgene [Gene or Genome]
   753   C1158478:Integration [Genetic Function]
   753   C1705422:Integration [Machine Activity]
   719   C0220908:screen [Health Care Activity]
   719   C1305399:screen [Functional Concept]
   719   C1705053:Screen [Medical Device]

Phrase: "by PCR amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "of the human STX-1A 3'-untranslated region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0017446:Region [Geographic Area]
   799   C0205147:Region [Spatial Concept]
   727 E C0205276:Regional [Spatial Concept]
   727 E C1947913:Regional [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primers F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "5'-GTGAGTGTGCGTCTGTACGGG-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "5'-TCAGGGTCACCTCTCCCCTAAC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.46: Cycles were performed as follows: 94C for 5 min; 

Phrase: "Cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1511572:Cycle [Temporal Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "94C for 5 min"

Phrase: ";"
Processing 00000000.tx.47: 35 cycles of 94C for 30 s, 60C for 45 s, and 72C for 30 s; 

Phrase: "35 cycles of 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "for 30 s,"

Phrase: "60C for 45 s,"

Phrase: "and"

Phrase: "72C for 30 s"

Phrase: ";"
Processing 00000000.tx.48: and a final extension of 72C for 10 min. 

Phrase: "and"

Phrase: "a final extension of 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231448:Extension [Functional Concept]
   760   C1880641:Extension [Conceptual Entity]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.49: The 291-bp product was resolved on a 3% agarose gel. 

Phrase: "The 291-bp product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "resolved on a 3% agarose gel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.50: Determination of transgene copy number and expression analysis. 

Phrase: "Determination of transgene copy number"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "expression analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.51: Copy-number determination was performed using the EagleEye II (Stratagene, La Jolla, CA). 

Phrase: "Copy-number determination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1148554:determination [Laboratory Procedure]
   734   C1707513:Copy Number [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the EagleEye II"

Phrase: "(Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)."
Processing 00000000.tx.52: Serial dilutions of the cosmid DNA representing different genome copy numbers of the transgene and genomic DNA from the transgenic lines were digested with EcoRI and BamHI, resolved on 0.8% agarose gels, and transferred to a nylon membrane by Southern blotting. 

Phrase: "Serial dilutions of the cosmid DNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0031082:serial [Intellectual Product,Manufactured Object]
   753   C0079240:dilutions [Laboratory Procedure]
   719 E C1948037:Dilution [Functional Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "different genome copy numbers of the transgene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1948062:Copy [Manufactured Object]
   745   C1707513:Copy Number [Quantitative Concept]

Phrase: "and"

Phrase: "genomic DNA from the transgenic lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017428:Genomic [Gene or Genome]
   753   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "were"

Phrase: "digested with EcoRI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "BamHI,"

Phrase: "resolved on 0.8% agarose gels,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   773   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]
   719 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred to a nylon membrane"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0025255:Membrane [Tissue]
   760   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0740034:Nylon [Biomedical or Dental Material]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "by Southern blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005862:Blotting, Southern [Molecular Biology Research Technique]
   983 E C1148472:Blot, Southern [Laboratory or Test Result]
   861   C1710133:Southern [Spatial Concept]
Processing 00000000.tx.53: The 291-bp human-specific PCR product from the 3'-untranslated region of STX-1A was used as a hybridization probe. 

Phrase: "The 291-bp human-specific PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1514468:product [Entity]
   799   C1704444:Product [Quantitative Concept]

Phrase: "from the 3'-untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600600:3' Untranslated Region [Biologically Active Substance,Nucleotide Sequence]
   913   C1883633:3' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "was"

Phrase: "used as a hybridization probe."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0020202:Hybridisation [Genetic Function]
   760   C0182400:Probe [Medical Device]
   760   C1273517:used [Finding]
   760   C1300517:Hybridization [Laboratory Procedure]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.54: To assess transgene expression, the same primer pair was used for RT-PCR amplification of the human STX-1A transcript from total RNA. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "transgene expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0282641:Transgene [Gene or Genome]

Phrase: "the same primer pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]

Phrase: "was"

Phrase: "used for RT-PCR amplification of the human STX-1A transcript"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   756   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0599161:RT-PCR [Molecular Biology Research Technique]
   756   C1420498:SYNTAXIN 1A [Gene or Genome]
   738   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   738   C0086418:Human [Human]
   738   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0450344:1A [Intellectual Product]
   738   C0677874:pCR [Finding]
   738   C1273517:used [Finding]
   738   C1517480:Amplification [Molecular Biology Research Technique]
   738   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C1521871:Amplification [Phenomenon or Process]
   738   C1553633:1a [Medical Device]
   738   C1705759:Amplification [Cell or Molecular Dysfunction]
   737   C1524063:Use of [Functional Concept]
   704 E C0042153:use [Functional Concept]
   704 E C0457083:Use [Functional Concept]
   704 E C1947944:Use [Intellectual Product]

Phrase: "from total RNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.55: RNA was extracted from tissues using TRIzol Reagent and reverse transcribed using SuperScript III (Invitrogen, Carlsbad, CA). 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from tissues"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0040300:Tissues [Tissue]
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C1547928:Tissue [Intellectual Product]
   756 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol Reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SuperScript III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA)."
Processing 00000000.tx.56: A control amplification of reverse transcription reaction without the addition of SuperScript III was used to ensure there was no DNA contamination. 

Phrase: "A control amplification of reverse transcription reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "without the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of SuperScript III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "there"

Phrase: "was"

Phrase: "no DNA contamination."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   861   C0259846:contamination [Human-caused Phenomenon or Process]
   861   C1881659:CONTAMINATION [Event]
   861   C2349974:Contamination [Idea or Concept]
Processing 00000000.tx.57: DNA construct and recombinant glutathione S-transferase proteins. 

Phrase: "DNA construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012931:DNA Construct [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "recombinant glutathione S-transferase proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.58: The construct pGEX-4T-1-STX-1A, used for generating glutathione S-transferase (GST)-STX-1A protein, has been reported previously (7). 

Phrase: "The construct pGEX-4T-1-STX-1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420498:SYNTAXIN 1A [Gene or Genome]
   799   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0450344:1A [Intellectual Product]
   799   C1553633:1a [Medical Device]

Phrase: "used for generating glutathione S-transferase (GST)-STX-1A protein,"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   790   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   790   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin-1A
   764   C1420498:SYNTAXIN 1A [Gene or Genome]
   762   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0288881:Syntaxin Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin
   762   C1418948:PROTEIN S [Gene or Genome]
   742   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0450344:1A [Intellectual Product]
   742   C1273517:used [Finding]
   742   C1553633:1a [Medical Device]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.59: GST-STX-1A protein expression and purification were performed following the instructions of Amersham Biosciences. 

Phrase: "GST-STX-1A protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C1171362:protein expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the instructions of Amersham Biosciences."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0302828:instructions [Intellectual Product]
   760   C1442085:Instructions [Idea or Concept]
   760   C3263700:Instructions [Clinical Attribute]
   726 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.60: Before elution of the GST fusion protein from glutathione agarose beads, STX-1A protein was obtained by cleavage of GST-STX-1A with thrombin to remove the GST (Sigma, St. Louis, MO) Intraperitoneal glucose tolerance test IPGTT. 

Phrase: "Before elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "of the GST fusion protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from glutathione agarose beads,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "STX-1A protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin-1A
   913   C0288881:Syntaxin Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "was"

Phrase: "obtained by cleavage of GST-STX-1A"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   764   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420498:SYNTAXIN 1A [Gene or Genome]
   742   C0010813:cleavage [Cell Function]
   742   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0450344:1A [Intellectual Product]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1301820:Obtained [Functional Concept]
   742   C1330957:cleavage [Cell Function]
   742   C1553633:1a [Medical Device]
   708 E C1706701:Obtain [Activity]

Phrase: "with thrombin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St. Louis,"

Phrase: "MO) Intraperitoneal glucose tolerance test IPGTT."
Processing 00000000.tx.61: Mice were fasted overnight between 12 and 16 h before experimental procedures were carried out to assay for glucose tolerance after fasting and subsequently to glucose challenge. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "overnight between 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "16 h before experimental procedures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "assay for glucose tolerance"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0178665:Glucose tolerance [Physiologic Function]
   770   C0005507:Assay [Laboratory Procedure]
   770   C0013220:Tolerance [Finding]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0020963:Tolerance [Pathologic Function]
   770   C0220929:tolerance [Mental Process]
   770   C0231197:Tolerance [Physiologic Function]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]
   770   C1704410:Tolerance [Qualitative Concept]
   715 E C0680282:toleration [Social Behavior]

Phrase: "after fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "subsequently to glucose challenge."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0798503:Challenge [Clinical Attribute]
   770   C0805586:Challenge [Health Care Activity]
   770   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.62: Their body weights before and after fasting were measured and recorded to the nearest gram unit. 

Phrase: "Their body weights before"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0005910:Weights, Body [Organism Attribute]
       E   weight
   833   C1305866:body weights [Diagnostic Procedure]
       E   weight
   770   C0043100:Weights [Quantitative Concept]
   770   C0242821:body [Human]
   770   C0460148:Body [Anatomical Structure]
   770   C1268086:Body [Anatomical Structure]
   737 E C1705104:Weight [Idea or Concept]

Phrase: "and after fasting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0015663:Fasting [Finding]
   790   C1515981:And [Idea or Concept]
   790   C1550565:fasting [Intellectual Product]
   756 E C0456962:Fast [Qualitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "recorded to the nearest gram unit."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C2608091:Unit/gram [Quantitative Concept]
   753   C0205107:Nearest [Spatial Concept]
   753   C0439148:Unit [Quantitative Concept]
   753   C0439208:gram [Quantitative Concept]
   753   C1519795:Unit [Quantitative Concept]
   753   C1704753:Unit [Manufactured Object]
   753   C1880519:Unit [Quantitative Concept]
   719   C0034869:Record [Intellectual Product]
Processing 00000000.tx.63: A drop of tail blood was taken by introducing a 23.5-gauge needle puncture and assayed for basal glucose levels (t = 0) using the OneTouch glucose meter (Lifescan, Vancouver, Canada). 

Phrase: "A drop of tail blood"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1321095:Drop [Quantitative Concept]
   760   C1705648:Drop [Activity]
   760   C2347093:Drop [Quantitative Concept]
   760   C2348338:Drop [Quantitative Concept]

Phrase: "was"

Phrase: "taken by introducing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1883727:Taken [Conceptual Entity]
   756   C1292748:introduce [Functional Concept]
   756 E C1515187:Take [Health Care Activity]

Phrase: "a 23.5-gauge needle puncture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0033119:Puncture [Finding]
   804   C0034117:Puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   804   C1881711:PUNCTURE [Phenomenon or Process]

Phrase: "and"

Phrase: "assayed for basal glucose levels"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0428548:glucose levels [Laboratory or Test Result]
   773 E C0337438:glucose level [Laboratory Procedure]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205112:Basal [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(t = 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the OneTouch glucose meter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475209:Meter [Quantitative Concept]
   827   C1706378:METER [Manufactured Object]

Phrase: "(Lifescan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470941:lifescan [Health Care Related Organization]

Phrase: "Vancouver,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.64: A 12 mg D-glucose/kg fasting body wt dose of glucose was injected into the intraperitoneum of the mice, and tail blood was taken at t = 15, 30, 45, 60, 90, and 120 min postinjection for glucose measurement. 

Phrase: "A 12 mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "D-"

Phrase: "glucose/kg fasting body wt dose of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "was"

Phrase: "injected into the intraperitoneum of the mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   714   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "tail blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "taken at t = 15,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]

Phrase: "30,"

Phrase: "45,"

Phrase: "60,"

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "and"

Phrase: "120 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "postinjection for glucose measurement."
Processing 00000000.tx.65: The mice were allowed to recover for 2 weeks before the next scheduled experiment. 

Phrase: "The mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover for 2 weeks"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439230:weeks [Temporal Concept]
   770   C0521108:recover [Qualitative Concept]
   770   C2004454:recover [Organism Function]
   737 E C0332174:/week [Temporal Concept]

Phrase: "before the next scheduled experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.66: These and all experiments below were carried out in accordance with the Canadian Council for Animal Care guidelines and were approved by the University of Toronto Animal Care Committee. 

Phrase: "These"

Phrase: "and"

Phrase: "all experiments below"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0681814:Experiments [Research Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in accordance with the Canadian Council"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0238884:CANADIAN [Finding]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1551807:Council [Population Group]

Phrase: "for Animal Care guidelines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0162791:Guidelines [Intellectual Product]
   827   C0220845:guidelines [Intellectual Product]
   827   C0282423:guidelines [Intellectual Product]
   734   C0178478:animal care [Occupation or Discipline]

Phrase: "and"

Phrase: "were"

Phrase: "approved by the University of Toronto Animal Care Committee."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0003045:Committee, Animal Care [Professional or Occupational Group]
   764   C0178478:animal care [Occupation or Discipline]
   742   C0003062:Animal [Animal]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0205540:Approved [Qualitative Concept]
   742   C1947933:Care [Activity]
   742   C2699414:Committee [Group]
Processing 00000000.tx.67: Determination of serum insulin during IPGTT. 

Phrase: "Determination of serum insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "during IPGTT."
Processing 00000000.tx.68: Mice were restrained in a 50-ml syringe tube (BD Biosciences, Toronto, Canada), with a punctured hole at the bottom of the tube to allow for continuous airflow. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "restrained in a 50-ml syringe tube"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0039142:Syringe [Medical Device]
   748   C0175730:Tube [Medical Device]
   748   C0439526:/mL [Quantitative Concept]
   748   C1547937:Tube NOS [Intellectual Product]
   748   C1561954:tube [Conceptual Entity]
   748   C1704730:TUBE [Medical Device]
   748   C1706072:Syringe [Manufactured Object]

Phrase: "(BD Biosciences,"

Phrase: "Toronto,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "with a punctured hole"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0544726:Hole [Finding]
   861   C1823381:hole [Gene or Genome]
   861   C1881060:HOLE [Event]

Phrase: "at the bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "of the tube to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0175730:Tube [Medical Device]
   861   C1547937:Tube NOS [Intellectual Product]
   861   C1561954:tube [Conceptual Entity]
   861   C1704730:TUBE [Medical Device]

Phrase: "allow for continuous airflow."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0231999:Airflow [Physiologic Function]
   770   C0549178:Continuous [Idea or Concept]
   770   C0683607:allow [Social Behavior]
Processing 00000000.tx.69: The hind leg was extended and fixed by holding the fold of skin between the tail and thigh. 

Phrase: "The hind leg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0023216:Leg [Body Location or Region]
   861   C1140621:Leg [Body Location or Region]
   861   C1285009:Leg [Body Location or Region]
   861   C2983612:Hind [Spatial Concept]

Phrase: "was"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "and"

Phrase: "fixed by holding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "the fold of skin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1446851:Skin fold [Laboratory Procedure]
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "between the tail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "thigh."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039866:Thigh [Body Location or Region]
  1000   C1281586:Thigh [Body Part, Organ, or Organ Component]
   944 E C0015811:Femoral [Body Part, Organ, or Organ Component]
Processing 00000000.tx.70: Leg hairs were shaved using a sterile blade until the saphenous vein was apparent for visualization. 

Phrase: "Leg hairs"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   983   C0926332:Leg hair [Body Part, Organ, or Organ Component]
   861   C0018494:Hairs [Body Part, Organ, or Organ Component]
   827 E C0444095:Hair [Body Part, Organ, or Organ Component]
   789 E C1539087:PILAR [Gene or Genome]
   777 E C0221958:Hairy [Functional Concept]
   761 E C0031921:pili [Cell Component]
   755 E C0019572:HAIRINESS [Finding]
   755 E C0020555:Hairiness [Disease or Syndrome]

Phrase: "were"

Phrase: "shaved"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0518505:shaved [Finding]
   966 E C0522772:shave [Therapeutic or Preventive Procedure]
   966 E C2828368:Shave [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a sterile blade until the saphenous vein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0179323:blade [Medical Device]
   748   C2700402:Blade [Plant]
   748   C2948008:Blade [Pharmacologic Substance]

Phrase: "was"

Phrase: "apparent for visualization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.71: A 23.5-gauge needle was then used to puncture the saphenous vein, and 50 l of blood was collected into a Microvette untreated with heparin (Sarstedt, Toronto, Canada), recorded as t = 0 min (basal level). 

Phrase: "A 23.5-gauge needle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0027551:Needle [Medical Device]
   812   C1704318:Needle [Medical Device]
   812   C1882041:Needle [Spatial Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "puncture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033119:Puncture [Finding]
  1000   C0034117:Puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1881711:PUNCTURE [Phenomenon or Process]

Phrase: "the saphenous vein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036186:Saphenous Vein [Body Part, Organ, or Organ Component]
  1000   C0392907:saphenous vein [Body Part, Organ, or Organ Component]
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "50 l of blood"

Phrase: "was"

Phrase: "collected into a Microvette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "untreated with heparin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332155:untreated [Finding]

Phrase: "(Sarstedt,"

Phrase: "Toronto,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "recorded as t = 0 min (basal level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205112:Basal [Spatial Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0702093:/min [Temporal Concept]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
   714   C0034869:Record [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.72: During the IPGTT, blood samples were obtained at t = 10, 30, and 120 min. 

Phrase: "During the IPGTT,"

Phrase: "blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained at t = 10,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "30,"

Phrase: "and"

Phrase: "120 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.73: The flow of blood had been optimized for collection by coating the surface of the epidermis with a thin film of Vaseline to prevent clotting and coagulation. 

Phrase: "The flow of blood"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0232338:Blood flow [Organism Function]
   770   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "had"

Phrase: "been"

Phrase: "optimized for collection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1516698:Collection [Functional Concept]
   790   C1704814:Collection [Idea or Concept]
   718 E C1516695:Collected [Idea or Concept]

Phrase: "by coating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522408:Coating [Qualitative Concept]
  1000   C1704806:Coating [Biomedical or Dental Material]

Phrase: "the surface of the epidermis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205148:Surface [Spatial Concept]

Phrase: "with a thin film"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1441759:Thin film [Laboratory Procedure]
   861   C0086296:Film [Manufactured Object]
   861   C1561571:film [Biomedical or Dental Material]
   861   C1561572:film [Substance]

Phrase: "of Vaseline to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0728774:Vaseline [Organic Chemical,Pharmacologic Substance]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "clotting"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0005778:Clotting [Organ or Tissue Function]
  1000   C1328723:clotting [Physiologic Function]
   966 E C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
   966 E C0302148:Clot [Acquired Abnormality]

Phrase: "and"

Phrase: "coagulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005778:Coagulation [Organ or Tissue Function]
  1000   C0441509:Coagulation [Therapeutic or Preventive Procedure]
  1000   C1328723:coagulation [Physiologic Function]
Processing 00000000.tx.74: Blood was allowed to stand at room temperature for at least 20 min to allow clotting. 

Phrase: "Blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stand at room temperature"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0596013:stand [Finding]
   770   C1547703:Room [Spatial Concept]
   770   C1704644:Stand [Medical Device]

Phrase: "for"

Phrase: "at least 20 min to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "clotting."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0005778:Clotting [Organ or Tissue Function]
  1000   C1328723:clotting [Physiologic Function]
   966 E C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
   966 E C0302148:Clot [Acquired Abnormality]
Processing 00000000.tx.75: Serum was then separated by spinning down the plasma at 4C, 8,00010,000 rpm. 

Phrase: "Serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "separated by spinning"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   756   C1415347:SPIN [Gene or Genome]
   756   C1823107:SPIN [Gene or Genome]

Phrase: "down the plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "8,"

Phrase: "00010,"

Phrase: "000 rpm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]
Processing 00000000.tx.76: Serum insulin levels were then assayed using the RIA Ultrasensitive Insulin kit (Linco Research, St. Charles, MO) or the ELISA (Crystal Chem, Chicago, IL). 

Phrase: "Serum insulin levels"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   966   C0428357:Serum insulin level [Laboratory Procedure]
           Serum insulin
   966   C1261415:serum insulin level [Laboratory or Test Result]
           serum insulin
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0229671:Serum [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the RIA Ultrasensitive Insulin kit (Linco Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]

Phrase: "St. Charles,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "or"

Phrase: "the ELISA (Crystal Chem,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.77: Intraperitoneal insulin tolerance test. 

Phrase: "Intraperitoneal insulin tolerance test."
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   923   C0236287:Insulin tolerance test [Laboratory Procedure]
   875   C0202098:insulin test [Laboratory Procedure]
   861   C0201777:Tolerance test [Laboratory Procedure]
   861   C0598703:insulin tolerance [Pathologic Function]
   812   C0013220:Tolerance [Finding]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:test [Intellectual Product]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1704410:Tolerance [Qualitative Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.78: Mice were fasted for 5 h before experimental procedures were carried out to assay for insulin tolerance after fasting. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "fasted for 5 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0015663:Fast [Finding]
   737   C0456962:Fast [Qualitative Concept]

Phrase: "before experimental procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "assay for insulin tolerance"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0598703:insulin tolerance [Pathologic Function]
   770   C0005507:Assay [Laboratory Procedure]
   770   C0013220:Tolerance [Finding]
   770   C0020963:Tolerance [Pathologic Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0220929:tolerance [Mental Process]
   770   C0231197:Tolerance [Physiologic Function]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1704410:Tolerance [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   715 E C0680282:toleration [Social Behavior]

Phrase: "after fasting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]
Processing 00000000.tx.79: Their body weights before and after fasting were measured and recorded to the nearest gram unit. 

Phrase: "Their body weights before"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0005910:Weights, Body [Organism Attribute]
       E   weight
   833   C1305866:body weights [Diagnostic Procedure]
       E   weight
   770   C0043100:Weights [Quantitative Concept]
   770   C0242821:body [Human]
   770   C0460148:Body [Anatomical Structure]
   770   C1268086:Body [Anatomical Structure]
   737 E C1705104:Weight [Idea or Concept]

Phrase: "and after fasting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0015663:Fasting [Finding]
   790   C1515981:And [Idea or Concept]
   790   C1550565:fasting [Intellectual Product]
   756 E C0456962:Fast [Qualitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "recorded to the nearest gram unit."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C2608091:Unit/gram [Quantitative Concept]
   753   C0205107:Nearest [Spatial Concept]
   753   C0439148:Unit [Quantitative Concept]
   753   C0439208:gram [Quantitative Concept]
   753   C1519795:Unit [Quantitative Concept]
   753   C1704753:Unit [Manufactured Object]
   753   C1880519:Unit [Quantitative Concept]
   719   C0034869:Record [Intellectual Product]
Processing 00000000.tx.80: A drop of tail blood was taken by introducing a 23.5-gauge needle puncture, and assayed for basal glucose levels (t = 0 min) using the OneTouch glucose meter (Lifescan). 

Phrase: "A drop of tail blood"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1321095:Drop [Quantitative Concept]
   760   C1705648:Drop [Activity]
   760   C2347093:Drop [Quantitative Concept]
   760   C2348338:Drop [Quantitative Concept]

Phrase: "was"

Phrase: "taken by introducing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1883727:Taken [Conceptual Entity]
   756   C1292748:introduce [Functional Concept]
   756 E C1515187:Take [Health Care Activity]

Phrase: "a 23.5-gauge needle puncture,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0033119:Puncture [Finding]
   804   C0034117:Puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   804   C1881711:PUNCTURE [Phenomenon or Process]

Phrase: "and"

Phrase: "assayed for basal glucose levels"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0428548:glucose levels [Laboratory or Test Result]
   773 E C0337438:glucose level [Laboratory Procedure]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205112:Basal [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(t = 0 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the OneTouch glucose meter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475209:Meter [Quantitative Concept]
   827   C1706378:METER [Manufactured Object]

Phrase: "(Lifescan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470941:lifescan [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.81: A 0.250.45 units insulin/kg fasting body wt injection of a short-acting human biosynthetic insulin (Novo Nordisk, Toronto, Canada) was injected into the intraperitoneum of the mice, and tail blood was taken at t = 15, 30, 45, 60, 90, and 120 min for insulin measurement. 

Phrase: "A 0.250.45 units insulin/kg fasting body wt injection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   846   C0199782:Insulin injection [Therapeutic or Preventive Procedure]
   846   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   790   C0021485:injection [Therapeutic or Preventive Procedure]
   790   C1272883:Injection [Biomedical or Dental Material]
   790   C1533685:Injection [Therapeutic or Preventive Procedure]
   790   C1828121:Injection [Functional Concept]

Phrase: "of a short-acting human biosynthetic insulin"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   911   C0356365:Insulin, Short-Acting [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   853   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Novo Nordisk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331875:Novo Nordisk [Health Care Related Organization]

Phrase: "Toronto,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "injected into the intraperitoneum of the mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   714   C1720154:Inject [Functional Concept]

Phrase: "and"

Phrase: "tail blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "taken at t = 15,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]

Phrase: "30,"

Phrase: "45,"

Phrase: "60,"

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "and"

Phrase: "120 min for insulin measurement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]
Processing 00000000.tx.82: The mice were allowed to recover for 2 weeks before the next scheduled experiment. 

Phrase: "The mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover for 2 weeks"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439230:weeks [Temporal Concept]
   770   C0521108:recover [Qualitative Concept]
   770   C2004454:recover [Organism Function]
   737 E C0332174:/week [Temporal Concept]

Phrase: "before the next scheduled experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.83: Immunoblotting. 

Phrase: "Immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.84: Electrophoretic separations of proteins by SDS-PAGE and immunoblotting were performed as previously described (6,7). 

Phrase: "Electrophoretic separations of proteins"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0237868:Separations [Social Behavior]
   737 E C0036679:Separation [Pathologic Function]
   737 E C1881713:SEPARATION [Phenomenon or Process]

Phrase: "by SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "were"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.85: The mouse islets were solubilized in sample buffer (with 2% SDS) and boiled for 5 min. 

Phrase: "The mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522528:Mouse Islets [Tissue]

Phrase: "were"

Phrase: "solubilized in sample buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: "with 2% SDS)"

Phrase: "and"

Phrase: "boiled for 5 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]
Processing 00000000.tx.86: Because the size and quality of islets can vary, particularly in diabetic rats, extra care was taken to ensure accurate protein loading. 

Phrase: "Because"

Phrase: "the size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "quality of islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332306:Quality [Qualitative Concept]

Phrase: "can"

Phrase: "vary"

Phrase: ","

Phrase: "particularly in diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0241863:DIABETIC [Finding]

Phrase: "extra care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947933:Care [Activity]

Phrase: "was"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "accurate protein loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708715:Loading [Activity]
Processing 00000000.tx.87: First, the protein quality and quantity of each islet sample were determined by a modified Lowrys method. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the protein quality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332306:Quality [Qualitative Concept]

Phrase: "and"

Phrase: "quantity of each islet sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1265611:Quantity [Quantitative Concept]
   760   C1554108:Quantity [Intellectual Product]
   760   C1561573:Quantity [Intellectual Product]

Phrase: "were"

Phrase: "determined by a modified Lowrys method."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0205349:Modified By [Qualitative Concept]
   753   C0025663:Method [Intellectual Product]
   753   C0392747:Modified [Functional Concept]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.88: Second, equal protein loading of these islet samples was confirmed by uniform Coomassie Blue staining of all lanes and in all gels. 

Phrase: "Second, equal protein loading of these islet samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "confirmed by uniform Coomassie Blue staining of all lanes"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   764   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   742   C0205375:Uniform [Qualitative Concept]
   742   C0487602:Staining [Laboratory Procedure]
   742   C0750484:Confirmed [Idea or Concept]
   742   C1260957:Blue [Qualitative Concept]
   742   C1608508:uniform [Quantitative Concept]
   742   C1704680:Staining [Finding]
   708 E C1456348:Confirm [Qualitative Concept]
   708   C1708639:Lane [Spatial Concept]

Phrase: "and in all gels."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017243:Gels [Biomedical or Dental Material]
   770   C1515981:And [Idea or Concept]
   737 E C1382104:Gel [Substance]
Processing 00000000.tx.89: From each sample, 20 g protein was loaded and separated on a 15% polyacrylamide gel. 

Phrase: "From each sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "20 g protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "separated on a 15% polyacrylamide gel."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]
Processing 00000000.tx.90: The proteins were then transferred to nitrocellulose membranes and incubated with the primary mouse monoclonal or rabbit polyclonal antibodies: STX-1A monoclonal antibody, 1:1,000 dilution (Sigma); 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "incubated with the primary mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "monoclonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746619:monoclonal [Finding]

Phrase: "or"

Phrase: "rabbit polyclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   896   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "STX-1A monoclonal antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.91: SNAP-25 monoclonal antibody, 1:1,000 (SMI-25; Sternberger Monoclonal, Lutherville, MD); 

Phrase: "SNAP-25 monoclonal antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   805   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0443737:Monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0700271:monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1317659:Protein.monoclonal [Laboratory or Test Result]
   767   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(SMI-25"

Phrase: "; Sternberger Monoclonal, Lutherville,"

Phrase: "MD)"

Phrase: ";"
Processing 00000000.tx.92: VAMP-2 polyclonal antibody, 1:1,000 (9,10); 

Phrase: "VAMP-2 polyclonal antibody,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   845   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   747   C0148340:Vesicle-Associated Membrane Protein 2 [Amino Acid, Peptide, or Protein,Receptor]
   747   C1421419:VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 [Gene or Genome]
   710   C0078208:Vesicle-Associated Membrane Protein [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(9,"

Phrase: "10"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.93: nSec1/Munc18a monoclonal antibody, 1:1,000 (BD Transduction Laboratories, San Jose, CA); 

Phrase: "nSec1/Munc18a monoclonal antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(BD Transduction Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "San Jose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: ";"
Processing 00000000.tx.94: and mouse anti-actin antibody, 1:20,000 (Roche Molecular Biochemicals, Qubec, Canada), all for 1.52 h at room temperature. 

Phrase: "and"

Phrase: "mouse anti-actin antibody,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   741 E C0439681:Actinic [Qualitative Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "20,000"

Phrase: "(Roche Molecular Biochemicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: "Qubec,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "all for 1.52 h"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C0700308:h 1 [Element, Ion, or Isotope]
   797   C0919528:ALL-1 [Gene or Genome]
   797   C1527868:ALL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0444868:All [Quantitative Concept]
   760   C0564385:/h [Quantitative Concept]
   760   C3539085:All [Idea or Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.95: These primary antibodies were then detected with appropriate secondary antibodies and visualized by chemiluminescence (Pierce Chemical, Rockford, IL) and exposure of the filters to Kodak BMR film (Eastman Kodak, Rochester, NY) for 1 s to 10 min. 

Phrase: "These primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "detected with appropriate secondary antibodies"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1548787:Appropriate [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "visualized by chemiluminescence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0234621:Visualized [Functional Concept]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]

Phrase: "(Pierce Chemical, Rockford,"

Phrase: "IL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "exposure of the filters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]

Phrase: "to Kodak BMR film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086296:Film [Manufactured Object]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]

Phrase: "(Eastman Kodak,"

Phrase: "Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "for 1 s"

Phrase: "to 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.96: For quantification of the SNARE protein signals, several film exposures of the blots were scanned and analyzed using NIH Image (version 1.61). 

Phrase: "For quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "of the SNARE protein signals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "several film exposures of the blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0274281:exposures [Injury or Poisoning]
   753   C0728853:exposures [Phenomenon or Process]
   719 E C0332157:Exposure [Clinical Attribute]

Phrase: "were"

Phrase: "scanned"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NIH Image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "(version 1.61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.97: Recording of K+ and Ca2+ currents. 

Phrase: "Recording of K+"

Phrase: "and"

Phrase: "Ca2+ currents."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.98: Mouse -cells were voltage-clamped in the whole-cell configuration using an EPC-9 amplifier and Pulse software (HEKA Electronik, Lambrecht, Germany) as we previously described (6,7). 

Phrase: "Mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "voltage-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598352:Voltage [Quantitative Concept]

Phrase: "clamped in the whole-cell configuration"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007634:Cell [Cell]
   753   C0444667:Whole [Quantitative Concept]
   753   C0449830:Configuration [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2827597:Configuration [Conceptual Entity]
   719   C0175721:Clamp [Medical Device]
   719   C1705942:Clamp [Manufactured Object]
   719   C1883710:Clamp [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an EPC-9 amplifier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002684:amplifier [Manufactured Object]
   827   C1706099:Amplifier [Manufactured Object]

Phrase: "and"

Phrase: "Pulse software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(HEKA Electronik,"

Phrase: "Lambrecht,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "as"

Phrase: "we previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.99: -Cells were identified by their characteristic display of substantial Na+ currents only at very negative (120 mV) holding potential. 

Phrase: "-Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "identified by their characteristic display of substantial Na+ currents only"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   739   C0205171:Only [Quantitative Concept]
   739   C0205396:Identified [Qualitative Concept]
   739   C0521116:currents [Temporal Concept]
   739   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1272460:{NA} [Qualitative Concept]
   739   C1521970:Characteristic [Qualitative Concept]
   739   C1550043:Identified [Finding]
   739   C1551388:Identified [Functional Concept]
   739   C1705417:Display [Manufactured Object]
   739   C1720467:Only [Intellectual Product]
   706 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "at very negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: "(120 mV) holding potential."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C3245505:Potential [Qualitative Concept]
   779   C1553387:Hold [Idea or Concept]
   779   C1948035:Hold [Activity]
Processing 00000000.tx.100: Recording pipettes were pulled from 1.5-mm borosilicate glass capillary tubes (World Precision Instruments, Sarasota, FL) using a programmable micropipette puller (Sutter Instrument, Novato, CA). 

Phrase: "Recording pipettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0182301:pipettes [Medical Device]
   827 E C1706407:Pipette [Medical Device]

Phrase: "were"

Phrase: "pulled from 1.5-mm borosilicate glass capillary tubes"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   764   C0184108:capillary tubes [Medical Device]
   762   C1418486:MM-1 [Gene or Genome]
   745   C0336635:Glass tube [Medical Device]
   745 E C1707263:Tube Capillary [Medical Device]
   742   C0006901:Capillary [Body Part, Organ, or Organ Component]
   742   C0017596:Glass [Manufactured Object]
   742   C0175730:tubes [Medical Device]
   742   C0580846:pulled [Finding]
   742   C0935624:Capillary [Body Part, Organ, or Organ Component]
   742   C1280521:Capillary [Body Part, Organ, or Organ Component]
   742   C1547937:Tubes [Intellectual Product]
   742   C1704474:Tubes [Quantitative Concept]
   742   C1947936:Glass [Medical Device]
   708 E C1561954:tube [Conceptual Entity]
   708 E C1704730:TUBE [Medical Device]

Phrase: "(World Precision Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0348000:instruments [Medical Device]

Phrase: "Sarasota,"

Phrase: "FL)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a programmable micropipette puller"

Phrase: "(Sutter Instrument,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:Instrument [Medical Device]

Phrase: "Novato,"

Phrase: "CA)."
Processing 00000000.tx.101: Pipettes were then heat-polished, and tip resistances ranged from 3.5 to 5 M when filled with intracellular solutions. 

Phrase: "Pipettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0182301:pipettes [Medical Device]
   966 E C1706407:Pipette [Medical Device]

Phrase: "were"

Phrase: "then heat-polished,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0220896:polished [Population Group]

Phrase: "and"

Phrase: "tip resistances"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   777 E C0332325:Resistant [Functional Concept]
   777 E C1550464:resistent [Idea or Concept]
   777 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "ranged from 3.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 5 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "when"

Phrase: "filled with intracellular solutions."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037633:Solutions [Substance]
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C1708059:Filled [Activity]
   737 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.102: The intracellular solution for Kv current measurements contained 140 mmol/l KCl, 1 mmol/l MgCl2, 1 mmol/l EGTA, 10 mmol/l HEPES, and 5 mmol/l MgATP (pH 7.25 adjusted with KOH). 

Phrase: "The intracellular solution for Kv current measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "140 mmol/l KCl,"

Phrase: "1 mmol/l MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 mmol/l EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10 mmol/l HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "5 mmol/l MgATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0024471:MgATP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "(pH 7.25"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "adjusted with KOH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0456081:Adjusted [Functional Concept]

Phrase: ")."
Processing 00000000.tx.103: For KATP current measurements, the intracellular solution was the same as above except that MgATP was reduced to 0.3 mmol/l to allow KATP channel opening. 

Phrase: "For KATP current measurements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "the intracellular solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "the same as above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1278655:SAME AS [Classification]
   770   C0445247:Same [Qualitative Concept]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that MgATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024471:MgATP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "reduced to 0.3 mmol/l to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1532563:mmol/L [Quantitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0439190:MMOLE [Quantitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "KATP channel opening."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0175566:Opening [Spatial Concept]
   827   C1882151:Opening [Spatial Concept]
Processing 00000000.tx.104: The intracellular solution for Ca2+ current measurement contained 120 mmol/l CsCl, 20 mmol/l tetraethylammonium (TEA)-Cl, 1 mmol/l MgCl2, 1 mmol/l EGTA, 10 mmol/l HEPES, and 5 mmol/l MgATP (pH 7.25 adjusted with CsOH). 

Phrase: "The intracellular solution for Ca2+ current measurement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "120 mmol/l CsCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20 mmol/l tetraethylammonium (TEA)-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "1 mmol/l MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 mmol/l EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10 mmol/l HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "5 mmol/l MgATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0024471:MgATP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "(pH 7.25"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "adjusted with CsOH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456081:Adjusted [Functional Concept]

Phrase: ")."
Processing 00000000.tx.105: The bath solution for Kv and KATP current measurements contained 140 mmol/l NaCl, 4 mmol/l KCl, 1 mmol/l MgCl2, 2 mmol/l CaCl2, 2 mmol/l D-glucose, and 10 mmol/l HEPES (pH 7.3 adjusted with NaOH). 

Phrase: "The bath solution for Kv"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "KATP current measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "140 mmol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "4 mmol/l KCl,"

Phrase: "1 mmol/l MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2 mmol/l CaCl2,"

Phrase: "2 mmol/l D-glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C1705052:2-D [Spatial Concept]

Phrase: "and"

Phrase: "10 mmol/l HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "adjusted with NaOH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456081:Adjusted [Functional Concept]

Phrase: ")."
Processing 00000000.tx.106: The bath solution for Ca2+ current measurement was the same as above except that 20 mmol/l TEA-Cl was also added, and the concentration of CaCl2 was increased to 10 mmol/l. 

Phrase: "The bath solution for Ca2+ current measurement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "the same as above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1278655:SAME AS [Classification]
   770   C0445247:Same [Qualitative Concept]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that 20 mmol/l TEA-Cl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "also"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the concentration of CaCl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "increased to 10 mmol/l."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1532563:mmol/L [Quantitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0439190:MMOLE [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
Processing 00000000.tx.107: After the whole-cell configuration was established, the cell was held at 70 mV and subject to various experimental protocols as detailed in RESULTS and in the figure legends. 

Phrase: "After the whole-cell configuration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449830:Configuration [Spatial Concept]
   827   C2827597:Configuration [Conceptual Entity]

Phrase: "was"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "held at 70 mV"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1948036:held [Idea or Concept]
   770   C2987518:hELD [Amino Acid, Peptide, or Protein]
   737 E C1553387:Hold [Idea or Concept]
   737 E C1948035:Hold [Activity]

Phrase: "and subject to various experimental protocols"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C0442711:Protocols [Intellectual Product]
   753   C0681850:Subject [Group]
   753   C1515981:And [Idea or Concept]
   753   C1517586:Experimental [Qualitative Concept]
   753   C1550501:{Subject} [Idea or Concept]
   753   C1706203:Subject [Idea or Concept]
   753   C2349001:Subject [Human]
   753   C2697811:Subject [Functional Concept]
   719 E C1507394:Protocol [Intellectual Product]
   719 E C1522729:Protocol [Intellectual Product]
   719 E C2348563:Protocol [Intellectual Product]

Phrase: "as"

Phrase: "detailed in RESULTS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1522508:Detailed [Qualitative Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756 E C1561567:detail [Functional Concept]
   756   C2825142:Result [Finding]

Phrase: "and in the figure legends."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1515981:And [Idea or Concept]
   726   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.108: All experiments were performed at room temperature (22C). 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed at room temperature"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1547703:Room [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(22C"

Phrase: ")."
Processing 00000000.tx.109: Simultaneous measurement of capacitance and Ca2+ currents. 

Phrase: "Simultaneous measurement of capacitance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "and"

Phrase: "Ca2+ currents."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.110: Recording electrodes were coated with orthodontic wax (Butler, Guelph, ON, Canada) close to the tips and heat-polished. 

Phrase: "Recording electrodes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013812:Electrodes [Medical Device]
   827 E C1705652:Electrode [Medical Device]

Phrase: "were"

Phrase: "coated with orthodontic wax"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0043076:wax [Biologically Active Substance,Biomedical or Dental Material,Lipid]
   770   C0332276:Orthodontic [Functional Concept]
   770   C0740486:Wax [Body Substance]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Butler,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402644:Butler [Professional or Occupational Group]

Phrase: "Guelph,"

Phrase: "ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "close to the tips"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0339897:TIPS [Therapeutic or Preventive Procedure]
   770   C0587267:Close [Functional Concept]
   737 E C1710425:Tip [Medical Device]
   737 E C3282898:Tip [Qualitative Concept]

Phrase: "and"

Phrase: "heat-polished."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220896:polished [Population Group]
Processing 00000000.tx.111: Resistances ranged from 3.5 to 5 M when pipettes were filled with the intracellular solution, which contained 120 mmol/l CsCl, 20 mmol/l TEA-Cl, 1 mmol/l MgCl2, 0.1 mmol/l EGTA, 10 mmol/l HEPES, 0.1 mmol/l cAMP, and 5 mmol/l MgATP (pH 7.25 adjusted with CsOH). 

Phrase: "Resistances"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0237834:Resistance [Mental Process]
  1000   C1514892:Resistance [Physiologic Function]
   916 E C0332325:Resistant [Functional Concept]
   916 E C1550464:resistent [Idea or Concept]
   916 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "ranged from 3.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 5 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "when"

Phrase: "pipettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0182301:pipettes [Medical Device]
   966 E C1706407:Pipette [Medical Device]

Phrase: "were"

Phrase: "filled with the intracellular solution,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037633:Solution [Substance]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1708059:Filled [Activity]

Phrase: "which"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "120 mmol/l CsCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]

Phrase: "20 mmol/l TEA-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "1 mmol/l MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.1 mmol/l EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10 mmol/l HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.1 mmol/l cAMP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "5 mmol/l MgATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0024471:MgATP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "(pH 7.25"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "adjusted with CsOH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456081:Adjusted [Functional Concept]

Phrase: ")."
Processing 00000000.tx.112: The extracellular solution contained 140 mmol/l NaCl, 4 mmol/l KCl, 1 mmol/l MgCl2, 10 mmol/l CaCl2, 20 mmol/l TEA, 2 mmol/l D-glucose, and 10 mmol/l HEPES (pH 7.3 adjusted with NaOH). 

Phrase: "The extracellular solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "140 mmol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "4 mmol/l KCl,"

Phrase: "1 mmol/l MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 mmol/l CaCl2,"

Phrase: "20 mmol/l TEA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0076252:Tetraethylammonium [Organic Chemical,Pharmacologic Substance]

Phrase: "2 mmol/l D-glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C1705052:2-D [Spatial Concept]

Phrase: "and"

Phrase: "10 mmol/l HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0601906:PH 3 [Pharmacologic Substance]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "adjusted with NaOH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456081:Adjusted [Functional Concept]

Phrase: ")."
Processing 00000000.tx.113: Cell capacitance was estimated by the Lindau-Neher technique, implementing the "Sine + DC" feature of the Lock-in module (40 mV peak to peak and a frequency of 500 Hz) in the standard whole-cell configuration. 

Phrase: "Cell capacitance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242264:capacitance [Quantitative Concept]

Phrase: "was"

Phrase: "estimated by the Lindau-Neher technique,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449851:Technique [Functional Concept]
   753   C0750572:Estimated [Quantitative Concept]

Phrase: "implementing"

Phrase: "the ""Sine + DC"" feature of the Lock-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "in module"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709061:Module [Conceptual Entity]
   900 E C1031041:Modulus [Eukaryote]

Phrase: "(40 mV peak to peak"

Phrase: "and"

Phrase: "a frequency of 500 Hz)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "in the standard whole-cell configuration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449830:Configuration [Spatial Concept]
   812   C2827597:Configuration [Conceptual Entity]
Processing 00000000.tx.114: Recordings were conducted using an EPC9 patch clamp amplifier and Pulse software. 

Phrase: "Recordings"

Phrase: "were"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an EPC9 patch clamp amplifier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0002684:amplifier [Manufactured Object]
   812   C1706099:Amplifier [Manufactured Object]

Phrase: "and"

Phrase: "Pulse software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.115: Exocytic events were elicited by a train of eight 500-ms depolarizing pulses (1-Hz stimulation frequency) from 70 to 0 mV. 

Phrase: "Exocytic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "were"

Phrase: "elicited by a train of eight 500-ms depolarizing pulses"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C0449265:Elicited by [Qualitative Concept]
           elicited
   739   C0034107:Pulses [Health Care Activity]
   739   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205454:Eight [Quantitative Concept]
   739   C0336809:Train [Manufactured Object]
   739   C0391850:PULSES [Physiologic Function]
   739   C1552514:Train [Manufactured Object]
   739   C2349943:Ms. [Conceptual Entity]
   739   C3539704:MS [Gene or Genome]
   706 E C0232117:PULSE [Clinical Attribute]
   706 E C1947910:Pulse [Phenomenon or Process]

Phrase: "(1-Hz stimulation frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0376249:frequency [Quantitative Concept]
   812   C0439603:Frequency [Temporal Concept]
   812   C0871396:Frequency [Quantitative Concept]
   812   C1561548:Frequency [Qualitative Concept]
   812   C1705502:Frequency [Quantitative Concept]
   741 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "from 70"

Phrase: "to 0 mV."
Processing 00000000.tx.116: The experimental temperature was set at 2830C. 

Phrase: "The experimental temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "was"

Phrase: "set at 2830C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.117: Statistics. 

Phrase: "Statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.118: Results are presented as means  SE. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as means  SE."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0449450:Presented [Idea or Concept]
   770   C1704970:Means [Conceptual Entity]
   737 E C0150312:Present [Quantitative Concept]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.119: ANOVA was used for multiple group comparisons, and statistical significance was determined by Students t test. 

Phrase: "ANOVA"

Phrase: "was"

Phrase: "used for multiple group comparisons,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0439064:Multiple [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1273517:used [Finding]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1707455:Comparison [Activity]
   726 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined by Students t test."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:Students [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   726 E C1551041:student [Idea or Concept]
   726 E C1552573:student [Intellectual Product]
Processing 00000000.tx.120: A P value <0.05 was considered statistically significant.  

Phrase: "A P value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "<0.05"

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.121: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Generation of transgenic mice expressing human STX-1A. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "expressing"

Phrase: "human STX-1A."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420498:SYNTAXIN 1A [Gene or Genome]
   827   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]
Processing 00000000.tx.122: Four mouse lines were born that had integrated the genomic DNA fragment and all were able to transmit the transgene through their germline. 

Phrase: "Four mouse lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "born"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004897:Bear [Mammal]

Phrase: "that"

Phrase: "had"

Phrase: "integrated"

Phrase: "the genomic DNA fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]
   734   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "all"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "transmit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332289:transmit [Functional Concept]

Phrase: "the transgene through their germline."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.123: Of these four lines, three (designated A11, B14, and B15) were found to express human STX-1A mRNA as evidenced by RT-PCR amplification of human-specific STX-1A transcript from brain total RNA. 

Phrase: "Of these four lines,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "(designated A11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1848335:A11 [Gene or Genome]

Phrase: "B14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417627:B14 [Gene or Genome]

Phrase: "and"

Phrase: "B15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417636:B15 [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "human STX-1A mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "evidenced by RT-PCR amplification of human-specific STX-1A transcript"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   756   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0599161:RT-PCR [Molecular Biology Research Technique]
   756   C1420498:SYNTAXIN 1A [Gene or Genome]
   738   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   738   C0086418:Human [Human]
   738   C0205369:Specific [Qualitative Concept]
   738   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0450344:1A [Intellectual Product]
   738   C0677874:pCR [Finding]
   738   C1517480:Amplification [Molecular Biology Research Technique]
   738   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C1521871:Amplification [Phenomenon or Process]
   738   C1552740:specific [Intellectual Product]
   738   C1553633:1a [Medical Device]
   738   C1705759:Amplification [Cell or Molecular Dysfunction]
   737   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "from brain total RNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.124: Copy number determination was performed, and the lines were calculated to contain four, two, and one copy of the human genomic fragment, respectively (Fig. 1A). 

Phrase: "Copy number determination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1148554:determination [Laboratory Procedure]
   734   C1707513:Copy Number [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "and"

Phrase: "the lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "four,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "two,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "and"

Phrase: "one copy of the human genomic fragment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1948062:Copy [Manufactured Object]

Phrase: "respectively"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.125: Expression analysis demonstrated an abundant human STX-1A message in the brains of all three lines, with barely detectable levels present in the liver, kidney, lung, and intestine (data not shown), suggesting that the transgene was expressed under the control of its endogenous regulatory elements. 

Phrase: "Expression analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "an abundant human STX-1A message in the brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0470166:Message [Intellectual Product]

Phrase: "of all three lines,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "with barely detectable levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "present in the liver,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]

Phrase: "was"

Phrase: "expressed under the control of its endogenous regulatory elements."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   742   C0013879:Elements [Element, Ion, or Isotope]
   742   C0205227:Endogenous [Functional Concept]
   742   C0220905:regulatory [Regulation or Law]
   742   C0243148:control [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1704735:Regulatory [Conceptual Entity]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   731   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   708 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.126: Irrespective of their genetic background, the STX-1A mice were indistinguishable from their control littermates with respect to their appearance, growth, and fertility in the animal facility. 

Phrase: "Irrespective of their genetic background,"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "the STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "were"

Phrase: "indistinguishable from their control littermates"

Phrase: "with respect to their appearance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233426:Appearance [Organism Attribute]
  1000   C0700364:Appearance [Qualitative Concept]

Phrase: "growth,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "fertility in the animal facility."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015895:Fertility [Organism Function]
   760   C0200069:Fertility [Diagnostic Procedure]
   760   C2986895:Fertility [Idea or Concept]
Processing 00000000.tx.127: The gross histology of the STX-1A mice brain (data not shown) and pancreas (Fig. 1B, islets indicated by arrows) were normal. 

Phrase: "The gross histology of the STX-1A mice brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0019638:Histology [Biomedical Occupation or Discipline]
   742   C0205462:histology [Functional Concept]
   742   C0344441:Histology [Laboratory Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "islets"

Phrase: "indicated by arrows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]

Phrase: ")"

Phrase: "were"

Phrase: "normal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.128: We did not observe any premature deaths recorded at birth for all lines of the STX-1A mice, and some of these mice were allowed to live past 52 weeks of age and remained healthy. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "any premature deaths"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1855073:Premature Deaths [Finding]
   861   C0011065:deaths [Organism Function]
   861   C1306577:DEATHS [Finding]

Phrase: "recorded at birth"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   841   C0005609:Record, Birth [Manufactured Object]
   790   C0005615:Birth [Organism Function]
   790   C1550722:birth [Idea or Concept]
   790   C3245487:birth [Intellectual Product]
   756   C0034869:Record [Intellectual Product]
   734 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   734 E C0314603:Genetic [Functional Concept]
   734 E C0454729:Natal [Geographic Area]
   706 E C0035150:Reproduction [Organism Function]
   706 E C0079946:origin [Classification]
   706 E C0439659:Origin [Temporal Concept]
   706 E C1550512:origin [Intellectual Product]

Phrase: "for all lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "of the STX-1A mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "and"

Phrase: "some of these mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "live"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1548795:Live [Qualitative Concept]
  1000   C1634625:% live [Qualitative Concept]
  1000   C2982691:Live [Activity]

Phrase: "past 52 weeks of age"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C2987125:Past Week [Temporal Concept]
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "and"

Phrase: "remained healthy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0018684:Health [Idea or Concept]
   789   C0031206:healthiness [Finding]
Processing 00000000.tx.129: View larger version (39K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.130: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.131: Generation of transgenic mice expressing human STX-1A. 

Phrase: "Generation of transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "expressing"

Phrase: "human STX-1A."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420498:SYNTAXIN 1A [Gene or Genome]
   827   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]
Processing 00000000.tx.132: A: Human STX-1A transgene copy number of the STX-1A mouse lines (A11, B14, and B15). 

Phrase: "A"

Phrase: ":"

Phrase: "Human STX-1A transgene copy number of the STX-1A mouse lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1707513:Copy Number [Quantitative Concept]
   736   C0237753:*Number [Quantitative Concept]
   736   C0449788:Number [Quantitative Concept]
   736   C1948062:Copy [Manufactured Object]

Phrase: "(A11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1848335:A11 [Gene or Genome]

Phrase: "B14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417627:B14 [Gene or Genome]

Phrase: "and"

Phrase: "B15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417636:B15 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.133: Replicate samples from two mice of each line are shown. 

Phrase: "Replicate samples from two mice of each line"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.134: B: STX-1A mice have normal pancreatic histology (hematoxylin and eosin stain). 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "have"

Phrase: "normal pancreatic histology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0019638:Histology [Biomedical Occupation or Discipline]
   827   C0205462:histology [Functional Concept]
   827   C0344441:Histology [Laboratory Procedure]

Phrase: "(hematoxylin and eosin stain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   902   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   812   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   812   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.135: Arrows point to the islets. 

Phrase: "Arrows point to the islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
Processing 00000000.tx.136: C: Basal serum glucose levels of the STX-1A A11 and B14 mouse lines at 1 year of age. 

Phrase: "C"

Phrase: ":"

Phrase: "Basal serum glucose levels of the STX-1A A11"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   784   C0583332:glucose levels serum [Laboratory or Test Result]
   764   C0202041:Serum Glucose [Laboratory Procedure]
   764   C0428548:glucose levels [Laboratory or Test Result]
   762 E C3534430:Glucose.serum [Laboratory or Test Result]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0229671:Serum [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   731 E C0337438:glucose level [Laboratory Procedure]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "B14 mouse lines at 1 year of age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439234:year [Temporal Concept]
   744   C0439508:/year [Temporal Concept]
Processing 00000000.tx.137: Values are means  SE (wild-type [WT] mice, n = 6; B14 STX-1A mice, n = 9; A11 STX-1A mice, n = 5). 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE (wild-type [WT] mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C1520150:Wild Type Mouse [Mammal]
   840   C1883559:Wild Type [Organism Attribute]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; B14 STX-1A mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; A11 STX-1A mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.138: **P < 0.01 compared with wild-type littermates.  

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with wild-type littermates."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.139: However, when we determined the basal fasting glucose levels at 1 year of age (Fig. 1C), the B14 STX-1A mouse line glucose levels were higher (7.50  0.12 mmol/l, n = 9) when compared with wild-type mice (5.30  0.32 mmol/l, n = 6, P < 0.01), whereas the A11 STX-1A mouse line exhibited even higher basal glucose levels (8.20  0.29 mmol/l, n = 5, P < 0.01). 

Phrase: "However,"

Phrase: "when"

Phrase: "we"

Phrase: "determined"

Phrase: "the basal fasting glucose levels at 1 year of age (Fig. 1C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0439234:year [Temporal Concept]
   736   C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "the B14 STX-1A mouse line glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   818   C0428548:glucose levels [Laboratory or Test Result]
   795   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   795   C0441889:Levels [Qualitative Concept]
   785 E C0337438:glucose level [Laboratory Procedure]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "(7.50  0.12 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "when"

Phrase: "compared with wild-type mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   828   C1520150:Wild Type Mouse [Mammal]
   806   C1883559:Wild Type [Organism Attribute]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "(5.30  0.32 mmol/l,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   895   C2348935:.5 L [Quantitative Concept]
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the A11 STX-1A mouse line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205132:Line [Spatial Concept]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "even higher basal glucose levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   840   C0428548:glucose levels [Laboratory or Test Result]
   836   C0860803:high glucose [Finding]
   806 E C0337438:glucose level [Laboratory Procedure]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "(8.20  0.29 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "n = 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.140: The basal glucose levels at 12 weeks of age were also similarly higher in the A11 (7.20  0.46 mmol/l, n = 4) and B14 (6.60  1.44 mmol/l, n = 3) lines compared with wild-type littermates (4.40  0.75 mmol/l, n = 6, P < 0.01). 

Phrase: "The basal glucose levels at 12 weeks of age"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   764   C0428548:glucose levels [Laboratory or Test Result]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0441889:Levels [Qualitative Concept]
   731 E C0337438:glucose level [Laboratory Procedure]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also similarly higher in the A11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(7.20  0.46 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "B14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417627:B14 [Gene or Genome]

Phrase: "(6.60  1.44 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "compared with wild-type littermates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "(4.40  0.75 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.141: Both the A11 and B14 lines also showed increased pancreatic islet expression of STX-1A protein (see below), which along with the corresponding increase in basal glucose levels (B15 line not tested), indicated that the STX-1A transgene was exerting an effect that was independent of the site of insertion in the mouse genome. 

Phrase: "Both"

Phrase: "the A11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1848335:A11 [Gene or Genome]

Phrase: "and"

Phrase: "B14 lines also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "increased pancreatic islet expression of STX-1A protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "which along with the corresponding increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in basal glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(B15 line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the STX-1A transgene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0282641:Transgene [Gene or Genome]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "was"

Phrase: "exerting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exerting [Organism Function]

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "was independent of the site of insertion"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0449682:Site of insertion [Spatial Concept]
           Insertion site
   778   C0332291:Independent of [Functional Concept]
   774   C1705686:Insertion Site [Nucleotide Sequence]
   774   C2945843:Site of [Qualitative Concept]
   748   C0021107:Insertion [Therapeutic or Preventive Procedure]
   748   C0043194:WAS [Disease or Syndrome]
   748   C0085862:Independent [Idea or Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441587:Insertion [Health Care Activity]
   748   C1299583:Independent [Finding]
   748   C1421478:WAS [Gene or Genome]
   748   C1512796:Insertion [Genetic Function]
   748   C1515974:Site [Body Location or Region]
   748   C1883719:Insertion [Functional Concept]
   748   C2825164:Site [Spatial Concept]

Phrase: "in the mouse genome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017428:Genome [Gene or Genome]
   861   C2338314:Genome [Conceptual Entity]
Processing 00000000.tx.142: Because the A11 line had higher islet STX-1A protein levels and more consistently exhibited higher baseline glucose levels, all subsequent studies on glucose homeostasis and islet functions were performed on the A11 line alone. 

Phrase: "Because"

Phrase: "the A11 line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "had"

Phrase: "higher islet STX-1A protein levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   839   C0288881:Syntaxin Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441889:Levels [Qualitative Concept]
   793   C0428479:Protein level [Laboratory or Test Result]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "more consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "higher baseline glucose levels,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0428548:glucose levels [Laboratory or Test Result]
   858   C0860803:high glucose [Finding]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "all subsequent studies on glucose homeostasis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "islet functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "were"

Phrase: "performed on the A11 line"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205132:Line [Spatial Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1848335:A11 [Gene or Genome]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.143: At 18 weeks of age, when these mice were of optimal size for the in vivo studies and islet isolation, we examined their weights. 

Phrase: "At 18 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "when"

Phrase: "these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were of optimal size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456389:size [Spatial Concept]
   770   C2698651:Optimal [Qualitative Concept]

Phrase: "for the in vivo studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0681829:in vivo study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "islet isolation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "their weights."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043100:Weights [Quantitative Concept]
   966 E C0005910:weight [Organism Attribute]
   966 E C1305866:weight [Diagnostic Procedure]
   966 E C1705104:Weight [Idea or Concept]
Processing 00000000.tx.144: The weights of the STX-1A mice (A11 line) and wild-type mice were not significantly different for either males (STX-1A, 30.00  2.00 g vs. wild type, 29.00  1.00 g; n = 14) or females (STX-1A, 26.00  1.00 g vs. wild type, 27.00  1.00 g; n = 14). 

Phrase: "The weights of the STX-1A mice"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0043100:Weights [Quantitative Concept]
   714 E C0005910:weight [Organism Attribute]
   714 E C1305866:weight [Diagnostic Procedure]
   714 E C1705104:Weight [Idea or Concept]

Phrase: "(A11 line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "not significantly different for either males"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "(STX-1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "30.00  2.00 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]

Phrase: "vs. wild type, 29.00  1.00 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0439267:g% [Quantitative Concept]

Phrase: "; n = 14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "(STX-1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "26.00  1.00 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]

Phrase: "vs. wild type, 27.00  1.00 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0439267:g% [Quantitative Concept]

Phrase: "; n = 14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.145: Expression of human STX-1A is confirmed in the pancreatic islets. 

Phrase: "Expression of human STX-1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "confirmed in the pancreatic islets."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   726 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.146: The basal hyperglycemia in the STX-1A mice suggested a possible insulin secretory defect of the pancreatic islets, in which STX-1A is known to be abundant and plays important roles in insulin secretion. 

Phrase: "The basal hyperglycemia in the STX-1A mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020456:Hyperglycaemia [Disease or Syndrome]
   731   C0162418:Hyperglycemic Mice [Mammal]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a possible insulin secretory defect of the pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1457869:Defect [Functional Concept]
   742   C1861101:DEFECT [Disease or Syndrome]

Phrase: "in which STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "abundant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "important roles in insulin secretion."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.147: Because the human STX-1A transgene expression is under its own transcriptional control, we expected to find corresponding changes in the STX-1A levels in the islets of the STX-1A mouse pancreas. 

Phrase: "Because"

Phrase: "the human STX-1A transgene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0282641:Transgene [Gene or Genome]

Phrase: "is under its own transcriptional control,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1158770:Transcriptional Control [Genetic Function]
   753   C0040649:Transcriptional [Genetic Function]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "corresponding changes in the STX-1A levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "in the islets"

Phrase: "of the STX-1A mouse pancreas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1518865:Mouse Pancreas [Tissue]
   812   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   812   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.148: Figure 2A shows a representative experiment of the actual blots of the levels of the indicated proteins of the isolated islets of a single wild-type and STX-1A mouse. 

Phrase: "Figure 2A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a representative experiment of the actual blots of the levels of the indicated proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0681814:Experiment [Research Activity]
   734   C1706386:Experiment [Conceptual Entity]

Phrase: "of the isolated islets"

Phrase: "of a single wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "STX-1A mouse."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]
Processing 00000000.tx.149: Figure 2B shows the densitometry quantification of three to four independent islet isolations, represented as percentages of the wild-type littermates signals. 

Phrase: "Figure 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the densitometry quantification of three to four independent islet isolations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709793:Quantification [Quantitative Concept]

Phrase: "represented as percentages of the wild-type littermates signals."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1883559:Wild Type [Organism Attribute]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C1547052:*Type [Quantitative Concept]
   708   C0439165:Percentage [Quantitative Concept]
   708   C1549488:Percentage [Idea or Concept]
   708   C1561533:Percentage [Idea or Concept]
   708   C1710082:Signal [Phenomenon or Process]
   708   C1882932:Represent [Activity]
Processing 00000000.tx.150: Islets from the A11 line showed a 28.38  8.09% (P < 0.05) increase in STX-1A protein expression, compared with those from the wild-type mice, whereas the B14 lines showed a small increase of only 510% (data not shown). 

Phrase: "Islets from the A11 line"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 28.38  8.09%"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increase in STX-1A protein expression,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin-1A
   790   C1171362:protein expression [Genetic Function]
   790   C1420498:SYNTAXIN 1A [Gene or Genome]
   783   C0288881:Syntaxin Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442805:Increase [Functional Concept]
   753   C0450344:1A [Intellectual Product]
   753   C1553633:1a [Medical Device]

Phrase: "compared with those from the wild-type mice,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1883559:Wild Type [Organism Attribute]
   767   C1520150:Wild Type Mouse [Mammal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1547052:*Type [Quantitative Concept]
   744   C1707455:Compared [Activity]

Phrase: "whereas"

Phrase: "the B14 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a small increase of only 510%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.151: The relatively low levels of STX-1A protein expression in each line are likely due to differences between humans and mice in the specificity of factors involved in the regulation of transcription or translation. 

Phrase: "The relatively low levels of STX-1A protein expression"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0748025:Low protein level [Finding]
   745   C0428479:Protein level [Laboratory or Test Result]
   745   C3244092:expression level [Idea or Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "in each line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: "are"

Phrase: "likely due to differences"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0332148:Likely [Qualitative Concept]
   770   C0750492:Likely [Idea or Concept]
   770   C3146286:Due [Idea or Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "and"

Phrase: "mice in the specificity of factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "involved in the regulation of transcription"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1158770:Transcription Regulation [Genetic Function]
   753   C0040649:Transcription [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1314939:Involved [Functional Concept]
   753   C1327622:Regulation [Biologic Function]

Phrase: "or"

Phrase: "translation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]
Processing 00000000.tx.152: We then examined whether this increase in STX-1A expression in the A11 STX-1A mouse islets might influence the expression of the cognate SNARE proteins (SNAP-25 and VAMP-2) and major STX-1Ainteracting protein Munc18a (19,20). 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "this increase in STX-1A expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in the A11 STX-1A mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C1522528:Mouse Islets [Tissue]

Phrase: "might"

Phrase: "influence"

Phrase: "the expression of the cognate SNARE proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(SNAP-25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   846   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "VAMP-2"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0148340:Vesicle-Associated Membrane Protein 2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 [Gene or Genome]
   937   C0078208:Vesicle-Associated Membrane Protein [Amino Acid, Peptide, or Protein,Receptor]
   853   C1167317:vesicle membrane [Cell Component]
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   804   C0333262:Vesicle [Acquired Abnormality]
   804   C0596901:Membrane [Cell Component]
   804   C1622418:vesicle [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
   733 E C0205287:Membranous [Qualitative Concept]
   733 E C0205378:Vesicular [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "major STX-1Ainteracting protein Munc18a"

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.153: Compared with wild-type littermate islets, the A11 STX-1A mice islet VAMP-2 and SNAP-25 levels were unchanged. 

Phrase: "Compared with wild-type littermate islets,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "the A11 STX-1A mice islet VAMP-2"
Meta Candidates (Total=23; Excluded=4; Pruned=0; Remaining=19)
   880   C0651677:Syntaxin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   880   C1823140:SYNTAXIN 2 [Gene or Genome]
   872   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   868   C0288881:Syntaxin Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1564880:vesicle-associated membrane protein 2, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0148340:Vesicle-Associated Membrane Protein 2 [Amino Acid, Peptide, or Protein,Receptor]
   861   C1421419:VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 [Gene or Genome]
   846   C1425576:ISLET 2 [Gene or Genome]
   840   C0078208:Vesicle-Associated Membrane Protein [Amino Acid, Peptide, or Protein,Receptor]
   830   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   813   C1167317:vesicle membrane [Cell Component]
   804   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0025255:Membrane [Tissue]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated [Qualitative Concept]
   790   C0333262:Vesicle [Acquired Abnormality]
   790   C0596901:Membrane [Cell Component]
   790   C1622418:vesicle [Cell Component]
   790   C1706182:Membrane [Manufactured Object]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0205287:Membranous [Qualitative Concept]
   718 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "SNAP-25 levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   822   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.154: Surprisingly, in the STX-1A mice (A11), islet Munc18a levels showed a paradoxical reduction in protein expression by 30.84  14.14% (P < 0.05) compared with those from the wild-type mice. 

Phrase: "Surprisingly,"

Phrase: "in the STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "(A11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1848335:A11 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "islet Munc18a levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a paradoxical reduction in protein expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "by 30.84  14.14%"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with those from the wild-type mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1883559:Wild Type [Organism Attribute]
   767   C1520150:Wild Type Mouse [Mammal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1547052:*Type [Quantitative Concept]
   744   C1707455:Compared [Activity]
Processing 00000000.tx.155: The expression levels of actin served as an indicator of equal protein loading. 

Phrase: "The expression levels of actin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "served as an indicator of equal protein loading."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205163:Equal [Qualitative Concept]
   744   C1235732:Indicator [Bird]
   744   C1522602:Indicator [Functional Concept]
   744   C1549782:Equal [Idea or Concept]
   744   C1708715:Loading [Activity]
Processing 00000000.tx.156: We also determined the insulin content of the A11 STX-1A mice islets (by radioimmunoassay), which was not significantly different from the wild-type littermates in both males (STX-1A, 1.87  0.29 ng/ml vs. wild type, 2.02  0.53 ng/ml) and females (STX-1A, 1.72  0.41 ng/ml vs. wild type, 1.92  0.13 ng/ml). 

Phrase: "We also"

Phrase: "determined"

Phrase: "the insulin content of the A11 STX-1A mice islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "("

Phrase: "by radioimmunoassay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:Radioimmunoassay [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "not significantly different from the wild-type littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]

Phrase: "in both males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: "(STX-1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "1.87  0.29 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "vs. wild type, 2.02  0.53 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439275:ng/mL [Quantitative Concept]
   793   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "(STX-1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "1.72  0.41 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "vs. wild type, 1.92  0.13 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439275:ng/mL [Quantitative Concept]
   793   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.157: View larger version (40K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.159: Pancreatic islet levels of SNARE and STX-1Aactivating proteins in the A11 STX-1A mouse line (four copies of the STX-1A transgene; Fig. 1A) and control wild-type (WT) littermates. 

Phrase: "Pancreatic islet levels of SNARE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "STX-1Aactivating proteins in the A11 STX-1A mouse line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   761   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0288881:Syntaxin Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0074447:Stx Protein [Hazardous or Poisonous Substance,Organic Chemical]
   741   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "copies of the STX-1A transgene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420498:SYNTAXIN 1A [Gene or Genome]
   753   C0282641:Transgene [Gene or Genome]
   753   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0450344:1A [Intellectual Product]
   753   C1553633:1a [Medical Device]
   753   C1948062:Copies [Manufactured Object]

Phrase: "; Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "littermates."
Processing 00000000.tx.160: Pancreatic islet samples (20 g protein per lane) were resolved on a 15% SDS-PAGE, and the separated proteins were identified by the indicated antibodies. 

Phrase: "Pancreatic islet samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]

Phrase: "(20 g protein per lane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   797 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "resolved on a 15% SDS-PAGE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C1514893:Resolved [Idea or Concept]
   753   C1704732:Page [Intellectual Product]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "the separated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "identified by the indicated antibodies."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0368672:Antibodies identified [Laboratory or Test Result]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205396:Identified [Qualitative Concept]
   760   C1444656:Indicated [Finding]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.161: A: A representative experiment of islets isolated from one set of wild-type and STX-1A mice. 

Phrase: "A"

Phrase: ":"

Phrase: "A representative experiment of islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0681814:Experiment [Research Activity]
   760   C1706386:Experiment [Conceptual Entity]

Phrase: "isolated from one"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205409:Isolated [Functional Concept]
   790   C0205447:One [Quantitative Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "set of wild-type"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0036849:Set [Mental Process]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1442518:Set [Functional Concept]
   770   C1547052:*Type [Quantitative Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "STX-1A mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]
Processing 00000000.tx.162: B: The densitometry performed on each of three to four independent islet isolations and presented as a percentage of the signals of the wild-type littermate. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "The densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]

Phrase: "performed on each of three to four independent islet isolations"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   757   C0332291:Independent of [Functional Concept]
   739   C0085862:Independent [Idea or Concept]
   739   C0204727:isolations [Therapeutic or Preventive Procedure]
   739   C0205449:Three [Quantitative Concept]
   739   C0205450:Four [Quantitative Concept]
   739   C0884358:Performed [Functional Concept]
   739   C1299583:Independent [Finding]
   706 E C0205409:Isolation [Functional Concept]
   706 E C0220862:isolation [Laboratory Procedure]
   706 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "presented as a percentage of the signals of the wild-type littermate."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C1883559:Wild Type [Organism Attribute]
   736   C0332307:Type [Qualitative Concept]
   736   C0439165:Percentage [Quantitative Concept]
   736   C0445392:Wild [Intellectual Product]
   736   C0449450:Presented [Idea or Concept]
   736   C1547052:*Type [Quantitative Concept]
   736   C1549488:Percentage [Idea or Concept]
   736   C1561533:Percentage [Idea or Concept]
   703 E C0150312:Present [Quantitative Concept]
   703   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.163: *P and **P are <0.05 compared with wild-type littermates.  

Phrase: "*P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and **"

Phrase: "P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "are <"

Phrase: "0.05"

Phrase: "compared with wild-type littermates."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.164: STX-1A mice exhibit glucose intolerance during IPGTT. 

Phrase: "STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "glucose intolerance during IPGTT."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0271650:Glucose Intolerance [Disease or Syndrome]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0231199:Intolerance [Organism Function]
   770   C1744706:intolerance [Intellectual Product]
   770   C2355652:Intolerance [Organism Attribute]
Processing 00000000.tx.165: We had hypothesized that the slight increase in STX-1A levels in the islets might be sufficient to induce an abnormality in glucose homeostasis, which we examined by IPGTT. 

Phrase: "We"

Phrase: "had"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the slight increase in STX-1A levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in the islets"

Phrase: "might"

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an abnormality in glucose homeostasis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0580546:Abnormal glucose [Finding]
   760   C1704258:Abnormality [Finding]

Phrase: "which"

Phrase: "we"

Phrase: "examined by IPGTT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332128:Examined [Finding]
Processing 00000000.tx.166: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.167: 3, both male and female groups of STX-1A mice exhibited significantly higher levels of fasting blood glucose levels compared with control littermates. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "both male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]

Phrase: "groups of STX-1A mice"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   806   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1420498:SYNTAXIN 1A [Gene or Genome]
   797   C0441862:Group 1A [Intellectual Product]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441833:Group [Idea or Concept]
   760   C0450344:1A [Intellectual Product]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1553633:1a [Medical Device]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "significantly higher levels of fasting blood glucose levels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   815   C0428568:blood fasting glucose levels [Laboratory Procedure]
   815   C1261430:blood fasting glucose levels [Laboratory or Test Result]
   800   C0428554:blood glucose levels [Laboratory or Test Result]
   770   C0428548:glucose levels [Laboratory or Test Result]
   737 E C0337438:glucose level [Laboratory Procedure]

Phrase: "compared with control littermates."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.168: This was more evident in the STX-1A male mice (STX-1A, 8.12  0.26 mmol/l, vs. wild type, 7.33  0.14 mmol/l, P < 0.05) than the STX-1A female mice (STX-1A, 7.88  0.22 mmol/l, vs. wild type, 6.54  0.04 mmol/l, P < 0.05). 

Phrase: "This"

Phrase: "was"

Phrase: "more evident in the STX-1A male mice"

Phrase: "(STX-1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "8.12  0.26 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "vs. wild type, 7.33  0.14 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1532563:mmol/L [Quantitative Concept]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "than the STX-1A female mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(STX-1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "7.88  0.22 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "vs. wild type, 6.54  0.04 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1532563:mmol/L [Quantitative Concept]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.169: After the intraperitoneal glucose injection, the serum glucose rise in both male and female groups of the STX-1A mice were significantly higher than the control littermates but were observed to be more severe in the male STX-1A mice. 

Phrase: "After the intraperitoneal glucose injection,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1828121:Injection [Functional Concept]

Phrase: "the serum glucose rise in both male"

Phrase: "and"

Phrase: "female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]

Phrase: "groups of the STX-1A mice"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420498:SYNTAXIN 1A [Gene or Genome]
   783   C0441862:Group 1A [Intellectual Product]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441833:Group [Idea or Concept]
   753   C0450344:1A [Intellectual Product]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1553633:1a [Medical Device]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "significantly higher than the control littermates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "but"

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more severe in the male STX-1A mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205082:Severe [Qualitative Concept]
Processing 00000000.tx.170: At 30 min, peak serum glucose levels for STX-1A male mice were 18.80  0.36 mmol/l, compared with wild-type male littermates of 13.10  0.15 mmol/l (P < 0.05). 

Phrase: "At 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "peak serum glucose levels for STX-1A male mice"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   784   C0583332:glucose levels serum [Laboratory or Test Result]
   770   C1546743:Serum, Peak Level [Intellectual Product]
   764   C0202041:Serum Glucose [Laboratory Procedure]
   764   C0428548:glucose levels [Laboratory or Test Result]
   762 E C3534430:Glucose.serum [Laboratory or Test Result]
   745   C0444505:Peak level [Quantitative Concept]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0229671:Serum [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   731 E C0337438:glucose level [Laboratory Procedure]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "18.80  0.36 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "compared with wild-type male littermates"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0024554:Male [Finding]
   753   C0086582:male [Population Group]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1706180:Male [Qualitative Concept]
   753   C1706428:Male [Qualitative Concept]
   753   C1706429:Male [Organism Attribute]
   753   C1707455:Compared [Activity]

Phrase: "of 13.10  0.15 mmol/l (P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   807   C1532563:mmol/L [Quantitative Concept]
   791   C0439190:MMOLE [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.171: At 30 min, serum glucose levels for STX-1A female mice were also measured to be at 15.02  0.32 mmol/l compared with wild-type female littermates of 13.28  0.42 mmol/l (P < 0.05). 

Phrase: "At 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "serum glucose levels for STX-1A female mice"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   793   C0583332:glucose levels serum [Laboratory or Test Result]
   770   C0202041:Serum Glucose [Laboratory Procedure]
   770   C0428548:glucose levels [Laboratory or Test Result]
   767 E C3534430:Glucose.serum [Laboratory or Test Result]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0229671:Serum [Body Substance]
   744   C0441889:Levels [Qualitative Concept]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   737 E C0337438:glucose level [Laboratory Procedure]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be at 15.02  0.32 mmol/l"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1532563:mmol/L [Quantitative Concept]
   744   C0439190:MMOLE [Quantitative Concept]
   744   C2987476:Be [Conceptual Entity]

Phrase: "compared with wild-type female littermates"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0015780:Female [Finding]
   753   C0043210:female [Population Group]
   753   C0086287:female [Population Group]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1705497:Female [Qualitative Concept]
   753   C1705498:Female [Qualitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "of 13.28  0.42 mmol/l (P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   807   C1532563:mmol/L [Quantitative Concept]
   791   C0439190:MMOLE [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.172: This abnormal glucose homeostasis was sustained up to 120 min of serum glucose recording; 

Phrase: "This abnormal glucose homeostasis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1326961:glucose homeostasis [Physiologic Function]
   827   C0019868:Homeostasis [Biologic Function]
   734   C0580546:Abnormal glucose [Finding]

Phrase: "was"

Phrase: "sustained up to 120 min of serum glucose recording"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C0202041:Serum Glucose [Laboratory Procedure]
   762 E C3534430:Glucose.serum [Laboratory or Test Result]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0229671:Serum [Body Substance]
   742   C0443318:Sustained [Functional Concept]
   742   C0702093:/min [Temporal Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   708 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.173: the STX-1A male and female mice had a recorded glucose level of 13.23  0.31 and 10.82  0.54 mmol/l, respectively, which were significantly higher than their control littermates of 8.60  0.28 and 8.00  0.37 mmol/l (P < 0.05), respectively. 

Phrase: "the STX-1A male"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0024554:Male [Finding]
   827   C0086582:male [Population Group]
   827   C1706180:Male [Qualitative Concept]
   827   C1706428:Male [Qualitative Concept]
   827   C1706429:Male [Organism Attribute]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "and"

Phrase: "female mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "a recorded glucose level of 13.23  0.31"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0337438:glucose level [Laboratory Procedure]
   764   C0428548:Glucose level [Laboratory or Test Result]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "10.82  0.54 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "respectively,"

Phrase: "which"

Phrase: "were"

Phrase: "significantly higher than their control littermates of 8.60  0.28"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   704   C0205250:High [Qualitative Concept]
   704   C1299351:High [Qualitative Concept]
   704   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "8.00  0.37 mmol/l (P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   807   C1532563:mmol/L [Quantitative Concept]
   791   C0439190:MMOLE [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.174: These results taken together suggest that the STX-1A mice exhibited glucose intolerance that was more severe in males compared with females. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "glucose intolerance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0271650:Glucose Intolerance [Disease or Syndrome]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0231199:Intolerance [Organism Function]
   861   C1744706:intolerance [Intellectual Product]
   861   C2355652:Intolerance [Organism Attribute]
   789 E C0231200:Intolerant [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "more severe in males"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205082:Severe [Qualitative Concept]

Phrase: "compared with females."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0015780:Females [Finding]
   790   C0086287:Females [Population Group]
   790   C1707455:Compared [Activity]
   756 E C0043210:female [Population Group]
   756 E C1705497:Female [Qualitative Concept]
   756 E C1705498:Female [Qualitative Concept]
Processing 00000000.tx.175: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.176: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.177: STX-1A mice exhibit fasting hyperglycemia and sustained hyperglycemia during an IPGTT compared with wild-type (WT) littermates. 

Phrase: "STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "fasting hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "sustained hyperglycemia during an IPGTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "compared with wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "littermates."
Processing 00000000.tx.178: All values are means  SE from six male mice per group and four female mice per group. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE from six male mice"

Phrase: "per group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "four female mice per group."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
Processing 00000000.tx.179: +P < 0.05 for male and *P < 0.05 for female STX-1A mice vs. wild-type mice.  

Phrase: "+P < 0.05 for male"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0024554:Male [Finding]
   760   C0086582:male [Population Group]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1706180:Male [Qualitative Concept]
   760   C1706428:Male [Qualitative Concept]
   760   C1706429:Male [Organism Attribute]
   760   C2603361:P' [Clinical Attribute]

Phrase: "and *"

Phrase: "P < 0.05 for female STX-1A mice"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420498:SYNTAXIN 1A [Gene or Genome]
   744   C0015780:Female [Finding]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0043210:female [Population Group]
   744   C0086287:female [Population Group]
   744   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0450344:1A [Intellectual Product]
   744   C1553633:1a [Medical Device]
   744   C1705497:Female [Qualitative Concept]
   744   C1705498:Female [Qualitative Concept]
   744   C2603361:P' [Clinical Attribute]

Phrase: "vs. wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.180: STX-1A mice release less insulin during IPGTT. 

Phrase: "STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "less insulin during IPGTT."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.181: The glucose intolerance exhibited by the STX-1A mice during the IPGTT can be due to either reduced insulin release into the circulation or the resistance of peripheral tissues to the insulin action. 

Phrase: "The glucose intolerance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0271650:Glucose Intolerance [Disease or Syndrome]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0231199:Intolerance [Organism Function]
   861   C1744706:intolerance [Intellectual Product]
   861   C2355652:Intolerance [Organism Attribute]
   789 E C0231200:Intolerant [Functional Concept]

Phrase: "exhibited by the STX-1A mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420498:SYNTAXIN 1A [Gene or Genome]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0450344:1A [Intellectual Product]
   753   C1553633:1a [Medical Device]
   719   C0015272:Exhibit [Intellectual Product]

Phrase: "during the IPGTT"

Phrase: "can"

Phrase: "be due to either reduced insulin release"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]

Phrase: "into the circulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]

Phrase: "or"

Phrase: "the resistance of peripheral tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1258192:Peripheral Resistance [Physiologic Function]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]

Phrase: "to the insulin action."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.182: We first examined the insulin that is released into the bloodstream during the IPGTT (Fig. 4A). 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "released into the bloodstream"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0005775:Bloodstream [Physiologic Function]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "during the IPGTT"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.183: Of note, the fasting serum levels were already significantly lower in both STX-1A male (0.30  0.02 ng/ml) and female (0.40  0.02 ng/ml) mice compared with the control male (0.42  0.05 ng/ml, P < 0.01) and female (0.56  0.03 ng/ml, P < 0.05) littermates, which may in part account for the differences in fasting blood glucose (in Fig. 2). 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the fasting serum levels"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0015663:Fasting [Finding]
   827   C0229671:Serum [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456079:Level [Classification]
   793 E C0456962:Fast [Qualitative Concept]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "already significantly lower in both STX-1A male"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0441994:Lower [Spatial Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C2003888:Lower [Activity]

Phrase: "(0.30  0.02 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]

Phrase: "(0.40  0.02 ng/ml) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "compared with the control male"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0024554:Male [Finding]
   760   C0086582:male [Population Group]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1706180:Male [Qualitative Concept]
   760   C1706428:Male [Qualitative Concept]
   760   C1706429:Male [Organism Attribute]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(0.42  0.05 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]

Phrase: "(0.56  0.03 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "littermates,"

Phrase: "which"

Phrase: "may in part account"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0449719:Part [Spatial Concept]
   770   C1551359:account [Idea or Concept]
   770   C1709471:Part [Quantitative Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "for the differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "in fasting blood glucose"
Meta Candidates (Total=17; Excluded=8; Pruned=0; Remaining=9)
  1000   C0428568:Fasting blood glucose [Laboratory Procedure]
  1000   C1261430:fasting blood glucose [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456962:Fast [Qualitative Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "("

Phrase: "in Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.184: Serum insulin levels were determined at 10, 30, and 120 min after glucose stimulation. 

Phrase: "Serum insulin levels"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   966   C0428357:Serum insulin level [Laboratory Procedure]
           Serum insulin
   966   C1261415:serum insulin level [Laboratory or Test Result]
           serum insulin
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0229671:Serum [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined at 10,"

Phrase: "30,"

Phrase: "and"

Phrase: "120 min after glucose stimulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]
Processing 00000000.tx.185: In Fig. 

Phrase: "In Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.186: 4B, we determined the integrated net rise in insulin levels above the basal fasting levels encompassed by these time points as the area under the curve. 

Phrase: "4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "we"

Phrase: "determined"

Phrase: "the integrated net rise in insulin levels"

Phrase: "above the basal fasting levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "encompassed by these time points"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "as the area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017446:Area [Geographic Area]
  1000   C0205146:Area [Spatial Concept]

Phrase: "under the curve."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curve [Spatial Concept]
Processing 00000000.tx.187: Here, STX-1A male and female mice had a net release of insulin of 86.40  0.20 ng/ml x 120 min and 89.70  1.60 ng/ml x 120 min, respectively, which were significantly lower than the wild-type male (125.20  2.60 ng/ml x 120 min, P < 0.01) and female littermates (108.40  3.30 ng/ml x 120 min, P < 0.05). 

Phrase: "Here,"

Phrase: "STX-1A male"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0024554:Male [Finding]
   827   C0086582:male [Population Group]
   827   C1706180:Male [Qualitative Concept]
   827   C1706428:Male [Qualitative Concept]
   827   C1706429:Male [Organism Attribute]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "and"

Phrase: "female mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "a net release of insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of 86.40  0.20 ng/ml x 120 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   842   C1827823:ng/min [Quantitative Concept]
   829   C0439445:mL/min [Quantitative Concept]
   791   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "89.70  1.60 ng/ml x 120 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   842   C1827823:ng/min [Quantitative Concept]
   829   C0439445:mL/min [Quantitative Concept]
   791   C0702093:/min [Temporal Concept]

Phrase: "respectively,"

Phrase: "which"

Phrase: "were"

Phrase: "significantly lower than the wild-type male"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "(125.20  2.60 ng/ml x 120 min,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   842   C1827823:ng/min [Quantitative Concept]
   829   C0439445:mL/min [Quantitative Concept]
   791   C0702093:/min [Temporal Concept]
   700   C0442755:20/120 [Finding]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "female littermates"

Phrase: "(108.40  3.30 ng/ml x 120 min,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   854   C0456693:/30 min [Temporal Concept]
   854   C1442458:30 min [Temporal Concept]
   842   C1827823:ng/min [Quantitative Concept]
   829   C0439445:mL/min [Quantitative Concept]
   791   C0702093:/min [Temporal Concept]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.188: Again, it appears that the male STX-1A mice had a more severe insulin secretory defect (31% reduction compared with wild-type littermates) than the female STX-1A mice (17% reduction compared with wild-type littermates). 

Phrase: "Again,"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "the male STX-1A mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "a more severe insulin secretory defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1457869:Defect [Functional Concept]
   804   C1861101:DEFECT [Disease or Syndrome]

Phrase: "(31% reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "compared with wild-type littermates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: ")"

Phrase: "than the female STX-1A mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(17% reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "compared with wild-type littermates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: ")."
Processing 00000000.tx.189: View larger version (23K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.190: 4. 

Phrase: "4."
Processing 00000000.tx.191: STX-1A mice exhibit decreased insulin secretion in vivo during the IPGTT. 

Phrase: "STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "decreased insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1371675:Decreased Insulin Secretion [Organ or Tissue Function]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in vivo during the IPGTT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.192: A: Assessment of insulin secretion after glucose challenge during IPGTT shows a reduction in STX-1A mice versus wild-type (WT) littermates. 

Phrase: "A"

Phrase: ":"

Phrase: "Assessment of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "after glucose challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "during IPGTT"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a reduction in STX-1A mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "versus"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "littermates."
Processing 00000000.tx.193: All values are means  SE from 11 male STX-1A mice and female wild-type mice and 10 male wild-type mice and female STX-1A mice. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE from 11 male STX-1A mice"

Phrase: "and"

Phrase: "female wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   890   C1520150:Wild Type Mouse [Mammal]
   861   C1883559:Wild Type [Organism Attribute]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "10 male wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C1520150:Wild Type Mouse [Mammal]
   840   C1883559:Wild Type [Organism Attribute]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "female STX-1A mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.194: ++P < 0.01 for male and *P < 0.05 for female STX-1A mice vs. wild-type mice. 

Phrase: "++P < 0.01 for male"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0024554:Male [Finding]
   760   C0086582:male [Population Group]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1706180:Male [Qualitative Concept]
   760   C1706428:Male [Qualitative Concept]
   760   C1706429:Male [Organism Attribute]
   760   C2603361:P' [Clinical Attribute]

Phrase: "and *"

Phrase: "P < 0.05 for female STX-1A mice"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420498:SYNTAXIN 1A [Gene or Genome]
   744   C0015780:Female [Finding]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0043210:female [Population Group]
   744   C0086287:female [Population Group]
   744   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0450344:1A [Intellectual Product]
   744   C1553633:1a [Medical Device]
   744   C1705497:Female [Qualitative Concept]
   744   C1705498:Female [Qualitative Concept]
   744   C2603361:P' [Clinical Attribute]

Phrase: "vs. wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.195: B: Net glucose-mediated insulin-release above basal levels quantified by the integration of the area under the curve. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Net glucose-mediated insulin-release above basal levels"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   767   C0202098:insulin levels [Laboratory Procedure]
   767   C0428405:insulin levels [Laboratory or Test Result]
   767   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "quantified by the integration of the area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]
   748   C1158478:Integration [Genetic Function]
   748   C1705422:Integration [Machine Activity]
   714   C1709793:Quantify [Quantitative Concept]

Phrase: "under the curve."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curve [Spatial Concept]
Processing 00000000.tx.196: All values are means  SE. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.197: ++P < 0.01; 

Phrase: "++P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.198: *P < 0.05.  

Phrase: "*P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.199: STX-1A male mice exhibit insulin resistance. 

Phrase: "STX-1A male mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.200: We then examined whether the abnormal glucose homeostasis in the STX-1A mice could be contributed by the resistance of peripheral tissues to insulin action by performing the intraperitoneal insulin tolerance test. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the abnormal glucose homeostasis in the STX-1A mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1326961:glucose homeostasis [Physiologic Function]
   742   C0019868:Homeostasis [Biologic Function]

Phrase: "could"

Phrase: "be"

Phrase: "contributed by the resistance of peripheral tissues"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   774   C1258192:Peripheral Resistance [Physiologic Function]
   748   C0040300:Tissues [Tissue]
   748   C0205100:Peripheral [Spatial Concept]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   714 E C1547928:Tissue [Intellectual Product]
   714   C1880177:Contribute [Activity]

Phrase: "to insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by performing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0884358:Perform [Functional Concept]
   966   C2947996:Perform [Pharmacologic Substance]

Phrase: "the intraperitoneal insulin tolerance test."
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   923   C0236287:Insulin tolerance test [Laboratory Procedure]
   875   C0202098:insulin test [Laboratory Procedure]
   861   C0201777:Tolerance test [Laboratory Procedure]
   861   C0598703:insulin tolerance [Pathologic Function]
   812   C0013220:Tolerance [Finding]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:test [Intellectual Product]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1704410:Tolerance [Qualitative Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.201: We predicted that insulin sensitivity would not be affected in the STX-1A mice because STX-1A is not a dominant exocytotic protein in insulin sensitive tissues (fat, muscle, and liver) (21). 

Phrase: "We"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that insulin sensitivity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "affected in the STX-1A mice"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420498:SYNTAXIN 1A [Gene or Genome]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392760:Affected [Functional Concept]
   753   C0450344:1A [Intellectual Product]
   753   C1314939:Affected [Functional Concept]
   753   C1553633:1a [Medical Device]
   719 E C0001721:Affect [Mental Process]

Phrase: "because"

Phrase: "STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a dominant exocytotic protein in insulin sensitive tissues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(fat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: "muscle,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: ")"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.202: The serum glucose incursion in the STX-1A mice would be expected to parallel the control littermates in their response to an insulin challenge. 

Phrase: "The serum glucose incursion in the STX-1A mice"

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "parallel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "the control littermates in their response"

Phrase: "to an insulin challenge."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.203: Again, and as expected, the fasting glucose levels were higher in the STX-1A male and female mice (Fig. 5) compared with their control littermates. 

Phrase: "Again,"

Phrase: "and"

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the fasting glucose levels"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456079:Level [Classification]
   793 E C0456962:Fast [Qualitative Concept]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "higher in the STX-1A male"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "female mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "compared with their control littermates."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.204: The glucose sensitivity to the insulin challenge was very similar for the female mice. 

Phrase: "The glucose sensitivity to the insulin challenge"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0920563:Insulin Sensitivity [Pathologic Function]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
   743   C0332324:Sensitive to [Functional Concept]

Phrase: "was"

Phrase: "very similar for the female mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.205: Specifically, the maximal reduction in blood glucose levels (difference between time 0 and at 40 min after intraperitoneal insulin injection) were 2.94  0.27 and 3.50  0.11 mmol/l (P = 0.19), and the corresponding rates of glucose reduction were 0.069 and 0.079 mmol  l1  min1, respectively, for the female STX-1A and wild-type littermates. 

Phrase: "Specifically,"

Phrase: "the maximal reduction in blood glucose levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(difference between time 0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1442103:Time Difference [Temporal Concept]
   819   C1547049:*Time Difference [Quantitative Concept]
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and at 40 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439509:/40 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "after intraperitoneal insulin injection"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   913   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   901   C0199782:Insulin injection [Therapeutic or Preventive Procedure]
   901   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1828121:Injection [Functional Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "2.94  0.27"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3.50  0.11 mmol/l (P = 0.19"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   807   C1532563:mmol/L [Quantitative Concept]
   791   C0439086:<3 [Quantitative Concept]
   791   C0439190:MMOLE [Quantitative Concept]
   791   C2827736:3+ [Quantitative Concept]
   791   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the corresponding rates of glucose reduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "0.069"

Phrase: "and"

Phrase: "0.079 mmol  l1  min1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3272448:MIN1 [Gene or Genome]

Phrase: "respectively,"

Phrase: "for the female STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420498:SYNTAXIN 1A [Gene or Genome]
   827   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "wild-type littermates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.206: The male wild-type littermates exhibited a similar maximal reduction of 3.33  0.03 mmol/l, and a rate of reduction of 0.074 mmol  l1  min1. 

Phrase: "The male wild-type littermates"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a similar maximal reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0301630:Reduction [Natural Phenomenon or Process]
   827   C0392756:Reduction [Qualitative Concept]
   827   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of 3.33  0.03 mmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532563:mmol/L [Quantitative Concept]

Phrase: "and"

Phrase: "a rate of reduction of 0.074 mmol  l1  min1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.207: But surprisingly, the STX-1A male mice exhibited insulin resistance with a maximal reduction in glucose levels of 1.98  0.06 mmol/l (P < 0.01 compared with wild-type males), with a corresponding reduced rate of glucose reduction of 0.063 mmol  l1  min1, and that was preceded by an initial lag. 

Phrase: "But"

Phrase: "surprisingly,"

Phrase: "the STX-1A male mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "insulin resistance with a maximal reduction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of 1.98  0.06 mmol/l (P < 0.01"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1532563:mmol/L [Quantitative Concept]
   791   C0439190:MMOLE [Quantitative Concept]
   791   C2827734:1+ [Quantitative Concept]
   791   C2981698:1+ [Classification]

Phrase: "compared with wild-type males"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0024554:Males [Finding]
   760   C0086582:Males [Population Group]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
   726 E C1706180:Male [Qualitative Concept]
   726 E C1706428:Male [Qualitative Concept]
   726 E C1706429:Male [Organism Attribute]

Phrase: ")"

Phrase: ","

Phrase: "with a corresponding reduced rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "of glucose reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of 0.063 mmol  l1  min1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3272448:MIN1 [Gene or Genome]

Phrase: "and"

Phrase: "that"

Phrase: "was"

Phrase: "preceded by an initial lag."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205265:Initial [Temporal Concept]
   760   C0332152:preceded [Temporal Concept]
   760   C1279901:Initial [Qualitative Concept]
   760   C1416797:Lag [Gene or Genome]
   760   C1555582:Initial [Idea or Concept]
   760   C1705685:INITIAL [Functional Concept]
Processing 00000000.tx.208: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.209: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.210: STX-1A mice exhibit insulin resistance during intraperitoneal insulin tolerance test compared with wild-type (WT) littermates. 

Phrase: "STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "insulin resistance during intraperitoneal insulin tolerance test"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C0236287:Insulin tolerance test [Laboratory Procedure]
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   774   C0202098:insulin test [Laboratory Procedure]
   774   C0598703:insulin tolerance [Pathologic Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "compared with wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "littermates."
Processing 00000000.tx.211: All values are means  SE from six male mice per group and four female mice per group. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE from six male mice"

Phrase: "per group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "four female mice per group."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
Processing 00000000.tx.212: For each mouse, multiple IPGTTs of at least four per mouse were carried out, and the mean of these multiple IPGTTs was considered to be n = 1. 

Phrase: "For each mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "multiple IPGTTs of"

Phrase: "at least four"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205450:Four [Quantitative Concept]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "per mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "and"

Phrase: "the mean of these multiple IPGTTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "n = 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.213: +P < 0.05 for male and *P < 0.05 for female STX-1A mice vs. the wild-type mice.  

Phrase: "+P < 0.05 for male"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0024554:Male [Finding]
   760   C0086582:male [Population Group]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1706180:Male [Qualitative Concept]
   760   C1706428:Male [Qualitative Concept]
   760   C1706429:Male [Organism Attribute]
   760   C2603361:P' [Clinical Attribute]

Phrase: "and *"

Phrase: "P < 0.05 for female STX-1A mice"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420498:SYNTAXIN 1A [Gene or Genome]
   744   C0015780:Female [Finding]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0043210:female [Population Group]
   744   C0086287:female [Population Group]
   744   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0450344:1A [Intellectual Product]
   744   C1553633:1a [Medical Device]
   744   C1705497:Female [Qualitative Concept]
   744   C1705498:Female [Qualitative Concept]
   744   C2603361:P' [Clinical Attribute]

Phrase: "vs."

Phrase: "the wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.214: STX-1A mouse islet -cells exhibit reduced exocytosis and Ca2+ currents. 

Phrase: "STX-1A mouse islet -cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   867   C1522528:Mouse Islet Cell [Tissue]
   840   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   806 E C1522529:Islet Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "reduced exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015283:Exocytosis [Cell Function]

Phrase: "and"

Phrase: "Ca2+ currents."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.215: The abnormal glucose homeostasis (Fig. 3) in these STX-1A mice is therefore largely contributed by the insulin secretory deficiency. 

Phrase: "The abnormal glucose homeostasis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1326961:glucose homeostasis [Physiologic Function]
   827   C0019868:Homeostasis [Biologic Function]
   734   C0580546:Abnormal glucose [Finding]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "in these STX-1A mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "is"

Phrase: "therefore largely"

Phrase: "contributed by the insulin secretory deficiency."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0011155:Deficiency [Functional Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0162429:Deficiency [Disease or Syndrome]
   753   C1327616:Secretory [Cell Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1623416:deficiency [Qualitative Concept]
   719   C1880177:Contribute [Activity]
Processing 00000000.tx.216: However, there seems to be a contribution by some insulin insensitivity of the peripheral tissues, at least in the male STX-1A mice (Fig. 5). 

Phrase: "However,"

Phrase: "there"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a contribution by some insulin insensitivity of the peripheral tissues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880177:Contribution [Activity]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in the male STX-1A mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.217: To distinguish and examine the direct contribution of islet -cell insulin secretory defect in the STX-1A mice, we used patch clamp membrane capacitance (Cm) measurements of single islet -cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish"

Phrase: "and"

Phrase: "examine"

Phrase: "the direct contribution of islet -cell insulin secretory defect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880177:Contribution [Activity]

Phrase: "in the STX-1A mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "patch clamp membrane capacitance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0025255:Membrane [Tissue]
   812   C0242264:capacitance [Quantitative Concept]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Cm) measurements of single islet -cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:measurements [Functional Concept]
Processing 00000000.tx.218: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.219: 6A, top, serial depolarizations triggered substantial exocytosis in the control mouse -cell. 

Phrase: "6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: "top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "serial depolarizations"

Phrase: "triggered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "substantial exocytosis in the control mouse -cell."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.220: This depolarization protocol would release the insulin granules from the primed immediately releasable pool (first two to three pulses) as well as mobilize granules from the reserve pool to refill the releasable pool (subsequent pulses) (2). 

Phrase: "This depolarization protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "would"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the insulin granules from the primed immediately releasable pool"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0010837:Granules [Cell Component]
   742   C0993609:Granules [Biomedical or Dental Material]

Phrase: "(first two to three pulses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: ")"

Phrase: "as well as"

Phrase: "mobilize"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185112:mobilize [Therapeutic or Preventive Procedure]
  1000   C0578718:mobilize [Finding]

Phrase: "granules from the reserve"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010837:Granules [Cell Component]
   770   C0993609:Granules [Biomedical or Dental Material]

Phrase: "pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "refill"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0807726:Refill [Idea or Concept]

Phrase: "the releasable pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "(subsequent pulses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0034107:Pulses [Health Care Activity]
   861   C0391850:PULSES [Physiologic Function]
   827 E C0232117:PULSE [Clinical Attribute]
   827 E C1947910:Pulse [Phenomenon or Process]

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.221: A massive Ca2+ current triggered by depolarization to 0 mV was simultaneously observed in this same cell (Fig. 6A, bottom). 

Phrase: "A massive Ca2+ current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0521116:Current [Temporal Concept]
   827   C1705970:Current [Natural Phenomenon or Process]

Phrase: "triggered by depolarization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1444748:Triggered by [Qualitative Concept]
           Trigger
   756   C0032930:Trigger [Clinical Attribute]

Phrase: "to 0 mV"

Phrase: "was"

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "observed in this same cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C0445247:Same [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.222: The increases in Cm in the STX-1A mouse -cells were attenuated in both the first two and later pulses (Fig. 6B, top). 

Phrase: "The increases in Cm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:increases [Functional Concept]

Phrase: "in the STX-1A mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "attenuated in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332161:Attenuated [Qualitative Concept]
   790   C0599946:Attenuated [Activity]

Phrase: "the first two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: "and"

Phrase: "later pulses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0034107:Pulses [Health Care Activity]
   861   C0391850:PULSES [Physiologic Function]
   827 E C0232117:PULSE [Clinical Attribute]
   827 E C1947910:Pulse [Phenomenon or Process]

Phrase: "(Fig. 6B,"

Phrase: "top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.223: This was also accompanied by a substantial reduction in Ca2+ influx (Fig. 6B, bottom). 

Phrase: "This"

Phrase: "was"

Phrase: "also"

Phrase: "accompanied by a substantial reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in Ca2+ influx"

Phrase: "(Fig. 6B,"

Phrase: "bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.224: Results are summarized in Figs. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "summarized in Figs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0349966:Figs [Food]
   756 E C1337208:FIG [Food]
Processing 00000000.tx.225: 6C and D, which show that exocytosis and Ca2+ currents were concomitantly and significantly reduced in STX-1A mouse -cells. 

Phrase: "6C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "and"

Phrase: "Ca2+ currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "concomitantly"

Phrase: "and"

Phrase: "significantly"

Phrase: "reduced in STX-1A mouse -cells."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420498:SYNTAXIN 1A [Gene or Genome]
   753   C0007634:Cells [Cell]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0450344:1A [Intellectual Product]
   753   C1553633:1a [Medical Device]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.226: These results suggest that STX-1A overexpression caused a major impairment in both the initial size of primed releasable pool of insulin granules and the subsequent mobilization of insulin granules from the reserve pool to the releasable pool. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that STX-1A overexpression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514559:Overexpression [Genetic Function]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a major impairment in both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0684336:Impairment [Pathologic Function]

Phrase: "the initial size of primed releasable pool of insulin granules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "the subsequent mobilization of insulin granules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   753   C0300926:mobilization [Functional Concept]

Phrase: "from the reserve pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "to the releasable pool."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]
Processing 00000000.tx.227: STX-1A directly binds and inhibits islet -cell Ca2+ channels, and in fact, STX-1A was postulated to tether the insulin granules to the sparse L-type Ca2+ channels to more tightly couple Ca2+ channel opening (and Ca2+ influx) to exocytosis (22,23). 

Phrase: "STX-1A directly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420498:SYNTAXIN 1A [Gene or Genome]
   827   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "islet -cell Ca2+ channels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "and in fact,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "was"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "tether"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0577538:tether [Functional Concept]

Phrase: "the insulin granules to the sparse L-type Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0010837:Granules [Cell Component]
   742   C0993609:Granules [Biomedical or Dental Material]

Phrase: "channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "to more tightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883351:To [Qualitative Concept]

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "Ca2+ channel opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0175566:Opening [Spatial Concept]
   827   C1882151:Opening [Spatial Concept]

Phrase: "("

Phrase: "and"

Phrase: "Ca2+ influx"

Phrase: ")"

Phrase: "to exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.228: Our results therefore also suggest that the reduced exocytosis in STX-1A mouse -cells is attributed at least in part to the reduced Ca2+ influx through plasma membrane voltage-dependent Ca2+ channels. 

Phrase: "Our results therefore also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the reduced exocytosis in STX-1A mouse -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015283:Exocytosis [Cell Function]

Phrase: "is"

Phrase: "attributed at least"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "to the reduced Ca2+ influx"

Phrase: "through plasma membrane voltage-dependent Ca2+ channels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   876   C0022009:Membrane Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C0439799:Channel [Spatial Concept]
   766   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.229: View larger version (36K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.230: 6. 

Phrase: "6."
Processing 00000000.tx.231: STX-1A mouse -cells exhibited reduced exocytosis and Ca2+ currents compared with wild-type (WT) mouse -cells (simultaneous measurement of exocytosis and Ca2+ currents). 

Phrase: "STX-1A mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "reduced exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015283:Exocytosis [Cell Function]

Phrase: "and"

Phrase: "Ca2+ currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "compared with wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "(WT) mouse -cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   858   C0449475:type cell [Intellectual Product]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756   C1520150:Wild Type Mouse [Mammal]

Phrase: "(simultaneous measurement of exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "and"

Phrase: "Ca2+ currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.232: A and B: Increases of Cm triggered by a train of eight 500-ms depolarizing pulses (1-Hz stimulation frequency) from 70 to 0 mV in control and STX-1A mouse -cells (top traces). 

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Increases of Cm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:increases [Functional Concept]

Phrase: "triggered by a train of eight 500-ms depolarizing pulses"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C1444748:Triggered by [Qualitative Concept]
           Trigger
   739   C0034107:Pulses [Health Care Activity]
   739   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205454:Eight [Quantitative Concept]
   739   C0336809:Train [Manufactured Object]
   739   C0391850:PULSES [Physiologic Function]
   739   C1552514:Train [Manufactured Object]
   739   C2349943:Ms. [Conceptual Entity]
   739   C3539704:MS [Gene or Genome]
   706   C0032930:Trigger [Clinical Attribute]
   706 E C0232117:PULSE [Clinical Attribute]
   706 E C1947910:Pulse [Phenomenon or Process]

Phrase: "(1-Hz stimulation frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0376249:frequency [Quantitative Concept]
   812   C0439603:Frequency [Temporal Concept]
   812   C0871396:Frequency [Quantitative Concept]
   812   C1561548:Frequency [Qualitative Concept]
   812   C1705502:Frequency [Quantitative Concept]
   741 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "from 70"

Phrase: "to 0 mV"

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "STX-1A mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(top traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0442822:Trace [Quantitative Concept]
   827   C1524031:Trace [Qualitative Concept]
   827   C1883002:Trace [Functional Concept]

Phrase: ")."
Processing 00000000.tx.233: Bottom traces show the Ca2+ currents triggered in the same cells. 

Phrase: "Bottom traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0442822:Trace [Quantitative Concept]
   827   C1524031:Trace [Qualitative Concept]
   827   C1883002:Trace [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the Ca2+ currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "triggered in the same cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0445247:Same [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726   C0032930:Trigger [Clinical Attribute]
   726 E C1269647:Cell [Cell]
   726   C1444748:Trigger [Qualitative Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.234: C: The change in Cm is normalized to cell size and plotted against the pulse number. 

Phrase: "C"

Phrase: ":"

Phrase: "The change in Cm"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0025320:The change [Physiologic Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "normalized to cell size"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0162658:Cell Size [Organism Attribute,Quantitative Concept]
   770   C0007634:Cell [Cell]
   770   C0456389:size [Spatial Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1882115:Normalized [Research Activity]
   770   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "plotted against the pulse number."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0232117:PULSE [Clinical Attribute]
   760   C0237753:*Number [Quantitative Concept]
   760   C0391850:Pulse [Physiologic Function]
   760   C0449788:Number [Quantitative Concept]
   760   C1947910:Pulse [Phenomenon or Process]
Processing 00000000.tx.235: D: The results for Ca2+ currents are summarized. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "The results for Ca2+ currents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "are"

Phrase: "summarized."
Processing 00000000.tx.236: All values are means  SE of five to six cells. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE of five"

Phrase: "to six cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.237: *P < 0.05 compared with wild-type control.  

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with wild-type control."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1883559:Wild Type [Organism Attribute]
   797   C1707504:Control Type [Research Activity]
   797   C1879930:Control Type [Intellectual Product]
   760   C0243148:control [Qualitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.238: STX-1A mouse islet -cells exhibit reduced Ca2+ channel activity. 

Phrase: "STX-1A mouse islet -cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   867   C1522528:Mouse Islet Cell [Tissue]
   840   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   806 E C1522529:Islet Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "reduced Ca2+ channel activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0086439:Reduced Activity [Sign or Symptom]
   861   C1153410:channel activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.239: In Figs. 

Phrase: "In Figs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0349966:Figs [Food]
   966 E C1337208:FIG [Food]
Processing 00000000.tx.240: 7A and B, we examined the voltage-dependent Ca2+ currents in greater detail in control and STX-1A mice independently of the Cm. 

Phrase: "7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the voltage-dependent Ca2+ currents in greater detail"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0521116:currents [Temporal Concept]
   711 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "STX-1A mice independently of the Cm."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
Processing 00000000.tx.241: Results are summarized in Fig. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "summarized in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.242: 7C, which shows the peak Ca2+ currents plotted against membrane potential. 

Phrase: "7C,"

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the peak Ca2+ currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0521116:currents [Temporal Concept]
   793 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "plotted against membrane potential."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0025251:Membrane Potential [Cell Function]
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   770   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.243: Inward Ca2+ currents were triggered when the -cell was depolarized to 30 mV, indicating that the Ca2+ currents were through high-voltageactivated Ca2+ channels (L-, N-type) but not low-voltageactivated Ca2+ channels (T-type, threshold of opening is 50 mV). 

Phrase: "Inward Ca2+ currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0521116:currents [Temporal Concept]
   793 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "triggered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "when"

Phrase: "the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "depolarized to 30 mV,"

Phrase: "indicating"

Phrase: "that"

Phrase: "the Ca2+ currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were through high-voltageactivated Ca2+ channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205250:High [Qualitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719   C0439799:Channel [Spatial Concept]
   719   C1706095:Channel [Conceptual Entity]

Phrase: "(L-, N-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "but"

Phrase: "not low-voltageactivated Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0439799:Channel [Spatial Concept]
   771   C1706095:Channel [Conceptual Entity]

Phrase: "(T-type,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "threshold of opening"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449864:Threshold [Qualitative Concept]

Phrase: "is"

Phrase: "50 mV"

Phrase: ")."
Processing 00000000.tx.244: Current density was significantly reduced by 30% in the STX-1A mouse group. 

Phrase: "Current density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced by 30%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "in the STX-1A mouse group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
Processing 00000000.tx.245: Note that the reduction of Ca2+ currents occur within the physiological depolarizing range (10 mV). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the reduction of Ca2+ currents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "occur within the physiological depolarizing range"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205463:Physiological [Functional Concept]
   753   C1514721:Range [Quantitative Concept]
   753   C1709305:Occur [Activity]
   753   C2348147:Range [Quantitative Concept]
   753   C2745955:OCCUR [Temporal Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "(10 mV"

Phrase: ")."
Processing 00000000.tx.246: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.247: 7. 

Phrase: "7."
Processing 00000000.tx.248: STX-1A mouse -cells have reduced voltage-operated Ca2+ current density. 

Phrase: "STX-1A mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "reduced voltage-operated Ca2+ current density."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0178587:density [Quantitative Concept]
   727 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.249: Ca2+ currents are triggered in wild-type (WT; A) and STX-1A mouse -cells (B) when the cells are held at 70 mV and then stimulated by increasing depolarizing voltage steps (500 ms) from 50 to +60 mV at 10-mV increments. 

Phrase: "Ca2+ currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "are"

Phrase: "triggered in wild-type"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   737   C0032930:Trigger [Clinical Attribute]
   737   C1444748:Trigger [Qualitative Concept]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "; A)"

Phrase: "and"

Phrase: "STX-1A mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "when"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "held at 70 mV"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1948036:held [Idea or Concept]
   770   C2987518:hELD [Amino Acid, Peptide, or Protein]
   737 E C1553387:Hold [Idea or Concept]
   737 E C1948035:Hold [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated by increasing depolarizing voltage steps"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0442808:Increasing [Functional Concept]
   753   C0598352:Voltage [Quantitative Concept]
   753   C1261552:steps [Conceptual Entity]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   719 E C0442805:Increase [Functional Concept]
   719 E C1704379:Step [Functional Concept]
   719 E C1705117:Step [Quantitative Concept]
   719 E C2825408:Step [Manufactured Object]

Phrase: "(500 ms) from 50 to +60 mV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C2349943:Ms. [Conceptual Entity]
   748   C3539704:MS [Gene or Genome]

Phrase: "at 10-mV increments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1705117:Increment [Quantitative Concept]
Processing 00000000.tx.250: C: Currents are normalized to cell size and plotted against voltage. 

Phrase: "C"

Phrase: ":"

Phrase: "Currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "are"

Phrase: "normalized to cell size"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0162658:Cell Size [Organism Attribute,Quantitative Concept]
   770   C0007634:Cell [Cell]
   770   C0456389:size [Spatial Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1882115:Normalized [Research Activity]
   770   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "plotted against voltage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0598352:Voltage [Quantitative Concept]
Processing 00000000.tx.251: All values are means  SE of seven to eight cells. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE of seven"

Phrase: "to eight cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.252: *P < 0.05 compared with wild-type control.  

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with wild-type control."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1883559:Wild Type [Organism Attribute]
   797   C1707504:Control Type [Research Activity]
   797   C1879930:Control Type [Intellectual Product]
   760   C0243148:control [Qualitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.253: STX-1A mouse islet -cell Kv and KATP channel activities were similar to wild-type mice. 

Phrase: "STX-1A mouse islet -cell Kv"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0556639:kV [Quantitative Concept]

Phrase: "and"

Phrase: "KATP channel activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1153410:channel activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "similar to wild-type mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.254: We had previously observed that a large excess of STX-1A, whether through dialysis of the STX-1A protein into rat islet -cells or by overexpression of STX-1A into Kv2.1-expressing HEK cells, inhibited Kv2.1 channels (7,8). 

Phrase: "We"

Phrase: "had"

Phrase: "previously"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "a large excess of STX-1A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1979886:Excess [Qualitative Concept]

Phrase: "whether through dialysis of the STX-1A protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin-1A
   770   C1420498:SYNTAXIN 1A [Gene or Genome]
   767   C0288881:Syntaxin Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Syntaxin
   744   C0011945:Dialysis [Natural Phenomenon or Process]
   744   C0011946:dialysis [Therapeutic or Preventive Procedure]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0450344:1A [Intellectual Product]
   744   C0917873:dialysis [Therapeutic or Preventive Procedure]
   744   C1059964:Dialysis [Eukaryote]
   744   C1553633:1a [Medical Device]

Phrase: "into rat islet -cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "or by overexpression of STX-1A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420498:SYNTAXIN 1A [Gene or Genome]
   753   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0450344:1A [Intellectual Product]
   753   C1514559:Overexpression [Genetic Function]
   753   C1553633:1a [Medical Device]

Phrase: "into Kv2.1-expressing HEK cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "Kv2.1 channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]
   734   C1416554:KV2.1 [Gene or Genome]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.255: We therefore examined whether the slight overexpression of STX-1A in the STX-1A mouse -cells might similarly reduce the Kv channel activities. 

Phrase: "We therefore"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the slight overexpression of STX-1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "in the STX-1A mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "might"

Phrase: "similarly"

Phrase: "reduce"

Phrase: "the Kv channel activities."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1153410:channel activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.256: Results in Fig. 

Phrase: "Results in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]
Processing 00000000.tx.257: 8A show that the Kv channel activities in STX-1A mouse -cells were only marginally and insignificantly reduced (upper and middle traces). 

Phrase: "8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553640:8a [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the Kv channel activities in STX-1A mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C1153410:channel activity [Molecular Function]
   742   C0441655:Activities [Activity]
   708 E C0205177:Activity [Functional Concept]
   708 E C0439167:% activity [Quantitative Concept]
   708 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "only marginally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "insignificantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: "and"

Phrase: "middle traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0442822:Trace [Quantitative Concept]
   827   C1524031:Trace [Qualitative Concept]
   827   C1883002:Trace [Functional Concept]

Phrase: ")."
Processing 00000000.tx.258: This would suggest that the -cell Kv2.1 channels are less sensitive to STX-1A than the Ca2+ channels. 

Phrase: "This"

Phrase: "would"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the -cell Kv2.1 channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "less sensitive to STX-1A than the Ca2+ channels."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420498:SYNTAXIN 1A [Gene or Genome]
   742   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0450344:1A [Intellectual Product]
   742   C1553633:1a [Medical Device]
Processing 00000000.tx.259: In support, dialysis of excess STX-1A protein (1 mol/l) into the STX-1A islet -cells was able to inhibit the Kv currents as we had previously reported (Fig. 8A, bottom trace) (7). 

Phrase: "In support,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "dialysis of excess STX-1A protein (1 mol/l)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0011945:Dialysis [Natural Phenomenon or Process]
   742   C0011946:dialysis [Therapeutic or Preventive Procedure]
   742   C0917873:dialysis [Therapeutic or Preventive Procedure]
   742   C1059964:Dialysis [Eukaryote]

Phrase: "into the STX-1A islet -cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   827 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the Kv currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "as"

Phrase: "we"

Phrase: "had"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(Fig. 8A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: "bottom trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0442822:Trace [Quantitative Concept]
   861   C1524031:Trace [Qualitative Concept]
   861   C1883002:Trace [Functional Concept]

Phrase: ")"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.260: Results are summarized in Fig. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "summarized in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.261: 8B. 

Phrase: "8B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424736:8B [Gene or Genome]
Processing 00000000.tx.262: In a recent report, we also showed that in rat -cells and the HIT -cell line, dialyzing excess STX-1A proteins strongly inhibited KATP currents (6,24). 

Phrase: "In a recent report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "we also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in rat -cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the HIT -cell line,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "dialyzing excess STX-1A proteins strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   839   C0288881:Syntaxin Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "KATP currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "(6,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.263: We therefore proceeded to compare the KATP current density in control and STX-1A mouse -cells, which also did not show a significant change in islet -cell KATP current density between the control and STX-1A mouse groups (data not shown). 

Phrase: "We therefore"

Phrase: "proceeded"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the KATP current density in control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]

Phrase: "and"

Phrase: "STX-1A mouse -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "which also"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a significant change in islet -cell KATP current density"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0541594:change density [Qualitative Concept]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "between the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "STX-1A mouse groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.264: It therefore appears that these islet -cell K+ channels are less sensitive to the small increase in islet -cell STX-1A levels (30%, in Fig. 2) than the L-type Ca2+ channels, indicating that these K+ channels are less functionally coupled to STX-1A than the Ca2+ channels. 

Phrase: "It therefore"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "these islet -cell K+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "less sensitive to the small increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C1550474:sensitive [Idea or Concept]

Phrase: "in islet -cell STX-1A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "(30%,"

Phrase: "in Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "than the L-type Ca2+ channels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "indicating"

Phrase: "that"

Phrase: "these K+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "less functionally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "coupled to STX-1A"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1420498:SYNTAXIN 1A [Gene or Genome]
   770   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0450344:1A [Intellectual Product]
   770   C1553633:1a [Medical Device]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]

Phrase: "than the Ca2+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.265: View larger version (25K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.266: 8. 

Phrase: "8."
Processing 00000000.tx.267: STX-1A mouse -cells have Kv channel densities comparable with those of wild-type (WT) mouse -cells. 

Phrase: "STX-1A mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "Kv channel densities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0178587:densities [Quantitative Concept]
   743 E C0439794:Dense [Qualitative Concept]

Phrase: "comparable with those of wild-type"

Phrase: "(WT) mouse -cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   858   C0449475:type cell [Intellectual Product]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756   C1520150:Wild Type Mouse [Mammal]
Processing 00000000.tx.268: A: Wild-type and STX-1A mouse -cells were held at 70 mV and then stimulated by increasing depolarizing voltage steps (200 ms) from 70 to +70 mV at 10-mV increments to trigger Kv currents (top and middle traces). 

Phrase: "A"

Phrase: ":"

Phrase: "Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "STX-1A mouse -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "held at 70 mV"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1948036:held [Idea or Concept]
   770   C2987518:hELD [Amino Acid, Peptide, or Protein]
   737 E C1553387:Hold [Idea or Concept]
   737 E C1948035:Hold [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stimulated by increasing depolarizing voltage steps"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0442808:Increasing [Functional Concept]
   753   C0598352:Voltage [Quantitative Concept]
   753   C1261552:steps [Conceptual Entity]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   719 E C0442805:Increase [Functional Concept]
   719 E C1704379:Step [Functional Concept]
   719 E C1705117:Step [Quantitative Concept]
   719 E C2825408:Step [Manufactured Object]

Phrase: "(200 ms) from 70 to +70 mV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C2349943:Ms. [Conceptual Entity]
   748   C3539704:MS [Gene or Genome]

Phrase: "at 10-mV increments to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1705117:Increment [Quantitative Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "Kv currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "(top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "middle traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0442822:Trace [Quantitative Concept]
   827   C1524031:Trace [Qualitative Concept]
   827   C1883002:Trace [Functional Concept]

Phrase: ")."
Processing 00000000.tx.269: The bottom trace shows the Kv currents in STX-1A mouse -cells dialyzed with 1 mol/l GST-STX-1A fusion protein for 6 min. 

Phrase: "The bottom trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0442822:Trace [Quantitative Concept]
   861   C1524031:Trace [Qualitative Concept]
   861   C1883002:Trace [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the Kv currents in STX-1A mouse -cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0521116:currents [Temporal Concept]
   711 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "dialyzed"

Phrase: "with 1 mol/l GST-STX-1A fusion protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0287683:Syntaxin-1A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   824   C0288881:Syntaxin Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332466:Fusion [Functional Concept]
   790   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "for 6 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.270: B: The currents are normalized to cell size and plotted against voltage. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "The currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "are"

Phrase: "normalized to cell size"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0162658:Cell Size [Organism Attribute,Quantitative Concept]
   770   C0007634:Cell [Cell]
   770   C0456389:size [Spatial Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1882115:Normalized [Research Activity]
   770   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "plotted against voltage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0598352:Voltage [Quantitative Concept]
Processing 00000000.tx.271: All values are means  SE of 1017 cells. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE of 1017 cells."
Processing 00000000.tx.272: *P < 0.05 compared with wild-type control and STX-1A groups.   

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with wild-type control"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1883559:Wild Type [Organism Attribute]
   797   C1707504:Control Type [Research Activity]
   797   C1879930:Control Type [Intellectual Product]
   760   C0243148:control [Qualitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "STX-1A groups."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]
Processing 00000000.tx.273: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The results from this work demonstrate that small fluctuations of STX-1A levels are sufficient to induce profound changes on the function of the secretory components controlling secretion. 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The results from this work"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that small fluctuations of STX-1A levels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0231239:fluctuations [Sign or Symptom]
   714 E C0231241:Fluctuation [Temporal Concept]
   714 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "are"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "profound changes on the function of the secretory components"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]
Processing 00000000.tx.274: It seems that out of the membrane ion channels involved in secretion, the Ca2+ channel is the most tightly coupled functionally to STX-1A, and therefore it is sensitive to even a slightly higher level of STX-1A. 

Phrase: "It"

Phrase: "seems"

Phrase: "that out of the membrane ion channels"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Membrane Channels
   748   C0022023:Ion [Element, Ion, or Isotope]
   748   C0025255:Membrane [Tissue]
   748   C0439787:Out [Spatial Concept]
   748   C0596901:Membrane [Cell Component]
   748   C0849355:Out [Qualitative Concept]
   748   C1700702:ION [Functional Concept]
   748   C1706182:Membrane [Manufactured Object]
   714   C0439799:Channel [Spatial Concept]
   714   C1706095:Channel [Conceptual Entity]

Phrase: "involved in secretion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]
   790   C1314939:Involved [Functional Concept]

Phrase: "the Ca2+ channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "the most tightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "functionally to STX-1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1420498:SYNTAXIN 1A [Gene or Genome]
   770   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0450344:1A [Intellectual Product]
   770   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "therefore"

Phrase: "it"

Phrase: "is"

Phrase: "sensitive to even"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0332324:Sensitive to [Functional Concept]
           Sensitive
   827   C1550474:sensitive [Idea or Concept]

Phrase: "a slightly higher level of STX-1A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.275: In support, we found that membrane depolarization caused a concomitant reduction of exocytosis (by Cm) and Ca2+ current in the STX-1A islet -cells. 

Phrase: "In support,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that membrane depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1816453:membrane depolarization [Cell Function]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a concomitant reduction of exocytosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "by Cm)"

Phrase: "and"

Phrase: "Ca2+ current in the STX-1A islet -cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0521116:Current [Temporal Concept]
   744   C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.276: STX-1A alone inhibits Ca2+ channels (25), but in the presence of SNAP-25, it would then exhibit a positive regulatory action (25). 

Phrase: "STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "but in the presence of SNAP-25,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   774   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0039067:synaptosome [Cell Component]
   738   C0233535:but [Mental or Behavioral Dysfunction]
   738   C0332281:Associated [Qualitative Concept]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C1532717:kDa [Quantitative Concept]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1706221:Associate [Professional or Occupational Group]

Phrase: "it"

Phrase: "would"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a positive regulatory action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441472:Action [Functional Concept]
   827   C3266814:Action [Activity]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.277: Therefore, the stoichiometry of cognate SNARE proteins, which was perturbed in the STX-1A islets, is important not only for the exocytic machinery, but also for the membrane ion channels, to enable the normal functioning and regulation of these channels. 

Phrase: "Therefore,"

Phrase: "the stoichiometry of cognate SNARE proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "perturbed in the STX-1A islets,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420498:SYNTAXIN 1A [Gene or Genome]
   753   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0450344:1A [Intellectual Product]
   753   C1553633:1a [Medical Device]

Phrase: "is"

Phrase: "important"

Phrase: "not only for the exocytic machinery,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205171:Only [Quantitative Concept]
   753   C0337076:machinery [Manufactured Object]
   753   C1518422:Not [Functional Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also for the membrane ion channels,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Membrane Channels
   753   C0022023:Ion [Element, Ion, or Isotope]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1700702:ION [Functional Concept]
   753   C1706182:Membrane [Manufactured Object]
   719   C0439799:Channel [Spatial Concept]
   719   C1706095:Channel [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "the normal functioning"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0542341:functioning [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "regulation of these channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.278: The overexpressed human STX-1A differs from the host mouse STX-1A by just three amino acid residues located at the COOH terminus, including amino acid 278: V (human) versus I (mouse); 

Phrase: "The overexpressed human STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420498:SYNTAXIN 1A [Gene or Genome]
   812   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450344:1A [Intellectual Product]
   812   C1553633:1a [Medical Device]

Phrase: "differs from the host mouse STX-1A"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1420498:SYNTAXIN 1A [Gene or Genome]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0450344:1A [Intellectual Product]
   748   C1167395:Host [Organism]
   748   C1553633:1a [Medical Device]

Phrase: "by just three amino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "located at the COOH terminus,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "amino acid 278"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "V (human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Human [Human]

Phrase: ")"

Phrase: "versus"

Phrase: "I (mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.279: amino acid 283: V (mouse) versus I (human); 

Phrase: "amino acid 283"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "V (mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: ")"

Phrase: "versus"

Phrase: "I (human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Human [Human]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.280: and the very COOH-terminal amino acid 288: A (human) versus G (mouse). 

Phrase: "and"

Phrase: "the very COOH-terminal amino acid 288"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C2917660:Amino Acid [Pharmacologic Substance]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]
   799   C0205088:Terminal [Temporal Concept]
   799   C0442824:Very [Qualitative Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]

Phrase: ":"

Phrase: "A (human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Human [Human]

Phrase: ")"

Phrase: "versus"

Phrase: "G (mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: ")."
Processing 00000000.tx.281: These substitutions are small, nonpolar, and hydrophobic conserved residues, only one of which is in the transmembrane domain, with the other two sticking out into the extracellular domain, and which are therefore not expected to exhibit different actions on exocytosis or on the membrane ion channels. 

Phrase: "These substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555721:Substitution [Idea or Concept]
   966   C1706204:Substitution [Activity]

Phrase: "are"

Phrase: "small, nonpolar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0813984:nonpolar [Quantitative Concept]

Phrase: "and"

Phrase: "hydrophobic conserved residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "only one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "is in the transmembrane domain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1519623:Transmembrane Domain [Amino Acid Sequence]
   760   C1167322:transmembrane [Cell Component]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C2752508:transmembrane [Cell Component]
   760   C3541951:Domain [Intellectual Product]

Phrase: "with the"

Phrase: "other two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "sticking"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1883170:STICKING [Event]
   966 E C1706582:Stick [Biomedical or Dental Material]
   966 E C1706583:Stick [Quantitative Concept]

Phrase: "out into the extracellular domain,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1517050:Extracellular Domain [Spatial Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0521119:Extracellular [Cell Component]
   760   C0849355:Out [Qualitative Concept]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "which"

Phrase: "are"

Phrase: "therefore"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "different actions on exocytosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441472:actions [Functional Concept]
   737 E C3266814:Action [Activity]

Phrase: "or on the membrane ion channels."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Membrane Channels
   753   C0022023:Ion [Element, Ion, or Isotope]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1700702:ION [Functional Concept]
   753   C1706182:Membrane [Manufactured Object]
   719   C0439799:Channel [Spatial Concept]
   719   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.282: Although STX-1A and SNAP-25, acting as a complex, are also important for regulating islet -cell Kv2.1 channel (26), this channel appears to be less sensitive to the slight increase in STX-1A levels. 

Phrase: "Although"

Phrase: "STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "SNAP-25,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   846   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "acting as a complex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]
   737   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "also important for"

Phrase: "regulating"

Phrase: "islet -cell Kv2.1 channel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0439799:Channel [Spatial Concept]
   804   C1706095:Channel [Conceptual Entity]
   708   C1416480:ISLET 1 [Gene or Genome]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "this channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "less sensitive to the slight increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C1550474:sensitive [Idea or Concept]

Phrase: "in STX-1A levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]
Processing 00000000.tx.283: Nonetheless, the subsequent addition of excess exogenous STX-1A protein could then inhibit the Kv currents of the STX-1A islet -cells. 

Phrase: "Nonetheless,"

Phrase: "the subsequent addition of excess exogenous STX-1A protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1883712:Addition [Functional Concept]

Phrase: "could"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the Kv currents of the STX-1A islet -cells."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0521116:currents [Temporal Concept]
   708 E C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.284: We also did not observe a significant effect on the KATP channels of the STX-1A islet -cells. 

Phrase: "We also"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "a significant effect on the KATP channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "of the STX-1A islet -cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   827 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.285: However, STX-1A levels in the islets of type 2 diabetic rodent models are reduced by >50% (10,11), and those levels become even further reduced with prolonged hyperglycemia (10). 

Phrase: "However,"

Phrase: "STX-1A levels in the islets of type 2 diabetic rodent models"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   736   C0441889:Levels [Qualitative Concept]
   734   C0456948:Level 2 [Intellectual Product]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "reduced by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0392756:Reduced [Qualitative Concept]

Phrase: ">50%"

Phrase: "(10,"

Phrase: "11"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "those levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "become"

Phrase: "even further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1517331:Further [Spatial Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "reduced with prolonged hyperglycemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020456:Hyperglycaemia [Disease or Syndrome]
   770   C0392756:Reduced [Qualitative Concept]
   770   C0439590:Prolonged [Temporal Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.286: Such low levels of the STX-1A could then adversely influence these K+ channels. 

Phrase: "Such low levels of the STX-1A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "then adversely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "influence"

Phrase: "these K+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.287: This could contribute to the abnormal islet -cell KATP channel function and its reduced glucose sensitivity in the diabetic GK rats (27). 

Phrase: "This"

Phrase: "could"

Phrase: "contribute to the abnormal islet -cell KATP channel function"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   764   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   764   C1522529:Islet Cell [Cell]
   762   C0007613:Cell Function [Cell Function]
   762   C0333717:Abnormal cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0031843:function [Physiologic Function]
   742   C0205161:Abnormal [Qualitative Concept]
   742   C0439799:Channel [Spatial Concept]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1705273:Function [Intellectual Product]
   742   C1706095:Channel [Conceptual Entity]
   742   C1880177:Contribute [Activity]
   742   C1948049:Cell [Spatial Concept]
   742   C2347472:% Abnormal [Quantitative Concept]
   742   C2699333:ABNORMAL [Intellectual Product]

Phrase: "and"

Phrase: "its reduced glucose sensitivity in the diabetic GK rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0036667:Sensitivity [Quantitative Concept]
   739   C0312418:Sensitivity [Mental Process]
   739   C0427965:Sensitivity [Finding]
   739   C1511883:Sensitivity [Quantitative Concept]
   739   C1522640:Sensitivity [Qualitative Concept]
   739   C2346484:SENSITIVITY [Phenomenon or Process]
   739   C2349185:Sensitivity [Qualitative Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.288: The elevated STX-1A levels can certainly also affect exocytosis per se, because STX-1A is one of three minimal components (SNAP-25 and VAMP-2 being the other two) that comprise the exocytic machinery (19). 

Phrase: "The elevated STX-1A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "can"

Phrase: "certainly also"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "per se,"

Phrase: "because"

Phrase: "STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "is"

Phrase: "one of three minimal components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "(SNAP-25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   846   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "VAMP-2"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0148340:Vesicle-Associated Membrane Protein 2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 [Gene or Genome]
   937   C0078208:Vesicle-Associated Membrane Protein [Amino Acid, Peptide, or Protein,Receptor]
   853   C1167317:vesicle membrane [Cell Component]
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   804   C0333262:Vesicle [Acquired Abnormality]
   804   C0596901:Membrane [Cell Component]
   804   C1622418:vesicle [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
   733 E C0205287:Membranous [Qualitative Concept]
   733 E C0205378:Vesicular [Qualitative Concept]

Phrase: "being"

Phrase: "the other two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: ")"

Phrase: "that"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the exocytic machinery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337076:machinery [Manufactured Object]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.289: Interestingly, we noted a 30% reduction in the islet levels of Munc18a in the STX-1A mice. 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "a 30% reduction in the islet levels of Munc18a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the STX-1A mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]
Processing 00000000.tx.290: Munc18a plays an important role in insulin exocytosis (20), specifically by activating STX-1A into an "open" conformation, which can then bind the cognate SNARE proteins to consummate exocytosis (19,28,29). 

Phrase: "Munc18a"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in insulin exocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "specifically by activating STX-1A"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1420498:SYNTAXIN 1A [Gene or Genome]
   760   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0450344:1A [Intellectual Product]
   760   C1553633:1a [Medical Device]
   760   C1879547:activating [Activity]
   726 E C1515877:Activate [Functional Concept]

Phrase: "into an """

Phrase: "open"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: """ conformation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "which"

Phrase: "can"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the cognate SNARE proteins to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "consummate"

Phrase: "exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "(19,"

Phrase: "28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.291: The reduced levels of Munc18a could result in a reduced efficiency of converting the moderate excess of STX-1A into its open form, which is required to prime secretory granules, and thereby contribute to the reduced size of the primed releasable pool and the less efficient mobilization of insulin granules to the releasable pool as observed in our study. 

Phrase: "The reduced levels of Munc18a"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "result in a reduced efficiency of converting"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0013682:Efficiency [Quantitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "the moderate excess of STX-1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1979886:Excess [Qualitative Concept]

Phrase: "into its open form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "secretory granules,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "contribute to the reduced size of the primed releasable pool"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0337051:Pool [Geographic Area]
   739   C0392756:Reduced [Qualitative Concept]
   739   C0456389:size [Spatial Concept]
   739   C0871133:primed [Functional Concept]
   739   C1509144:pool [Clinical Attribute]
   739   C1880177:Contribute [Activity]
   739   C2349200:Pool [Functional Concept]

Phrase: "and"

Phrase: "the less efficient mobilization of insulin granules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   748   C0300926:mobilization [Functional Concept]

Phrase: "to the releasable pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "as"

Phrase: "observed in our study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1441672:Observed [Functional Concept]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.292: Munc18a however has not been demonstrated to directly affect Ca2+ channels. 

Phrase: "Munc18a however"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "Ca2+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.293: The open conformation of STX-1A regulates -cell Kv2.1 and KATP channels more effectively than wild-type STX-1A (8,24), but presumably, the small changes in Munc18a levels on STX-1A in the STX-1A mouse islets may not be sufficient to severely perturb STX-1A actions on these K+ channels. 

Phrase: "The open conformation of STX-1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0026377:Conformation [Spatial Concept]

Phrase: "regulates -"

Phrase: "cell Kv2.1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1416554:KV2.1 [Gene or Genome]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "KATP channels more effectively than wild-type STX-1A"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420498:SYNTAXIN 1A [Gene or Genome]
   764   C1883559:Wild Type [Organism Attribute]
   764   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   742   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C0450344:1A [Intellectual Product]
   742   C1547052:*Type [Quantitative Concept]
   742   C1553633:1a [Medical Device]
   708   C0439799:Channel [Spatial Concept]
   708   C1706095:Channel [Conceptual Entity]

Phrase: "(8,"

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "presumably,"

Phrase: "the small changes in Munc18a levels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0025320:The change [Physiologic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0700321:Small [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "on STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "in the STX-1A mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522528:Mouse Islets [Tissue]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "sufficient to severely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205082:Severely [Qualitative Concept]
   827   C0205410:Sufficient [Qualitative Concept]

Phrase: "perturb"

Phrase: "STX-1A actions on these K+ channels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441472:actions [Functional Concept]
   714 E C3266814:Action [Activity]
Processing 00000000.tx.294: Why the islet Munc18a levels in STX-1A pancreatic islets are reduced is not clear, but it could be the effects of the overexpressed STX-1A on Munc18a synthesis or stability. 

Phrase: "Why"

Phrase: "the islet Munc18a levels in STX-1A pancreatic islets"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "the effects of the overexpressed STX-1A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on Munc18a synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "or"

Phrase: "stability."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.295: The abnormal glucose homeostasis in the STX-1Aoverexpressing male mice was due not only to abnormal insulin secretion, but surprisingly, we also found reduced insulin sensitivity of the peripheral tissues. 

Phrase: "The abnormal glucose homeostasis in the STX-1Aoverexpressing male mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1326961:glucose homeostasis [Physiologic Function]
   739   C0019868:Homeostasis [Biologic Function]

Phrase: "was"

Phrase: "due"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678226:due [Functional Concept]
  1000   C3146286:Due [Idea or Concept]

Phrase: "not only to abnormal insulin secretion,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C1256369:insulin secretion [Cell Function]
   783   C0679330:abnormal secretion [Pathologic Function]
   783   C1547211:Not abnormal [Intellectual Product]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0205161:Abnormal [Qualitative Concept]
   753   C0205171:Only [Quantitative Concept]
   753   C1518422:Not [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1720467:Only [Intellectual Product]
   753   C2347472:% Abnormal [Quantitative Concept]
   753   C2699333:ABNORMAL [Intellectual Product]

Phrase: "but"

Phrase: "surprisingly,"

Phrase: "we also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "reduced insulin sensitivity of the peripheral tissues."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0920563:Insulin Sensitivity [Pathologic Function]
   757   C0234235:Tissue sensitivity [Sign or Symptom]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.296: Glucose transport via Glut4 in the insulin-sensitive tissues, including fat and muscles, is also regulated by SNARE proteins (21); 

Phrase: "Glucose transport via Glut4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0178666:glucose transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "in the insulin-sensitive tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: "and"

Phrase: "muscles,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0026845:Muscles [Tissue]
  1000   C1995013:Muscles [Body Part, Organ, or Organ Component]
   916 E C0442025:Muscular [Spatial Concept]

Phrase: "is"

Phrase: "also"

Phrase: "regulated by SNARE proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
           SNARE
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0183362:Snare [Medical Device]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1153540:SNARE [Molecular Function]

Phrase: "(21"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.297: however, the primary syntaxin that regulates Glut4 transport is STX-4 (along with SNAP-23 and VAMP-2) and not STX-1A (21). 

Phrase: "however,"

Phrase: "the primary syntaxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "regulates"

Phrase: "Glut4 transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "STX-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036248:STX [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]
   861   C1539874:STX [Gene or Genome]

Phrase: "("

Phrase: "along with SNAP-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "and"

Phrase: "VAMP-2"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0148340:Vesicle-Associated Membrane Protein 2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 [Gene or Genome]
   937   C0078208:Vesicle-Associated Membrane Protein [Amino Acid, Peptide, or Protein,Receptor]
   853   C1167317:vesicle membrane [Cell Component]
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   804   C0333262:Vesicle [Acquired Abnormality]
   804   C0596901:Membrane [Cell Component]
   804   C1622418:vesicle [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
   733 E C0205287:Membranous [Qualitative Concept]
   733 E C0205378:Vesicular [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "not STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420498:SYNTAXIN 1A [Gene or Genome]
   827   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.298: Therefore, the defective insulin sensitivity of these tissues might be due to secondary defects of neural and hormonal release (cortisol, catecholamines, and growth hormone) mechanisms, and perhaps even islet -cell glucagon release. 

Phrase: "Therefore,"

Phrase: "the defective insulin sensitivity of these tissues"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0920563:Insulin Sensitivity [Pathologic Function]
   757   C0234235:Tissue sensitivity [Sign or Symptom]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "might"

Phrase: "be due to secondary defects of neural"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0678226:Due to [Functional Concept]
           due
   774   C0175668:Secondary to [Temporal Concept]
           Secondary
   748   C0027627:secondary [Neoplastic Process]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0243067:defects [Functional Concept]
   748   C0599851:Neural [Functional Concept]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]
   714 E C1457869:Defect [Functional Concept]
   714 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "hormonal release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(cortisol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020268:Cortisol [Hormone,Pharmacologic Substance,Steroid]

Phrase: "catecholamines,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0007412:Catecholamines [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   966 E C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "and"

Phrase: "growth hormone"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0037663:Growth Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0169964:Growth hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0019932:Hormone [Hormone]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: ")"

Phrase: "mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "perhaps even islet -cell glucagon release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0030685:Release [Health Care Activity]
   799   C0391871:Release [Functional Concept]
   799   C0439180:% release [Quantitative Concept]
   799   C0680255:release [Health Care Activity]
   799   C1283071:Release [Functional Concept]
   799   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.299: Because these neural and endocrine (i.e., pituitary and adrenal glands and islet -cells) tissues are also regulated by STX-1A, they would likely also be affected by the overexpression of STX-1A, which could possibly cause abnormal hormone release and in turn influence not only insulin sensitivity of the peripheral tissues but also -cell insulin secretion as well. 

Phrase: "Because"

Phrase: "these neural"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0599851:Neural [Functional Concept]
   944 E C0027740:Nerve [Tissue]
   944 E C0027757:NERVE [Tissue]
   944 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   907 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "endocrine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014136:Endocrine [Body System]
  1000   C0521425:Endocrine [Functional Concept]

Phrase: "(i.e., pituitary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "and"

Phrase: "adrenal glands"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0001625:Adrenal Glands [Body Part, Organ, or Organ Component]
   966 E C1268989:Adrenal gland [Body Part, Organ, or Organ Component]
   966 E C1515890:GLAND, ADRENAL [Tissue]
   861   C1285092:Glands [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "islet -cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "are"

Phrase: "also"

Phrase: "regulated by STX-1A,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1420498:SYNTAXIN 1A [Gene or Genome]
   770   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0450344:1A [Intellectual Product]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1553633:1a [Medical Device]

Phrase: "they"

Phrase: "would"

Phrase: "likely also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "affected by the overexpression of STX-1A,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1420498:SYNTAXIN 1A [Gene or Genome]
   748   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392760:Affected [Functional Concept]
   748   C0450344:1A [Intellectual Product]
   748   C1314939:Affected [Functional Concept]
   748   C1514559:Overexpression [Genetic Function]
   748   C1553633:1a [Medical Device]
   714 E C0001721:Affect [Mental Process]

Phrase: "which"

Phrase: "could"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "abnormal hormone release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "influence"

Phrase: "not only insulin sensitivity of the peripheral tissues"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0920563:Insulin Sensitivity [Pathologic Function]
   750   C0234235:Tissue sensitivity [Sign or Symptom]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036667:Sensitivity [Quantitative Concept]
   744   C0312418:Sensitivity [Mental Process]
   744   C0427965:Sensitivity [Finding]
   744   C1511883:Sensitivity [Quantitative Concept]
   744   C1522640:Sensitivity [Qualitative Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2346484:SENSITIVITY [Phenomenon or Process]
   744   C2349185:Sensitivity [Qualitative Concept]

Phrase: "but"

Phrase: "also -cell insulin secretion as well."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1256369:insulin secretion [Cell Function]
   783   C0030281:Insulin Cell [Cell]
   783   C1327616:Cell secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.300: Of note, the abnormal insulin sensitivity was manifested only in the male STX-1A mice and not the female STX-1A mice. 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the abnormal insulin sensitivity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   901   C0920563:Insulin Sensitivity [Pathologic Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2346484:SENSITIVITY [Phenomenon or Process]
   827   C2349185:Sensitivity [Qualitative Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "manifested"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205319:manifested [Functional Concept]
  1000   C1280444:manifested [Qualitative Concept]

Phrase: "only in the male STX-1A mice"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1420498:SYNTAXIN 1A [Gene or Genome]
   748   C0024554:Male [Finding]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0086582:male [Population Group]
   748   C0205171:Only [Quantitative Concept]
   748   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0450344:1A [Intellectual Product]
   748   C1553633:1a [Medical Device]
   748   C1706180:Male [Qualitative Concept]
   748   C1706428:Male [Qualitative Concept]
   748   C1706429:Male [Organism Attribute]
   748   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the female STX-1A mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.301: This suggests an even more important role of the sex hormones, either a favorable influence by female hormones (i.e., estrogens and progesterone) or unfavorable influence by male hormones (i.e., testosterone) on insulin sensitivity of the peripheral tissues. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an even more important role of the sex hormones,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0017253:Sex Role [Social Behavior]
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "either"

Phrase: "a favorable influence by female hormones"

Phrase: "(i.e., estrogens"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   793 E C2936882:Estrogen [Pharmacologic Substance]
   743 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "and"

Phrase: "progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "or"

Phrase: "unfavorable influence by male hormones"

Phrase: "(i.e., testosterone"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   771 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: ")"

Phrase: "on insulin sensitivity"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0920563:Insulin Sensitivity [Pathologic Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "of the peripheral tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.302: The release of male and female hormones might also be affected by STX-1A either directly or via the STX-1Amediated neurohormonal (i.e., pituitary-adrenal) release pathways. 

Phrase: "The release of male"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "female hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "affected by STX-1A either directly"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420498:SYNTAXIN 1A [Gene or Genome]
   753   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392760:Affected [Functional Concept]
   753   C0450344:1A [Intellectual Product]
   753   C1314939:Affected [Functional Concept]
   753   C1553633:1a [Medical Device]
   753   C1947931:Directly [Qualitative Concept]
   719 E C0001721:Affect [Mental Process]

Phrase: "or via the STX-1Amediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036248:STX [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]
   760   C1539874:STX [Gene or Genome]

Phrase: "neurohormonal"

Phrase: "(i.e., pituitary-adrenal"

Phrase: ")"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.303: The increase in STX-1A levels produced in these mice are well within the range of the effects of polymorphic changes within regulatory elements seen for other genes and so are physiologically relevant. 

Phrase: "The increase in STX-1A levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "produced in these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "well within the range of the effects of polymorphic changes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   739   C0205170:Well [Qualitative Concept]
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   739   C1280500:effects [Qualitative Concept]
   739   C1514721:Range [Quantitative Concept]
   739   C1882417:Polymorphic [Qualitative Concept]
   739   C2348147:Range [Quantitative Concept]
   739   C3146287:Well [Manufactured Object]
   739   C3542016:Range [Intellectual Product]
   706 E C1705241:Change [Quantitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "within regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "seen for other genes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0017337:Genes [Gene or Genome]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "and"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "are"

Phrase: "physiologically relevant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.304: The factor VII locus contains five common polymorphisms that influence circulating levels of factor VII: three within the promoter, one intronic, and one coding (30). 

Phrase: "The factor VII locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1708726:Locus [Gene or Genome]
   734   C0015502:Factor VII [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C1333523:FACTOR VII [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "five common polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "influence"

Phrase: "circulating levels of factor VII"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   835   C0427593:factor levels vii [Laboratory or Test Result]
   760   C0175630:Circulating [Functional Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: ":"

Phrase: "three within the promoter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0205449:Three [Quantitative Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "intronic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "one coding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009219:Coding [Occupational Activity]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.305: Together, these polymorphisms account for close to one-half of the variation in protein levels seen between individuals and appear to have a clinical effect because they can act as either risk or protective factors for myocardial infarction (31,32). 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "account for close"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0587267:Close [Functional Concept]
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]

Phrase: "to one-half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825407:Half [Quantitative Concept]

Phrase: "of the variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "in protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "seen between individuals"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   756   C0027361:Individual [Population Group]
   756 E C0042789:see [Organism Function]
   756   C0237401:Individual [Human]
   756 E C1947903:See [Activity]

Phrase: "and"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a clinical effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "because"

Phrase: "they"

Phrase: "can"

Phrase: "act as either risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035647:Risk [Qualitative Concept]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "protective factors for myocardial infarction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0679688:protective factors [Biologic Function]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.306: Similar polymorphisms that produce modest changes in STX-1A protein levels may also exist in the general population and alter individuals susceptibility to glucose intolerance or diabetes. 

Phrase: "Similar polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "produce"

Phrase: "modest changes in STX-1A protein levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "exist in the general population"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0683971:General Population [Population Group]
   760   C0032659:Population [Quantitative Concept]
   760   C0205246:General [Spatial Concept]
   760   C1257890:Population [Population Group]
   760   C1553889:General [Idea or Concept]
   760   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "individuals susceptibility to glucose intolerance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "or"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.307: We had previously shown that type 2 diabetic rodent models exhibited reduced levels of SNARE proteins in the pancreatic islets, including STX-1A (10). 

Phrase: "We"

Phrase: "had"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that type 2 diabetic rodent models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Models [Intellectual Product]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "reduced levels of SNARE proteins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   764   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.308: This may also be an underlying mechanism contributing to diabetes in humans. 

Phrase: "This"

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "an underlying mechanism contributing to diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contributing [Activity]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.309: The extremely high frequency of abnormal glucose tolerance reported in adults with WBS, far higher than adults in the general population with similar BMIs (15), strongly suggests an underlying genetic cause, presumably the dominant effect of the deletion of one or more genes within the WBS region. 

Phrase: "The extremely high frequency of abnormal glucose tolerance"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0205212:High frequency [Temporal Concept]
   767   C0860803:glucose high [Finding]
   744   C0205250:High [Qualitative Concept]
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "reported in adults"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0001675:Adults [Age Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C1706450:Adult [Human]
   756 E C3273238:Report [Intellectual Product]

Phrase: "with WBS,"

Phrase: "far higher than adults"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in the general population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "with similar BMIs"

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "strongly"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an underlying genetic cause,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015127:cause [Functional Concept]
   827   C1524003:Cause [Conceptual Entity]

Phrase: "presumably"

Phrase: "the dominant effect of the deletion of one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "more genes within the WBS region."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.310: We had postulated that hemizygosity for STX-1A may be a primary cause of abnormal glucose metabolism and neurological abnormalities in WBS (16), raising the possibility that STX-1A could be a diabetogene (33). 

Phrase: "We"

Phrase: "had"

Phrase: "postulated"

Phrase: "that hemizygosity for STX-1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1881036:Hemizygosity [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a primary cause of abnormal glucose metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1523925:primary metabolism [Organism Function]
   748   C0015127:cause [Functional Concept]
   748   C0205225:Primary [Qualitative Concept]
   748   C0439631:Primary [Therapeutic or Preventive Procedure]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "neurological abnormalities in WBS (16"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: ")"

Phrase: ","

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that STX-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "could"

Phrase: "be"

Phrase: "a diabetogene"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.311: The effects on glucose metabolism from only a moderate change in STX-1A protein levels seen in our transgenic mouse model indicate that the pancreatic -cells may be exquisitely sensitive to such alterations. 

Phrase: "The effects on glucose metabolism"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1158774:glucose effect [Genetic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "from only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a moderate change in STX-1A protein levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "seen in our transgenic mouse model"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0025936:Mouse, Transgenic [Mammal]
   790   C2986594:Mouse Model [Experimental Model of Disease]
   783   C1519606:Transgenic Model [Experimental Model of Disease]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0205397:Seen [Qualitative Concept]
   753   C3161035:Model [Intellectual Product]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "exquisitely sensitive to such alterations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.312: We postulated that increasing or decreasing the levels of STX-1A within the -cells may disrupt the proper assembly or function of the insulin exocytotic machinery, either through changing the stoichiometry of the SNARE complex itself or perhaps by altering its interaction with Munc18a. 

Phrase: "We"

Phrase: "postulated"

Phrase: "that increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "or"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the levels of STX-1A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "within the -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the proper assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "or"

Phrase: "function of the insulin exocytotic machinery,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "either through changing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:Changing [Functional Concept]
   790   C0443172:changing [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "the stoichiometry of the SNARE complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "itself"

Phrase: "or"

Phrase: "perhaps by altering"

Phrase: "its interaction with Munc18a."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.313: Elucidation of the precise components of the insulin secretory machinery that are altered by a reduced level of STX-1A awaits the generation of mice that are hemizygous for STX-1A. 

Phrase: "Elucidation of the precise components of the insulin secretory machinery"

Phrase: "that"

Phrase: "are"

Phrase: "altered by a reduced level of STX-1A"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420498:SYNTAXIN 1A [Gene or Genome]
   744   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0392747:Altered [Functional Concept]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0450344:1A [Intellectual Product]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C1553633:1a [Medical Device]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "awaits"

Phrase: "the generation of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "that"

Phrase: "are"

Phrase: "hemizygous for STX-1A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1881036:Hemizygous [Qualitative Concept]
Processing 00000000.tx.314: Our results, demonstrating that small fluctuations of STX-1A levels could profoundly affect ion channels and exocytosis, are of broader relevance to a number of neurological diseases (besides WBS, above) in which the cellular levels of STX-1A are also severely perturbed. 

Phrase: "Our results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrating"

Phrase: "that small fluctuations of STX-1A levels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0231239:fluctuations [Sign or Symptom]
   714 E C0231241:Fluctuation [Temporal Concept]
   714 E C2827773:Fluctuation% [Qualitative Concept]

Phrase: "could"

Phrase: "profoundly"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "ion channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "exocytosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "are of broader relevance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1551058:Are [Quantitative Concept]
   770   C2347946:Relevance [Qualitative Concept]
   737   C0332464:Broad [Spatial Concept]

Phrase: "to a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of neurological diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C0027765:neurological disease [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "("

Phrase: "besides WBS,"

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "in which"

Phrase: "the cellular levels of STX-1A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "also severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205082:Severely [Qualitative Concept]

Phrase: "perturbed."
Processing 00000000.tx.315: The frontal cortexes of patients with schizophrenia and depression whose cause of death was suicide were noted to exhibit elevated STX-1A levels compared with patients who died of other causes (34). 

Phrase: "The frontal cortexes of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   726   C0007776:Cortex [Body Part, Organ, or Organ Component]
   726   C1176472:Cortex [Body Part, Organ, or Organ Component]
   726   C2700441:Cortex [Plant]

Phrase: "with schizophrenia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036341:Schizophrenia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "depression"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "whose"

Phrase: "cause of death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007465:Cause of Death [Finding]
           Death Cause
  1000   C0804771:Cause of death [Clinical Attribute]
   790   C0011065:Death [Organism Function]
   790   C0015127:cause [Functional Concept]
   790   C1306577:Death, NOS [Finding]
   790   C1524003:Cause [Conceptual Entity]

Phrase: "was"

Phrase: "suicide"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0038661:Suicide [Finding]
   928 E C0438696:Suicidal [Finding]
   900 E C3166387:Suicidality [Clinical Attribute]

Phrase: "were"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "elevated STX-1A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1707455:Compared [Activity]

Phrase: "who"

Phrase: "died of other causes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0011065:Died [Organism Function]
   770   C0015127:causes [Functional Concept]
   770   C1314792:Causes [Functional Concept]
   770   C1546956:Died [Finding]
   737 E C1524003:Cause [Conceptual Entity]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.316: These reports taken together suggest that abnormalities in STX-1A levels, either an excess or a deficit, along with the complexes formed with its interacting proteins (ion channels and exocytic proteins) could provide the molecular substrates for abnormalities of neural connectivity, perhaps as a result of the formation of abnormal "nonfunctioning" excitosome complexes (22). 

Phrase: "These reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that abnormalities in STX-1A levels,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]

Phrase: "either"

Phrase: "an excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979886:Excess [Qualitative Concept]

Phrase: "or"

Phrase: "a deficit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162429:Deficit, NOS [Disease or Syndrome]
  1000   C2987487:Deficit [Qualitative Concept]

Phrase: "along with the complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "formed with its interacting proteins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205431:Formed [Functional Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "(ion channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "exocytic proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "could"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the molecular substrates for abnormalities of neural connectivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1710236:Substrate [Manufactured Object]

Phrase: "perhaps as a result of the formation of abnormal ""nonfunctioning"" excitosome complexes"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   751   C0459424:Abnormal result [Finding]
   736   C0205161:Abnormal [Qualitative Concept]
   736   C0220781:formation [Biologic Function]
   736   C0439634:formation [Spatial Concept]
   736   C1274040:Result [Functional Concept]
   736   C1522492:Formation [Functional Concept]
   736   C1546471:Result [Idea or Concept]
   736   C1704241:Complexes [Chemical Viewed Structurally]
   736   C2347472:% Abnormal [Quantitative Concept]
   736   C2699333:ABNORMAL [Intellectual Product]
   736   C2825142:Result [Finding]
   703 E C0439855:Complex [Qualitative Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.317: In summary, our work demonstrates that even slight fluctuation of islet STX-1A (and presumably other cognate SNARE proteins) levels could contribute to the changing patterns of insulin secretory responses in health and in type 2 diabetes.  

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "demonstrates"

Phrase: "that even slight fluctuation of islet STX-1A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0231239:Fluctuation [Sign or Symptom]
   744   C0231241:Fluctuation [Temporal Concept]
   744   C2827773:Fluctuation% [Qualitative Concept]

Phrase: "("

Phrase: "and"

Phrase: "presumably"

Phrase: "other cognate SNARE proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0300824:SNARE Proteins [Amino Acid, Peptide, or Protein,Receptor]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "contribute to the changing patterns of insulin secretory responses"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   748   C1272746:Change patterns [Qualitative Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0392747:Changing [Functional Concept]
   742   C0443172:changing [Quantitative Concept]
   742   C0449774:Patterns [Spatial Concept]
   742   C0871261:responses [Organism Attribute]
   742   C1327616:Secretory [Cell Function]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1880177:Contribute [Activity]
   708 E C1704632:Response [Finding]
   708 E C1705241:Change [Quantitative Concept]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "in health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018684:Health [Idea or Concept]
   900 E C0031206:healthiness [Finding]

Phrase: "and in type 2 diabetes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.318: ACKNOWLEDGMENTS  H.Y.G. and L.R.O. have received Canadian Diabetes Association Grant 1630 and Canadian Institutes for Health Research Grant CIHR MOP-64465. 

Phrase: "ACKNOWLEDGMENTS  H.Y.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0560020:h g [Quantitative Concept]
   812   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "L.R.O."

Phrase: "have"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "Canadian Diabetes Association Grant 1630"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0004083:Association [Mental Process]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0018173:Grant [Quantitative Concept]
   804   C0238884:CANADIAN [Finding]
   804   C0439849:Association [Qualitative Concept]
   804   C0596306:Association [Phenomenon or Process]
   804   C0699792:association [Social Behavior]
   804   C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "Canadian Institutes for Health Research Grant CIHR MOP-64465."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0035172:Research Institutes [Organization]
   742   C0021622:Institutes [Organization]
   708 E C1272753:Institute [Idea or Concept]
Processing 00000000.tx.319: P.P.L.L. has received a Canadian Institutes for Health Research-Canadian Digestive Health Foundation Graduate Studentship; 

Phrase: "P.P.L.L."

Phrase: "has"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "a Canadian Institutes for Health Research-Canadian Digestive Health Foundation Graduate Studentship"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   751   C0035172:Research Institutes [Organization]
   736   C0021622:Institutes [Organization]
   703 E C1272753:Institute [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.320: and Y. 

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.321: Leung has received a postdoctoral fellowship from the Canadian Diabetes Association. 

Phrase: "Leung"

Phrase: "has"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "a postdoctoral fellowship from the Canadian Diabetes Association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015770:Fellowship [Educational Activity]
Processing 00000000.tx.322: We thank Peter Pasceri for technical assistance in generating the STX-1A mice.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Peter Pasceri for technical assistance"

Phrase: "in generating"

Phrase: "the STX-1A mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]
Processing 00000000.tx.323: FOOTNOTES  P.P.L.L. and Y.-M.L. contributed equally to this work. 

Phrase: "FOOTNOTES  P.P.L.L."

Phrase: "and"

Phrase: "Y.-M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.324: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.325: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.326: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.327: Address correspondence and reprint requests to Herbert Y. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Herbert Y."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0331828:Herbert [Health Care Related Organization]
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]
Processing 00000000.tx.328: Gaisano, MD, University of Toronto, Room 7226, Medical Science Building, 1 Kings College Circle, Toronto, Ontario, Canada M5S 1A8. 

Phrase: "Gaisano,"

Phrase: "MD,"

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Room 7226,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]

Phrase: "Medical Science Building,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1547706:Building [Functional Concept]
   827   C1999269:Building [Manufactured Object]
   734   C0025118:Medical Science [Biomedical Occupation or Discipline]

Phrase: "1 Kings College Circle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1282913:Circle [Spatial Concept]
   812   C1551714:Circle [Population Group]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada M5S 1A8."
Processing 00000000.tx.329: E-mail: herbert.gaisano{at}utoronto.ca . Or Lucy R. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "herbert.gaisano{at}utoronto.ca ."

Phrase: "Or"

Phrase: "Lucy R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.330: Osborne, PhD, University of Toronto, Room 7238, Medical Science Building, 1 Kings College Circle, Toronto, Ontario, Canada M5S 1A8. 

Phrase: "Osborne,"

Phrase: "PhD,"

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Room 7238,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]

Phrase: "Medical Science Building,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1547706:Building [Functional Concept]
   827   C1999269:Building [Manufactured Object]
   734   C0025118:Medical Science [Biomedical Occupation or Discipline]

Phrase: "1 Kings College Circle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1282913:Circle [Spatial Concept]
   812   C1551714:Circle [Population Group]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada M5S 1A8."
Processing 00000000.tx.331: E-mail: lucy.osborne{at}utoronto.ca Received for publication November 23, 2004 and accepted in revised form June 7, 2005 Cm, membrane capacitance; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "lucy.osborne{at}utoronto.ca"

Phrase: "Received for publication November 23,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C0450348:23 [Quantitative Concept]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2004"

Phrase: "and"

Phrase: "accepted in revised form June 7,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2005 Cm,"

Phrase: "membrane capacitance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0025255:Membrane [Tissue]
   861   C0242264:capacitance [Quantitative Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.332: GST, glutathione S-transferase; 

Phrase: "GST,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glutathione S-transferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.333: IPGTT, intraperitoneal glucose tolerance test; 

Phrase: "IPGTT,"

Phrase: "intraperitoneal glucose tolerance test"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   923   C0017741:Glucose tolerance test [Diagnostic Procedure]
   875   C0337438:glucose test [Laboratory Procedure]
   875   C0595310:GLUCOSE TEST [Medical Device]
   861   C0178665:Glucose tolerance [Physiologic Function]
   861   C0201777:Tolerance test [Laboratory Procedure]
   812   C0013220:Tolerance [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:test [Intellectual Product]
   812   C1704410:Tolerance [Qualitative Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: ";"
Processing 00000000.tx.334: KATP channel, ATP-sensitive K+ channel; 

Phrase: "KATP channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "ATP-sensitive K+ channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0439799:Channel [Spatial Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1706095:Channel [Conceptual Entity]
   812   C1708601:K' [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.335: Kv channel, voltage-gated potassium channel; 

Phrase: "Kv channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "voltage-gated potassium channel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0814023:Voltage-Gated Potassium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597675:voltage gated channel [Physiologic Function]
   861   C0032824:Potassium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0032821:Potassium [Element, Ion, or Isotope]
   812   C0439799:Channel [Spatial Concept]
   812   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1706095:Channel [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.336: NSF, N-ethylmaleimidesensitive factor; 

Phrase: "NSF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417857:NSF [Gene or Genome]

Phrase: "N-ethylmaleimidesensitive factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.337: SNAP-25, synaptosome-associated protein of 25 kDa; 

Phrase: "SNAP-25,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   846   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synaptosome-associated protein of 25 kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   846   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.338: SNARE, soluble NSF attachment protein receptor; 

Phrase: "SNARE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0183362:Snare [Medical Device]
  1000   C0300824:SNARE [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1153540:SNARE [Molecular Function]

Phrase: "soluble NSF attachment protein receptor"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   937   C0169272:soluble NSF attachment protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           NSF Attachment Protein
   937   C0300824:NSF Attachment Protein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0185023:Attachment [Therapeutic or Preventive Procedure]
   804   C1417857:NSF [Gene or Genome]
   804   C1749467:soluble [Cell Component]
   804   C1947904:Attachment [Activity]
   804   C1948047:Soluble [Qualitative Concept]
   804   C1999228:Attachment [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.339: STX-1A, syntaxin-1A; 

Phrase: "STX-1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "syntaxin-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ";"
Processing 00000000.tx.340: TEA, tetraethylammonium; 

Phrase: "TEA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076252:Tetraethylammonium [Organic Chemical,Pharmacologic Substance]

Phrase: "tetraethylammonium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076252:Tetraethylammonium [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.341: VAMP-2, vesicle-associated membrane protein 2; 

Phrase: "VAMP-2,"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0148340:Vesicle-Associated Membrane Protein 2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 [Gene or Genome]
   937   C0078208:Vesicle-Associated Membrane Protein [Amino Acid, Peptide, or Protein,Receptor]
   853   C1167317:vesicle membrane [Cell Component]
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   804   C0333262:Vesicle [Acquired Abnormality]
   804   C0596901:Membrane [Cell Component]
   804   C1622418:vesicle [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
   733 E C0205287:Membranous [Qualitative Concept]
   733 E C0205378:Vesicular [Qualitative Concept]

Phrase: "vesicle-associated membrane protein 2"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0148340:Vesicle-Associated Membrane Protein 2 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1421419:VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 [Gene or Genome]
   937   C0078208:Vesicle-Associated Membrane Protein [Amino Acid, Peptide, or Protein,Receptor]
   853   C1167317:vesicle membrane [Cell Component]
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   804   C0333262:Vesicle [Acquired Abnormality]
   804   C0596901:Membrane [Cell Component]
   804   C1622418:vesicle [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
   733 E C0205287:Membranous [Qualitative Concept]
   733 E C0205378:Vesicular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.342: WBS, Williams-Beuren syndrome  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Daniel S, Noda M, Straub SG, Sharp GWG: Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. 

Phrase: "WBS,"

Phrase: "Williams-Beuren syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175702:Williams-Beuren Syndrome [Disease or Syndrome]
           Williams Syndrome
           Beuren Syndrome
  1000   C1414382:Williams-Beuren syndrome [Gene or Genome]
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Daniel S,"

Phrase: "Noda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Straub SG,"

Phrase: "Sharp GWG"

Phrase: ":"

Phrase: "Identification of the docked granule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "responsible for the first phase of glucose-stimulated insulin secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1273518:Responsible [Finding]
Processing 00000000.tx.343: Diabetes48 :1686 1690,1999[Abstract] Rorsman P, Renstrom E: Insulin granule dynamics in pancreatic -cells. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "1686 1690,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rorsman P,"

Phrase: "Renstrom E"

Phrase: ":"

Phrase: "Insulin granule dynamics in pancreatic -cells."
Processing 00000000.tx.344: Diabetologia46 :1029 1045,2003[Medline] MacDonald PE, Wheeler MB: Voltage-dependent K(+) channels in pancreatic beta cells: role, regulation and potential as therapeutic targets. 

Phrase: "Diabetologia46"

Phrase: ":"

Phrase: "1029 1045,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] MacDonald PE,"

Phrase: "Wheeler MB"

Phrase: ":"

Phrase: "Voltage-dependent K(+)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "channels in pancreatic beta cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   862   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   760   C0007634:Cells [Cell]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C0439799:Channel [Spatial Concept]
   760   C1706095:Channel [Conceptual Entity]
   760   C2004068:Beta [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "role,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "potential as therapeutic targets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.345: Diabetologia8 :1046 1062,2003 Yang S-N, Larsson O, Brnstrm R, Bertorello AM, Leibiger B, Leibiger IB, Moede T, Khler T, Meister B, Berggren P-O: Syntaxin interacts with the LD subtype of voltage-gated Ca2+ channels in pancreatic  cells. 

Phrase: "Diabetologia8"

Phrase: ":"

Phrase: "1046 1062,"

Phrase: "2003 Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945617:yang [Idea or Concept]

Phrase: "S-"

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Larsson O,"

Phrase: "Brnstrm R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bertorello"

Phrase: "AM"

Phrase: ","

Phrase: "Leibiger B,"

Phrase: "Leibiger IB,"

Phrase: "Moede T,"

Phrase: "Khler T,"

Phrase: "Meister B,"

Phrase: "Berggren P-O"

Phrase: ":"

Phrase: "Syntaxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts with the LD subtype of voltage-gated Ca2+ channels"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   761   C0597675:voltage gated channel [Physiologic Function]
   760   C3258486:Voltage-gated [Qualitative Concept]
   739   C0449560:Subtype [Classification]
   739   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0598352:Voltage [Quantitative Concept]
   706   C0439799:Channel [Spatial Concept]
   706   C1706095:Channel [Conceptual Entity]

Phrase: "in pancreatic  cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.346: Proc Natl Acad Sci U S A96 :10164 ,1999[Abstract/Free FullText] Kang YH, Huang XH, Pasyk EA, Ji J, Holz H, Wheeler MB, Tsushima R, Gaisano HY: Syntaxins-3 and -1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines. 

Phrase: "Proc Natl Acad Sci U S A96"

Phrase: ":"

Phrase: "10164 ,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kang YH,"

Phrase: "Huang XH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2247463:XH [Molecular Function]

Phrase: "Pasyk EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Ji J,"

Phrase: "Holz H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Wheeler MB,"

Phrase: "Tsushima R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gaisano HY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: ":"

Phrase: "Syntaxins-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0288875:Syntaxin 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   983   C1823141:SYNTAXIN 3 [Gene or Genome]
   861   C0288881:Syntaxins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "L-type calcium channel activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C1153433:calcium channel activity [Molecular Function]
   840   C1153410:channel activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0288263:L-Type Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C3538943:L-type calcium channel [Molecular Function]

Phrase: "insulin biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "exocytosis in beta-cell lines."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.347: Diabetologia45 :231 241,2002[Medline] Pasyk E, Kang Y, Huang X, Cui N, Sheu L, Gaisano HY: SNARE binds the nucleotide binding folds of pancreatic islet beta cell sulfonylurea receptor to regulate the KATP channel. 

Phrase: "Diabetologia45"

Phrase: ":"

Phrase: "231 241,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pasyk E,"

Phrase: "Kang Y,"

Phrase: "Huang X,"

Phrase: "Cui N,"

Phrase: "Sheu L,"

Phrase: "Gaisano HY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: ":"

Phrase: "SNARE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0183362:Snare [Medical Device]
  1000   C0300824:SNARE [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1153540:SNARE [Molecular Function]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the nucleotide binding folds of pancreatic islet beta cell sulfonylurea receptor to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0598153:nucleotide binding fold [Amino Acid Sequence]
   736   C0332462:Fold [Spatial Concept]
   736   C1880834:FOLD [Phenomenon or Process]

Phrase: "regulate"

Phrase: "the KATP channel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.348: J Biol Chem279 :4234 4240,2004[Abstract/Free FullText] Leung YM, Kang YH, Gao X, Xia F, Xie H, Sheu L, Tsuk S, Lotan I, Tsushima R Gaisano HY: Syntaxin 1A binds to the cytoplasmic C-terminus of Kv2.1 to regulate channel gating and trafficking. 

Phrase: "J Biol Chem279"

Phrase: ":"

Phrase: "4234 4240,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Leung YM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349168:ym [Quantitative Concept]

Phrase: "Kang YH,"

Phrase: "Gao X,"

Phrase: "Xia F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Xie H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sheu L,"

Phrase: "Tsuk S,"

Phrase: "Lotan I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tsushima R Gaisano HY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1539791:HY [Gene or Genome]

Phrase: ":"

Phrase: "Syntaxin 1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "binds to the cytoplasmic C-terminus of Kv2.1 to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1416554:KV2.1 [Gene or Genome]
   739   C0010834:Cytoplasmic [Cell Component]
   739   C0521449:Cytoplasmic [Body Location or Region]
   739   C1145667:Bind [Activity]
   739   C1167622:bind [Molecular Function]

Phrase: "regulate"

Phrase: "channel gating"

Phrase: "and"

Phrase: "trafficking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]
Processing 00000000.tx.349: J Biol Chem278 :17532 17538,2003[Abstract/Free FullText] Leung Y-M, Kang Y, Xia F, Sheu L, Gao X, Xie H, Tsushima RG, Gaisano HY: Open form syntaxin-1A is more potent than the wild type form in inhibiting Kv2.1 channel: implications for membrane potential regulation in exocytosis. 

Phrase: "J Biol Chem278"

Phrase: ":"

Phrase: "17532 17538,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Leung Y-M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Kang Y,"

Phrase: "Xia F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Sheu L,"

Phrase: "Gao X,"

Phrase: "Xie H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tsushima RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Gaisano HY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: ":"

Phrase: "Open form syntaxin-1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420498:SYNTAXIN 1A [Gene or Genome]
   812   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0450344:1A [Intellectual Product]
   812   C1553633:1a [Medical Device]

Phrase: "is"

Phrase: "more potent than the wild type form"

Phrase: "in inhibiting Kv2.1 channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439799:Channel [Spatial Concept]
   812   C1706095:Channel [Conceptual Entity]

Phrase: ":"

Phrase: "implications for membrane potential regulation"

Phrase: "in exocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.350: Biochem J387 :195 202,2005[Medline] Chan CB, MacPhail RM, Sheu L, Wheeler M, Gaisano HY: -Cell hypertrophy in fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression. 

Phrase: "Biochem J387"

Phrase: ":"

Phrase: "195 202,"

Phrase: "2005"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chan CB,"

Phrase: "MacPhail RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Sheu L,"

Phrase: "Wheeler M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gaisano HY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: ": -"

Phrase: "Cell hypertrophy in fa/fa rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020564:Hypertrophy [Pathologic Function]

Phrase: "is"

Phrase: "associated with basal glucose hypersensitivity"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0020517:Hypersensitivity [Pathologic Function]
   760   C0205112:Basal [Spatial Concept]
   760   C0520946:Hypersensitivity [Finding]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "reduced SNARE protein expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.351: Diabetes48 :997 1005,1999[Abstract] Gaisano HY, Ostenson C-G, Sheu L, Wheeler WB, Efendic S: Abnormal expression of pancreatic islet exocytotic SNARE proteins in GK rats is partially restored by phlorizin treatment. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "997 1005,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gaisano HY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: "Ostenson C-G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Sheu L,"

Phrase: "Wheeler WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582525:Wb [Quantitative Concept]

Phrase: "Efendic S"

Phrase: ":"

Phrase: "Abnormal expression of pancreatic islet exocytotic SNARE proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "is"

Phrase: "partially"

Phrase: "restored by phlorizin treatment."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0031562:Phlorizin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0885670:phlorizin [Organic Chemical,Pharmacologic Substance]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.352: Endocrinology143 :4218 4226,2002[Abstract/Free FullText] Sheu L, Pasyk EA, Ji J, Huang X, Gao X, Varoqueaux F, Brose N, Gaisano HY: Regulation of insulin exocytosis by Munc13-1. 

Phrase: "Endocrinology143"

Phrase: ":"

Phrase: "4218 4226,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sheu L,"

Phrase: "Pasyk EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Ji J,"

Phrase: "Huang X,"

Phrase: "Gao X,"

Phrase: "Varoqueaux F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Brose N,"

Phrase: "Gaisano HY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: ":"

Phrase: "Regulation of insulin exocytosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1159356:Regulation of Exocytosis [Cell Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by Munc13-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1427949:MUNC13-1 [Gene or Genome]
   861   C1421356:MUNC13 [Gene or Genome]
   861   C1436571:munc13 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1706404:MUNC13 [Gene or Genome]
Processing 00000000.tx.353: J Biol Chem278 :27556 27563,2003[Abstract/Free FullText] Ohara-Imaizumi M, Nishiwaki C, Kikuta T, Nagai S, Nakamichi Y, Nagamatsu S: TIRF imaging of docking and fusion of single insulin granule motion in primary rat pancreatic beta-cells: different behaviour of granule motion between normal and Goto-Kakizaki diabetic rat beta-cells. 

Phrase: "J Biol Chem278"

Phrase: ":"

Phrase: "27556 27563,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ohara-Imaizumi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Nishiwaki C,"

Phrase: "Kikuta T,"

Phrase: "Nagai S,"

Phrase: "Nakamichi Y,"

Phrase: "Nagamatsu S"

Phrase: ":"

Phrase: "TIRF"

Phrase: "imaging of docking"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0011923:Imaging [Diagnostic Procedure]
   790   C0079595:Imaging [Diagnostic Procedure]
   790   C0442632:docking [Manufactured Object]
   790   C1522290:Docking [Molecular Function]
   756 E C0330386:Dock [Plant]
   756 E C1704254:Image [Intellectual Product]
   756 E C1704922:Image [Entity]
   756 E C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "fusion of single insulin granule motion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332466:Fusion [Functional Concept]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "in primary rat pancreatic beta-cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   884   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   804   C0007634:Cells [Cell]
   804   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C2004068:Beta [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "different behaviour of granule motion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0004927:Behavior [Individual Behavior]
   760   C2707008:Behavior [Clinical Attribute]

Phrase: "between normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "Goto-Kakizaki diabetic rat beta-cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   799   C0007634:Cells [Cell]
   799   C0330390:Beta [Plant]
   799   C0439096:Beta [Intellectual Product]
   799   C2004068:Beta [Qualitative Concept]
   799   C3282337:Cells [Cell]
   793   C0030281:Beta cell [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.354: Biochem J381 :13 18,2004[Medline] Nagamatsu S, Nakamichi Y, Yamamura C, Matsushima S, Watanabe T, Ozawa S, Furukawa H, Ishida H: Decreased expression of t-SNARE, syntaxin-1 and SNAP-25 in pancreatic beta cells is involved in impaired insulin secretion from diabetic GK rat islets, restoration of decreased t-SNARE proteins improves impaired insulin secretion. 

Phrase: "Biochem J381"

Phrase: ":"

Phrase: "13 18,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nagamatsu S,"

Phrase: "Nakamichi Y,"

Phrase: "Yamamura C,"

Phrase: "Matsushima S,"

Phrase: "Watanabe T,"

Phrase: "Ozawa S,"

Phrase: "Furukawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ishida H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Decreased expression of t-SNARE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "syntaxin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0287682:Syntaxin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1 [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "SNAP-25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   846   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in pancreatic beta cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "involved in impaired insulin secretion"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1314939:Involved [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from diabetic GK rat islets,"

Phrase: "restoration of decreased t-SNARE proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449982:Restoration [Intellectual Product]

Phrase: "improves"

Phrase: "impaired insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.355: Diabetes48 :2367 2373,1999[Abstract] Nagamatsu S, Fujiwara T, Nakamichi Y, Watanabe T, Katahira H, Sawa H, Akagawa K: Expression and functional role of syntaxin 1/HPC-1 in pancreatic beta cells: syntaxin 1A, but not 1B, plays a negative role in regulatory insulin release pathway. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "2367 2373,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Nagamatsu S,"

Phrase: "Fujiwara T,"

Phrase: "Nakamichi Y,"

Phrase: "Watanabe T,"

Phrase: "Katahira H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Akagawa K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "functional role of syntaxin 1/HPC-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1705810:Functional Role [Conceptual Entity]
           Role
   748   C0035820:Role [Social Behavior]

Phrase: "in pancreatic beta cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "syntaxin 1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420498:SYNTAXIN 1A [Gene or Genome]
   861   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "but"

Phrase: "not 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a negative role in regulatory insulin release pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.356: J Biol Chem271 :1160 1165,1996[Abstract/Free FullText] Cherniske E, Carpenter TO, Klaiman C, Young E, Bregman J, Insogna K, Schultz RT, Pober BR: Multisystem study of 20 older adults with Williams syndrome. 

Phrase: "J Biol Chem271"

Phrase: ":"

Phrase: "1160 1165,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cherniske E,"

Phrase: "Carpenter TO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0336362:Carpenter [Professional or Occupational Group]

Phrase: "Klaiman C,"

Phrase: "Young E,"

Phrase: "Bregman J,"

Phrase: "Insogna K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Schultz RT,"

Phrase: "Pober BR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "Multisystem study of 20 older adults"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "with Williams syndrome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175702:Williams Syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.357: Am J Med Genet131 :255 264,2004 Osborne LR, Soder S, Shi XM, Pober B, Costa T, Scherer SW, Tsui LC: Hemizygous deletion of the syntaxin 1A gene in individuals with Williams syndrome. 

Phrase: "Am"

Phrase: "J Med Genet131"

Phrase: ":"

Phrase: "255 264,"

Phrase: "2004 Osborne LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0023617:LR [Geographic Area]
   827   C2986899:LR [Idea or Concept]

Phrase: "Soder S,"

Phrase: "Shi XM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421539:XM [Gene or Genome]

Phrase: "Pober B,"

Phrase: "Costa T,"

Phrase: "Scherer SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Tsui LC"

Phrase: ":"

Phrase: "Hemizygous deletion of the syntaxin 1A gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0017260:Gene Deletion [Genetic Function]
   774   C1442161:Gene Deletion [Cell or Molecular Dysfunction]
           Deletion
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with Williams syndrome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175702:Williams Syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.358: Am J Hum Genet61 :449 452,1997[Medline] Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on Diagnosis and Classification of Diabetes Mellitus. 

Phrase: "Am"

Phrase: "J Hum Genet61"

Phrase: ":"

Phrase: "449 452,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Expert Committee on the Diagnosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2699414:Committee [Group]

Phrase: "and"

Phrase: "Classification of Diabetes Mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]

Phrase: ":"

Phrase: "Report of the Expert Committee"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "on Diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "Classification of Diabetes Mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classification [Classification]
   770   C0008903:classification [Functional Concept]
   770   C0678229:classification [Occupational Activity]
Processing 00000000.tx.359: Diabetes Care22 (Suppl. 1) :S5 S19,1999 Ellis J, Talbot D, Dillon N, Grosveld F: Synthetic human beta-globin 5'HS2 constructs function as locus control regions only in multicopy transgene concatamers. 

Phrase: "Diabetes Care22"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S5 S19,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1335641:S19 [Gene or Genome]

Phrase: "1999 Ellis J,"

Phrase: "Talbot D,"

Phrase: "Dillon N,"

Phrase: "Grosveld F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Synthetic human beta-globin 5'HS2 constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C0598279:synthetic construct [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C2827421:Construct [Classification]

Phrase: "function as locus control regions only"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   833   C0525013:Regions, Locus Control [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0023953:locus control [Idea or Concept]
   783   C2587213:Control function [Functional Concept]
           Control
   753   C0031843:function [Physiologic Function]
   753   C0205171:Only [Quantitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1550141:Control [Substance]
   753   C1705273:Function [Intellectual Product]
   753   C1708726:Locus [Gene or Genome]
   753   C1720467:Only [Intellectual Product]
   753   C1882979:Control [Conceptual Entity]
   753   C3274648:Control [Qualitative Concept]
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "in multicopy transgene concatamers."
Processing 00000000.tx.360: EMBO J12 :127 134,1993[Abstract] Gerber SH, Sudhof TC: Molecular determinants of regulated exocytosis. 

Phrase: "EMBO J12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442782:J12 [Finding]

Phrase: ":"

Phrase: "127 134,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gerber SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Sudhof TC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041405:TC [Geographic Area]
   861   C1824670:TC [Gene or Genome]
   861   C3272447:TC [Gene or Genome]

Phrase: ":"

Phrase: "Molecular determinants of regulated exocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.361: Diabetes51 (Suppl. 1) :S3 S11,2002 Zhang W, Efanov A, Yang SN, Fired G, Kolare S, Brown H, Zaitsev S, Berggren PO, Meister B: Munc18 associates with syntaxin and serves as a negative regulator of exocytosis in the pancreatic -cell. 

Phrase: "Diabetes51"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S3 S11,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1419031:S11 [Gene or Genome]
   861   C1419700:S11 [Gene or Genome]
   861   C1419791:S11 [Gene or Genome]

Phrase: "2002 Zhang W,"

Phrase: "Efanov A,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "SN,"

Phrase: "Fired G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kolare S,"

Phrase: "Brown H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Zaitsev S,"

Phrase: "Berggren PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Meister B"

Phrase: ":"

Phrase: "Munc18"

Phrase: "associates with syntaxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0288881:Syntaxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "serves as a negative regulator of exocytosis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0015283:Exocytosis [Cell Function]
   748   C0182953:REGULATOR [Medical Device]
   748   C0205160:Negative [Qualitative Concept]
   748   C1513916:Negative [Finding]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "in the pancreatic -cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.362: J Biol Chem275 :41521 41527,2000[Abstract/Free FullText] Thurmond DC, Pessin JE: Molecular machinery involved in the insulin-regulated fusion of GLUT4-containing vesicles with the plasma membrane. 

Phrase: "J Biol Chem275"

Phrase: ":"

Phrase: "41521 41527,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Thurmond DC,"

Phrase: "Pessin JE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: ":"

Phrase: "Molecular machinery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337076:machinery [Manufactured Object]

Phrase: "involved in the insulin-regulated fusion of GLUT4-containing vesicles"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   741   C1326474:vesicle fusion [Cell Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332256:Containing [Functional Concept]
   739   C0332466:Fusion [Functional Concept]
   739   C0333262:VESICLES [Acquired Abnormality]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1293131:Fusion [Therapeutic or Preventive Procedure]
   739   C1314939:Involved [Functional Concept]
   739   C1420175:GLUT4 [Gene or Genome]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C2700400:Containing [Activity]
   739   C2982484:GLUT4 [Gene or Genome]
   706 E C1622418:vesicle [Cell Component]

Phrase: "with the plasma membrane."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.363: Mol Membr Biol18 :237 245,2001[Medline] Wiser O, Trus M, Hernandez A, Renstrom E, Barg S, Rorsman P, Atlas D: The voltage sensitive Lc-type calcium channel is functionally coupled to the exocytotic machinery. 

Phrase: "Mol Membr Biol18"

Phrase: ":"

Phrase: "237 245,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wiser O,"

Phrase: "Trus M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hernandez A,"

Phrase: "Renstrom E,"

Phrase: "Barg S,"

Phrase: "Rorsman P,"

Phrase: "Atlas D"

Phrase: ":"

Phrase: "The voltage sensitive Lc-type calcium channel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C1153440:voltage-sensitive calcium channel [Molecular Function]
   827   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0439799:Channel [Spatial Concept]
   799   C1706095:Channel [Conceptual Entity]
   799   C2936886:Calcium [Pharmacologic Substance]

Phrase: "is"

Phrase: "functionally"

Phrase: "coupled to the exocytotic machinery."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0337076:machinery [Manufactured Object]
   760   C1948027:Coupled [Functional Concept]
   726 E C0010222:couple [Family Group]
Processing 00000000.tx.364: Proc Natl Acad Sci U S A96 :248 253,1999[Abstract/Free FullText] Barg S, Ma X, Eliasson L, Galvanovskis J, Gopel SO, Obermuller S, Platzer J, Renstrom E, Trus M, Atlas D, Striessnig J, Rorsman P: Fast exocytosis with few Ca (2+) channels in insulin-secreting mouse pancreatic B cells. 

Phrase: "Proc Natl Acad Sci U S A96"

Phrase: ":"

Phrase: "248 253,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Barg S,"

Phrase: "Ma X,"

Phrase: "Eliasson L,"

Phrase: "Galvanovskis J,"

Phrase: "Gopel SO,"

Phrase: "Obermuller S,"

Phrase: "Platzer J,"

Phrase: "Renstrom E,"

Phrase: "Trus M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Atlas D,"

Phrase: "Striessnig J,"

Phrase: "Rorsman P"

Phrase: ":"

Phrase: "Fast exocytosis with few Ca (2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015283:Exocytosis [Cell Function]

Phrase: ")"

Phrase: "channels in insulin-secreting mouse pancreatic B cells."
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   807   C1522214:Mouse Insulin Secreting Cell [Cell]
           Mouse Insulin Cell
   800   C0030281:Pancreatic B Cells [Cell]
           Insulin-Secreting Cells
           Insulin Cell
   776   C1522109:Mouse B Cell [Cell]
   770   C0004561:B-Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0439799:Channel [Spatial Concept]
   744   C1327616:Secreting [Cell Function]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1706095:Channel [Conceptual Entity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.365: Biophys J81 :3308 3323,2001[Abstract/Free FullText] Cui N, Kang Y, He Y, Leung Y-M, Pasyk E, Xie H, Gao X, Sheu L, Hansen JB, Wahl P, Tsushima RG, Gaisano HY: H3 Domain of syntaxin 1A inhibits sulfonylurea receptor 1/KATP channels by its actions on nucleotide-binding folds-1 and -2. 

Phrase: "Biophys J81"

Phrase: ":"

Phrase: "3308 3323,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cui N,"

Phrase: "Kang Y,"

Phrase: "He Y,"

Phrase: "Leung Y-M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Pasyk E,"

Phrase: "Xie H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gao X,"

Phrase: "Sheu L,"

Phrase: "Hansen JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Wahl P,"

Phrase: "Tsushima RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Gaisano HY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: ":"

Phrase: "H3 Domain of syntaxin 1A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "sulfonylurea receptor 1/KATP channels by its actions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   767   C3272384:KATP-1 [Amino Acid, Peptide, or Protein]
   711   C0439799:Channel [Spatial Concept]
   711   C1706095:Channel [Conceptual Entity]

Phrase: "on nucleotide-binding folds-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0598153:nucleotide binding fold [Amino Acid Sequence]
   861   C1148916:nucleotide binding [Molecular Function]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C0332462:Fold [Spatial Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "and -"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.366: J Biol Chem279 :53259 53265,2004[Abstract/Free FullText] Wiser O, Bennett MK, Atlas D: Functional interaction of syntaxin and SNAP-25 with voltage-sensitive L- and N-type Ca2+ channels. 

Phrase: "J Biol Chem279"

Phrase: ":"

Phrase: "53259 53265,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wiser O,"

Phrase: "Bennett MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Atlas D"

Phrase: ":"

Phrase: "Functional interaction of syntaxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "SNAP-25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   846   C0075689:Synaptosomal-Associated Protein 25 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with voltage-sensitive L-"

Phrase: "and"

Phrase: "N-type Ca2+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.367: EMBO J15 :4100 4110,1996[Abstract] Michaelevski I, Chikvashvili D, Tsuk S, Singer-Lahat D, Kang Y, Linial M, Gaisano HY, Fili O, Lotan I: Direct interaction of t-SNAREs with the Kv2.1 channel: modal regulation of channel activation and inactivation gating. 

Phrase: "EMBO J15"

Phrase: ":"

Phrase: "4100 4110,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Michaelevski I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Chikvashvili D,"

Phrase: "Tsuk S,"

Phrase: "Singer-Lahat D,"

Phrase: "Kang Y,"

Phrase: "Linial M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gaisano HY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: "Fili O,"

Phrase: "Lotan I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Direct interaction of t-SNAREs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with the Kv2.1 channel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
   734   C1416554:KV2.1 [Gene or Genome]

Phrase: ":"

Phrase: "modal regulation of channel activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "inactivation gating."
Processing 00000000.tx.368: J Biol Chem278 :34320 34330,2003[Abstract/Free FullText] Tsuura Y, Ishida H, Okamoto Y, Kato S, Sakamoto K, Horie M, Ikeda H, Okada Y, Seino Y: Glucose sensitivity of ATP-sensitive K+ channels is impaired in beta-cells of the GK rat: a new genetic model of NIDDM. 

Phrase: "J Biol Chem278"

Phrase: ":"

Phrase: "34320 34330,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tsuura Y,"

Phrase: "Ishida H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Okamoto Y,"

Phrase: "Kato S,"

Phrase: "Sakamoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Horie M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ikeda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Okada Y,"

Phrase: "Seino Y"

Phrase: ":"

Phrase: "Glucose sensitivity of ATP-sensitive K+ channels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C1547341:Channel sensitivity [Idea or Concept]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "is"

Phrase: "impaired in beta-cells of the GK rat"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   742   C0007634:Cells [Cell]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0221099:Impaired [Functional Concept]
   742   C0330390:Beta [Plant]
   742   C0439096:Beta [Intellectual Product]
   742   C0684336:Impaired [Pathologic Function]
   742   C2004068:Beta [Qualitative Concept]
   742   C3282337:Cells [Cell]
   731   C0030281:Beta cell [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "a new genetic model of NIDDM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026343:Model, Genetic [Intellectual Product]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.369: Diabetes42 :1446 1453,1993[Abstract] Weimer RM, Jorgensen EM: Controversies in synaptic vesicle exocytosis. 

Phrase: "Diabetes42"

Phrase: ":"

Phrase: "1446 1453,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Weimer RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Jorgensen EM"

Phrase: ":"

Phrase: "Controversies in synaptic vesicle exocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680243:controversies [Social Behavior]
Processing 00000000.tx.370: J Cell Sci116 :3661 3666,2003[Free FullText] Dulubova I, Sugita S, Hill S, Hosaka M, Fernandez I, Sudhof TC, Rizo J: A conformational switch in syntaxin during exocytosis, a role of Munc18. 

Phrase: "J Cell Sci116"

Phrase: ":"

Phrase: "3661 3666,"

Phrase: "2003"

Phrase: "[Free FullText"

Phrase: "] Dulubova I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sugita S,"

Phrase: "Hill S,"

Phrase: "Hosaka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fernandez I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sudhof TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041405:TC [Geographic Area]
   861   C1824670:TC [Gene or Genome]
   861   C3272447:TC [Gene or Genome]

Phrase: "Rizo J"

Phrase: ":"

Phrase: "A conformational switch in syntaxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707719:Switch [Manufactured Object]

Phrase: "during exocytosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "a role of Munc18."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.371: EMBO J18 :4372 4382,1999[Abstract/Free FullText] Lane DA, Grant PJ: Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. 

Phrase: "EMBO J18"

Phrase: ":"

Phrase: "4372 4382,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lane DA,"

Phrase: "Grant PJ"

Phrase: ":"

Phrase: "Role of hemostatic gene polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in venous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042449:Venous [Body Part, Organ, or Organ Component]
  1000   C0348013:Venous [Spatial Concept]

Phrase: "and"

Phrase: "arterial thrombotic disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   913   C0852949:Arterial disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.372: Blood95 :1517 1532,2000[Free FullText] Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S, Manzato F, Mazzucco A, Bernardi F, Corrocher R: Polymorphisms in the factor VII gene. 

Phrase: "Blood95"

Phrase: ":"

Phrase: "1517 1532,"

Phrase: "2000"

Phrase: "[Free FullText"

Phrase: "] Girelli D,"

Phrase: "Russo C,"

Phrase: "Ferraresi P,"

Phrase: "Olivieri O,"

Phrase: "Pinotti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Friso S,"

Phrase: "Manzato F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mazzucco A,"

Phrase: "Bernardi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Corrocher R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Polymorphisms in the factor VII gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0678951:gene polymorphisms [Genetic Function]
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.373: N Engl J Med343 :774 780,2000[Abstract/Free FullText] Bozzini C, Girelli D, Bernardi F, Ferraresi P, Olivieri O, Pinotti M, Martinelli N, Manzato F, Friso S, Villa G, Pizzolo F, Beltrame F, Corrocher R: Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis. 

Phrase: "N Engl J Med343"

Phrase: ":"

Phrase: "774 780,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bozzini C,"

Phrase: "Girelli D,"

Phrase: "Bernardi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ferraresi P,"

Phrase: "Olivieri O,"

Phrase: "Pinotti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Martinelli N,"

Phrase: "Manzato F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Friso S,"

Phrase: "Villa G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pizzolo F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Beltrame F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Corrocher R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Influence of polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0021399:influential [Idea or Concept]

Phrase: "in the factor VII gene promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "on activated factor VII levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   906   C0427593:Factor VII level [Laboratory or Test Result]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756   C0015505:Factor VII, Activated [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and on the risk of myocardial infarction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0027051:Myocardial Infarction [Disease or Syndrome]
   778   C0428953:MYOCARDIAL INFARCTION [Finding]
   778   C2926063:Myocardial infarction [Clinical Attribute]
   748   C0021308:Infarction [Pathologic Function]
   748   C0027061:Myocardial [Tissue]
   748   C0035647:Risk [Qualitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1522564:Myocardial [Spatial Concept]

Phrase: "in advanced coronary atherosclerosis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0010054:Coronary Atherosclerosis [Disease or Syndrome]
   901   C2733225:Coronary atherosclerosis [Disease or Syndrome]
   827   C0004153:Atherosclerosis [Disease or Syndrome]
   827   C0018787:coronary [Body Part, Organ, or Organ Component]
   755 E C0333482:Atherosclerotic [Functional Concept]
Processing 00000000.tx.374: Thromb Haemost92 :541 549,2004[Medline] Tsunoda K, Sanke T, Nakagawa T, Furuta H, Nanjo K: Single nucleotide polymorphism (D68D, T to C) in the syntaxin 1A gene correlates to age at onset and insulin requirement in type II diabetic patients. 

Phrase: "Thromb Haemost92"

Phrase: ":"

Phrase: "541 549,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tsunoda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sanke T,"

Phrase: "Nakagawa T,"

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nanjo K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Single nucleotide polymorphism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(D68D,"

Phrase: "T to C) in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2603360:T' [Clinical Attribute]

Phrase: "the syntaxin 1A gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0287683:Syntaxin-1A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420498:SYNTAXIN 1A [Gene or Genome]

Phrase: "correlates to age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0206132:Onset Age [Quantitative Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "insulin requirement in type II diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.375: Diabetologia44 :2092 2097,2001[Medline] Honer WG, Falkai P, Bayer TA, Xie J, Hu L, Li H-Y, Arango V, Mann JJ, Dwork AJ, Trimble W S: Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. 

Phrase: "Diabetologia44"

Phrase: ":"

Phrase: "2092 2097,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Honer WG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]

Phrase: "Falkai P,"

Phrase: "Bayer TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Xie J,"

Phrase: "Hu L,"

Phrase: "Li H-Y,"

Phrase: "Arango V,"

Phrase: "Mann JJ,"

Phrase: "Dwork AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Trimble W S"

Phrase: ":"

Phrase: "Abnormalities of SNARE mechanism proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   756   C0311448:abnormal proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C1704258:Abnormality [Finding]

Phrase: "in anterior frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C0205123:Frontal [Spatial Concept]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "in severe mental illness."
Meta Candidates (Total=17; Excluded=13; Pruned=0; Remaining=4)
   901   C0004936:Mental illness [Mental or Behavioral Dysfunction]
   829 E C0025360:Mentally Ill [Patient or Disabled Group]
   827   C0205082:Severe [Qualitative Concept]
   827   C0221423:Illness [Finding]
   827   C0229992:mental [Mental Process]
   755 E C0231218:Ill [Sign or Symptom]
   755 E C0332271:worse [Qualitative Concept]
   755 E C1279889:Worse [Finding]
   755 E C1457868:Worse [Qualitative Concept]
   755 E C1522166:Worst [Qualitative Concept]
   743 E C0229993:Psychic [Functional Concept]
   727 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   727 E C0042241:DIAPHRAGM [Medical Device]
   727 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   727 E C1705367:Diaphragm [Medical Device]
   716 E C0086045:mindfulness [Mental Process]
   716 E C3542996:Mindfulness [Mental Process]
Processing 00000000.tx.376: Cereb Cortex12 :349 356,2002[Abstract/Free FullText]

Phrase: "Cereb Cortex12"

Phrase: ":"

Phrase: "349 356,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

